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ABSTRACT 
My graduate research has focused on separation science and bioanalytical analysis, which 
emphasized in method development. It includes three major areas: enantiomeric separations 
using high performance liquid chromatography (HPLC), Super/subcritical fluid 
chromatography (SFC), and capillary electrophoresis (CE); drug-protein binding behavior 
studies using CE; and carbohydrate analysis using liquid chromatograph-electrospray 
ionization mass spectrometry (LC-ESI-MS). 
Enantiomeric separations continue to be extremely important in the pharmaceutical industry. 
An in-depth evaluation of the enantiomeric separation capabilities of macrocyclic 
glycopeptides CSPs with SFC mobile phases was investigated using a set of over 100 chiral 
compounds. It was found that the macrocyclic based CSPs were able to separate enantiomers 
of various compounds with different polarities and functionalities. Seventy percent of all 
separations were achieved in less than 4 min due to the high flow rate (4.0 ml/min) that can 
be used in SFC. 
Drug-protein binding is an important process in determining the activity and fate of a drug 
once it enters the body. Two drug/protein systems have been studied using frontal analysis 
CE method. More sensitive fluorescence detection was introduced in this assay, which 
overcame the problem of low sensitivity that is common when using UV detection for drug-
protein studies. In addition, the first usage of an argon ion laser with 257 nm beam coupled 
vii 
with CCD camera as a frontal analysis detection method enabled the simultaneous 
observation of drug fluorescence as well as the protein fluorescence. 
LC-ESI-MS was used for the separation and characterization of underivatized 
oligosaccharide mixtures. With the limits of detection as low as 50 picograms, all individual 
components of oligosaccharide mixtures (up to 11 glucose-units long) were baseline resolved 
on a Cyclobond I 2000 column and detected using ESI-MS. This system is characterized by 
high chromatographic resolution, high column stability, and high sensitivity. In addition, this 
method showed potential usefulness for the sensitive and quick analysis of hydrolysis 
products of polysaccharides, and for trace level analysis of individual oligosaccharides or 
oligosaccharide isomers from biological systems. 
1 
CHAPTER 1 
GENERAL INTRODUCTION AND LITERATURE REVIEW 
1.1. GENERAL INTRODUCTION 
Enantiomeric separations and analysis have become increasingly important in many areas of 
science and technology. In pharmaceutical and medicinal science, drug chirality is extremely 
important because of variations in enantiomeric uptake, disposition, elimination and overall 
effect. Guidelines, originally set forth by the U.S. Food and Drug Administration, require that 
individual stereoisomers must be thoroughly evaluated and continuously assayed throughout 
development and, ultimately, production. The impetus for these guidelines was provided by 
advances in LC enantiomeric separations in the 1980's that permitted facile pharmacokinetic 
and pharmacodynamic studies of drug antipodes (as well as product assays) for the first time. 
Subsequently, there has been a dramatically increase in the number of drugs marketed as 
single isomers. Chiral drugs comprised nearly a $146 billion market in 2001 (compared to 
$123 billion in 2000, an increase of 18.7%), of which approximately 36% were sold as single 
enantiomers (compared to approximately 30% in 2000, a 20% increase). These numbers will 
continue to increase in the future. In addition, the top two drugs in terms of global sales— 
Lipitor and Zocor, with combined sales of almost $14 billion in 2002—are all single-
enantiomer small-molecule drugs. As a result, there has been a substantial increase in 
research and development related to chirality over the last twenty years. Besides traditional 
crystallization techniques, promising asymmetric synthetic methods, newly introduced 
biotransformation studies, and powerful enantiomeric separation approaches continue to be 
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refined as effective procedures to obtain single enantiomers. To analyze the enantiomeric 
distribution of pharmacologically and biologically active compounds, various analytical scale 
separation techniques have been used including high performance liquid chromatography 
(HPLC), supercritical fluid chromatography (SFC), capillary electrophoresis (CE), capillary 
electrochromatography (CEC), gas chromatography (GC). Among these aforementioned 
separation techniques, HPLC is still one of the most widely used enantiomeric separation 
techniques both analytically and preparatively. In this dissertation, besides the HPLC 
technique, I will mainly focus on the investigation of enantiomeric separations using SFC 
and CE. 
The concept of utilizing macrocyclic glycopeptides as chiral stationary phases for HPLC 
separations was first introduced by Armstrong et al. in 1994. Since then, the macrocyclic 
glycopeptide CSPs, as multi-modal CSPs, have proven to have broad enantioselectivities for 
most types of neutral, acidic, and basic compounds including amino acids and peptides, 
derivatized amino acids, alcohols, sulfoxides, etc. Four types of glycopeptide-based CSPs are 
now available commercially. They are vancomycin (Chirobiotic V), ristocetin A (Chirobiotic 
R), teicoplanin (Chirobiotic T), and teicoplanin aglycon (with sugar moieties removed from 
teicoplanin, Chirobiotic TAG). They can be used effectively not only in the reversed-phase 
and polar organic phase modes, but also in the normal phase mode without any irreversible 
change in enantioselectivity or denaturation. However, the enantioselectivity usually is 
different in each mode. 
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Recently, supercritical fluid chromatography has become a promising chiral separation 
technique that is increasingly used in industrial applications due to its fast separation speed 
and suitability for preparative analysis. The goal of this part of the research is to expand the 
applications of macrocyclic glycopeptide CSPs with SFC mobile phases. In other words, our 
goal is not only to show how to correlate a HPLC separation conditions to SFC conditions 
and how to optimize separations in SFC, but also to demonstrate the possible groups of chiral 
compounds that can be successfully separated with SFC mobile phase on these macrocyclic 
glycopeptide CSPs. 
Drug-protein binding is an important process in determining the activity and fate of a drug 
once it enters the body. In biological system, unbound drugs in plasma can easily reach the 
target organ, whereas bound drugs are hard to pass through the blood capillary wall. 
Therefore, understanding the binding behavior between plasma protein and drugs is essential 
for drug development because the concentration of unbound drugs shows a better correlation 
to the pharmacological activity than the total drug concentration. In addition, many 
pharmacokinetic properties such as hepatic metabolism rate, renal excretion rate, 
biomembrane partition rate and steady-state distribution volume are a function of unbound 
drug fraction (unbound/bound concentration ratio). Therefore, better understanding drug-
protein binding is also essential to pharmacokinetic study and therapeutic dosing regimen. 
Currently, capillary electrophoresis (CE) has been proven a new attractive analytical tool for 
examining the nature and strength of biological interactions between drug and protein. 
Various CE methods exist and capillary electrophoresis-frontal analysis (FA) has been 
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focused on the interactions of drugs with plasma proteins. The goal of this part of the 
research is to expand the potential usefulness of CE-FA applications by coupling with the 
more sensitive laser induced fluorescence detection. In addition, we first introduced the use 
of an UV laser (excitation at 257 nm) coupled with CCD camera as a FA detection method. 
Not only can this detection method overcome the low sensitivity problem commonly 
encountered when using UV detection for drug-protein studies, but also it enables 
simultaneous observation of drug fluorescence as well as protein fluorescence. 
The separation and characterization of underivatized oligosaccharides have continued to gain 
attention in recent years due to their ubiquity in nature and their significant roles and uses in 
industry, consumer products and biology where they are crucial for the development, growth, 
function or survival of an organism. Identification of the carbohydrate substituents on 
glycoproteins and glycopeptides (which affect or control their function) is an important and 
often difficult endeavor. A variety of chromatographic methods have been used to separate 
saccharides and oligosaccharides. However, most of the columns used have problems, 
particularly in terms of column stability, lifetime and separation reproducibility. In addition, 
most of the techniques involve an introduction of a derivatization reagent in order to enhance 
detectability during chromatographic analysis, and most derivatization techniques require 
tedious procedures, and often suffer from poor reproducibility. Our goal was to establish a 
highly selective and sensitive method to separate and characterize oligosaccharide mixtures 
without further derivatization by using high performance liquid chromatography coupled 
with electrospray ionization mass spectrometry technique. In this work, a native beta-
cyclodextrin stationary phase (Cylcobond I 2000) was used to separate a variety of related 
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oligosaccharides using MS compatible mobile phase. With limits of detection as low as 50 
picograms, all individual components of oligosaccharide mixtures (up to 11 glucose-units 
long) were baseline resolved on a Cyclobond I 2000 column and detected using ESI-MS. 
Low flow rates and narrow ID columns increase the ESI-MS sensitivity significantly. The 
method showed potential usefulness for the sensitive and quick analysis of hydrolysis 
products of polysaccharides, and for trace level analysis of individual oligosaccharides or 
oligosaccharide isomers from biological systems. 
1.2. DISSERTATION ORGANIZATION 
This dissertation is presented with a general introduction and literature review plus three 
parts containing a total of five scientific papers. Finally there is a general conclusion that 
summarizes the work. The focus of the first part is on method development and mechanism 
studies for enantiomeric separations using two different separation techniques: 
super/subcritical fluid chromatography and capillary electrophoresis. This part includes three 
papers, which are listed as Chapters 2, 3, and 4, respectively. Basically it involves an in-
depth evaluation of the enantiomeric separation capabilities of macrocyclic glycopeptide 
CSPs with SFC mobile phases using a set of 111 chiral compounds in one study, and a 
unique series of chiral substituted dihydrofurocoumarin derivatives using both SFC and CE 
in the other studies. All of these applications were successful and mechanistic considerations 
of the enantiomeric separations were examined as well. The second part of this dissertation 
(Chapter 5) described the successful binding studies between drugs and proteins using frontal 
analysis-capillary electrophoresis coupled with laser induced fluorescence detection. The last 
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part (Chapter 6) involves the separation and characterization of underivatized 
oligosaccharides using LC and LC-ESI-MS. 
1.3. ENANTIOMERIC SEPARATION LITERATURE REVIEW 
A review paper published in Journal of liquid chromatography and related technologies1 
Ying Liu, Andrew W. Lantz, and Daniel W. Armstrong 
1. Introduction 
Enantiomeric separations and analysis have become increasingly important in many areas of 
science and technology. In pharmaceutical and medicinal science, drug chirality is extremely 
important because of variations in enantiomeric uptake, disposition, elimination and overall 
effect (1). Guidelines, originally set forth by the U.S. Food and Drug Administration, require 
that individual stereoisomers must be thoroughly evaluated and continuously assayed 
throughout development and, ultimately, productions (2). The impetus for these guidelines 
was provided by advances in LC enantiomeric separations in the 1980's that permitted facile 
pharmacokinetic and pharmacodynamic studies of drug antipodes (as well as product assays) 
for the first time (1-4). Subsequently, there has been a dramatically increase in the number of 
drugs marketed as single-isomers. Chiral drugs comprised nearly a $146 billion market in 
2001 (compared to $123 billion in 2000, an increase of 18.7%), of which approximately 36% 
were sold as single enantiomers (compared to approximately 30% in 2000, a 20% increase) 
(5). These numbers will continue to increase in the future. In the environmental area, many 
chiral pesticides and herbicides also have enantioselective effects and biodégradation rates 
(6,7). In addition, food and beverage companies have increasing interests in the analysis of 
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enantiomers that can affect flavor, nutrition and fragrance (8,9). As a result, there has been a 
substantial increase in research and development related to chirality over the last twenty 
years (10-19). Besides traditional crystallization techniques, promising asymmetric synthetic 
methods, newly introduced biotransformation studies, and powerful enantiomeric separation 
approaches continue to be refined as effective procedures to obtain single enantiomers. To 
analyze the enantiomeric distribution of pharmacologically and biologically active 
compounds, various analytical scale separation techniques have been used including high 
performance liquid chromatography (HPLC), supercritical fluid chromatography (SFC), 
capillary electrophoresis (CE), capillary electrochromatography (CEC), gas chromatography 
(GC), and thin layer chromatography (TLC). Each separation technique has unique and often 
complementary properties. This overview will not consider enantiomeric separations using 
GC and TLC, but will examine the other aforementioned chromatographic separation 
techniques. We will focus on the evolution of chiral selectors, their use and overall 
effectiveness. Representative applications of each method are presented as well. 
2. Liquid Chromatography 
In the past two decades, high-performance liquid chromatography used for enantiomeric 
separations has developed dramatically. It has become the most widespread and useful 
enantiomeric separation technique dealing with drugs, agrochemicals, natural products, etc. 
The use of HPLC as an enantiomeric separation technique can be used not only for the 
determination of enantiomeric purity, but also for obtaining stereoisomers in a large scale. 
The first two chiral stationary phases (CSPs) to become available commercially were the 3,5-
dinitrobenzoyl phenylglycine CSP by Regis Technologies (20) and the (3- cyclodextrin CSP 
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by Advanced Separation Technologies (21). Since their inception, both types of CSPs have 
been mimicked, copied, and reproduced by companies and individuals worldwide. These 
initial CSPs were followed by two protein-based CSPs that utilized bovine serum albumin 
(BSA) (22) and cti-acid glycoprotein (23) as chiral selectors. Now numerous chiral stationary 
phases have been prepared and over 200 CSPs have been commercialized. The CSPs usually 
consist of either small chiral molecules or chiral polymers immobilized onto a support such 
as silica gel. There are several ways to classify chiral selectors. In this overview, the chiral 
selectors will be discussed as they are classified in Table 1. Table 1 also indicates the 
separation modes in which these chiral selectors have been successfully utilized. 
Chiral selectors LC SFC CE 
Macrocyclic 
Cyclodextrins and derivatives • • • 
Glycopeptides (macrocyclic antibiotics) • • • 
Chiral crown ether • • 
Polymeric 
Proteins • • 
Native and Derivatized carbohydrates • • • 
Synthetic polymers • • • 
Tt-Complex • • 
Ligand exchange • 
Chiral surfactants • 
Miscellaneous and hybrid types • • • 
Table 1. Classes of chiral selectors used in liquid chromatography, supercritical fluid 
chromatography and capillary electrophoresis. 
MACROCYCLIC CHIRAL SELECTORS 
Macrocyclic chiral selectors have had a great impact on modern enantiomeric separations. 
Three main types of chiral selectors belong to this particular group. They are cyclodextrins 
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and their derivatives, glycopeptides, and chiral crown ethers. Altogether, this particular group 
of macrocyclic compounds is responsible for over 90 % of GC and CE enantiomeric 
separations, (Derivatized cyclodextrins dominate chiral GC, while the cyclodextrins and 
glycopeptides are the most useful chiral selectors for CE enantioseparations). In HPLC, 
however, the field is more divided among several classes of chiral selectors. Cyclodextrin 
and macrocyclic glycopeptide CSPs are multi-modal. That is, they can be used in the 
reversed-phase and polar organic separation modes as well as the normal phase mode. 
However, chiral crown ether CSPs are mainly used in the reversed-phase mode. 
Cyclodextrins and their Derivatives 
Cyclodextrins (CDs) are cyclic oligosaccharides produced naturally from starch by the 
enzyme cyclodextrin transglycosylase. Cyclodextrins containing six, seven, and eight glucose 
units linked via a (1-4) glycosidic linkage are most common, and they are called a-
cyclodextrin, /^-cyclodextrin, and ^-cyclodextrin, respectively (Figure la). Native CD is a 
hollow, truncated cone having a cavity with primary hydroxyl groups (C(6) position) around 
its narrower rim and, secondary hydroxyl groups (C(2) and C(3) positions) on the opposite, 
more open rim (3,4,21,28). The interior cavity consists of the glycosidic bonds and carbon 
skeleton. Hence, the inner cavity of CDs is hydrophobic, while the outer surface is 
hydrophilic in nature (Figure lb). Because the size of the internal cavity of the cyclodextrins 
increases with the increase of the number of glucose units involved, this implies that different 
sized cyclodextrins will accommodate analyte molecules differently. 
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Hydrophobic Cavity Secondary hydroxyl rim 
H 
HO 
Primary hydroxyl rim 
(a) (b) 
Figure 1. (a) Structure of y9-cyclodextrin (b) Simplified depiction of the toroidal shape of a 
cyclodextrin molecule. 
As mentioned previously, cyclodextrin bonded stationary phases developed by Armstrong et 
al. were the first commercially available reversed-phase chiral stationary phases. Since then, 
a wide variety of derivatized cyclodextrin CSPs have been developed and used (24-28). The 
different moieties used to functionalize cyclodextrins can greatly alter their 
enantioselectivity. Figure 2 shows different derivatives of cyclodextrins that have became 
successful CSPs. Although methylated and acetylated cyclodextrin CSPs (i.e. Cyclobond I 
DM, and Cyclobond I AC), along with native cyclodextrin CSPs, can provide good 
enantioselectivity in certain cases, the most widely used and effective cyclodextrin CSPs are 
the hydroxypropyl-^-cyclodextrin CSP (Cyclobond I RSP) and aromatic derivatized 
cyclodextrin CSPs, such as dimethylphenylcarbamate-/?-cyclodextrin (Cyclobond I DMP) 
and naphthylethylcarbamate-/?-cyclodextrin (Cyclobond IRN or SN depending on the 
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¥ OR 
OK H OR 
R Derivative Cyclobond I 2000 
Suffix 
—OCH3 
—COCH3 
—CH2CHCH3 
OH 
° ch3 
C N C^—& /) 
H H ^ // 
\ ) 
N /=< 
C hH / 
xch3 
dimethylated 
acetylated 
hydroxypropyl 
ether 
naphthylethyl 
carbamate) 
3,5-
dimethylphenyl 
carbamate 
DM 
AC 
SP or RSP 
RNor SN 
DMP 
Figure 2. Different Derivatives of Cyclodextrins available as Chiral Stationary Phases (CSPs) 
configuration). CSPs based on cyclodextrins and their derivatives are good for most 
reversed-phase and polar organic mode separations. So far, a wide variety of compounds, 
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including /^-blockers, alkaloids, carboxylic acids, neutral molecules, etc, have been 
successfully separated on these CSPs (28). However, it should be pointed out that the 
Cyclobond I RN and SN CSPs also work well in normal phase mode because the aromatic 
functionalized cyclodextrins can be used as ^-complex CSPs (n-electron donor). Any analyte 
that is a ^-electron acceptor is capable of being resolved on these CSPs (28). 
m 
(a) (b) 
Figure 3. Simplified schematic illustrating two different enantioselective retention mechanisms for 
the native [3-cyclodextrin/propranolol system, (a) In the reversed-phase mode, retention is mainly due 
to hydrophobic inclusion complexation, while enantioselectivity also requires hydrogen bonding and 
steric interactions at the mouth of the cyclodextrin cavity, (b) The polar-organic mode where 
acetonitrile occupies the hydrophobic cavity and the analyte is retained via a combination of 
hydrogen bonding and dipolar interactions at the mouth of the cyclodextrin. Steric interactions also 
can contribute to chiral recognition. (From Ref. 30) 
There are two different enantioselective retention mechanisms possible with cyclodextrin-
based CSPs (Figure 3). In case A, in aqueous and hydro-organic solutions (reversed-phase 
mobile phases), the retention is mainly due to hydrophobic inclusion complexation. 
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Enantioselectivity also requires hydrogen bonding and steric interactions at the mouth of the 
cyclodextrin cavity. In order to obtain the best enantiomeric separations, the hydrophobic 
group of the chiral analyte has to have comparable size with the cyclodextrin hydrophobic 
cavity. Structural features such as an aromatic ring system in the a or j3 position to the 
stereogenic center, at least one hydrogen-bonding group near the stereogenic center, and a 
second n system (e.g. a carbonyl group, imine, etc) somewhere on the molecule are also 
beneficial to reversed-phase enantioseparations (29). In case B, the polar-organic mode, the 
presence of nonpolar solvents (such as acetonitrile) suppress or prevent the formation of an 
inclusion complex between the trace levels of the sample and the cyclodextrin. It is thought 
that the analyte is retained via a combination of hydrogen bonding and dipole-dipole 
interactions at the mouth of the cyclodextrin (30). Steric interactions also can contribute to 
chiral recognition. The polar organic mode of enantiomeric separations seems to prefer more 
polar molecules. Structural features that are necessary for chiral recognition and enantiomeric 
separation include a minimum of two separate hydrogen-bonding groups (one of which 
should be on or near the stereogenic center), and a bulky moiety close to the stereogenic 
center (31,32). Cyclodextrin-based CSPs have and will continue to play an important role in 
the field of enantiomeric separations (19,24-34). 
Glycopeptide Antibiotics 
Macrocyclic glycopeptide CSPs are among the newest and fastest developing chiral 
stationary phases. Four types of glycopeptide-based CSPs are now available commercially. 
They are vancomycin (Chirobiotic V), ristocetin A (Chirobiotic R), teicoplanin (Chirobiotic 
T), and teicoplanin aglycon (with sugar moieties removed from teicoplanin, Chirobiotic 
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TAG). Their structures and physicochemical characteristics are shown in Figure 4 and Table 
2, respectively (35). 
(a) (b) 
N 
•Mi 
CHI 
OH 
mj 
(c) (d) 
NH, 
Figure 4. Structures of the macrocyclic glycopeptides. (a) Vancomycin (b) Ristocetin A (c) 
Teicoplanin (d) Teicoplanin aglycon (From Ref. 44.) 
All the related glycopeptide antibiotic compounds consist of an aglycon "basket" and 
pendent carbohydrate moieties (except for the teicoplanin aglycon). The aglycon portion of 
these related compounds is made up of 3 or 4 macrocyclic rings, which contain ether, amide 
and peptide linkages. In addition, one or more carbohydrate moieties are attached at various 
locations to each of the aglycons. Vancomycin only has a single attached disaccharide 
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consisting of D-glucose and vancosamine, while teicoplanin has three attached 
monosaccharides, one of which has an associated nine-carbon hydrophobic "tail". Ristocetin 
A has a pendant tetrasaccharide and two monosaccharide moieties. Generally speaking, the 
aglycon basket is semi-rigid and can flex somewhat, but the carbohydrate moieties are 
relatively mobile and free to change orientation. In addition, the aglycon portion has an 
amine moiety, a carboxylic acid moiety (esterified in ristocetin A) and phenolic moieties. 
These ionizable groups, along with the attached amino-saccharides, control the charge of 
Table 2. Comparison of the Physicochemical Properties of Vancomycin, Ristocetin A, Teicoplanin 
and Teicoplanin aglycon Macrocyclic Antibiotics 
Characteristics Vancomycin Ristocetin A Teicoplanin Teicoplanin 
aglycon 
Molecular weight 1449 2066" 1877" 1197 
no. of stereogenic centers 18 38 20 8 
Produced from fermentation Streptomyces Nocardia Actinoplanes Synthesis 
product of orientalis Lurida teicomyceticus from 
teicoplanin 
no. of macrocycles 3 4 4 4 
no. of monomer sugar 2 6 3 0 
moieties 
hydrophobic tail 0 0 1 0 
no. of OH groupsc 9(3) 21(4) 14(4) 7(6) 
no. of amine groups 2 2 1 1 
no. of carboxylic acid groups 1 0 1 1 
no. of amido groups 7 6 8 6 
no. of aromatic groups^ 5(2) 7(0) 7(2) 7(2) 
methyl esters 0 1 0 0 
pf 7.2 7.5 4.2, 6.5 N/A 
relative stability 1 -2 weeks 3-4 weeks 2-3 weeks N/A 
aggregations! behavio/ no no yes no 
" Ristocetin A is a mixture of two structurally similar compounds differing by the number of carbons in one of 
its sugar moieties. The mixture used in this study is > 90 % ristocetin A.6 Teicoplanin is a mixture of five 
closely related compounds differing by the number of carbons (i.e., (C10-C11) and substituted groups attached 
to the fatty acid side chain terminating off the amino sugar (see Figure 4).r The number in parentheses 
corresponds to phenolic moieties. d The number in parentheses corresponds to the number of chlorinated 
substitueras attached to the aglycon baskets. The p/ values were determined using dilute solutions of the 
respective macrocyclic antibiotics in 0.1 M phosphate buffer. Methanol was used as the EOF marker/This is 
the aggregation behavior under the buffered conditions. (Revised From Ref. 35) 
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these glycopeptides and are thought to play an important role in enantioselective recognition 
of chiral analytes. For example, the aglycon "basket" provides hydrophobic sites, hydrogen-
bonding sites, dipolar sites, and ^-interaction sites. 
The concept of utilizing macrocyclic glycopeptides as chiral stationary phases for HPLC 
separations was first introduced by Armstrong, et al. in 1994 (36). Since then, the 
macrocyclic glycopeptide CSPs, as multi-modal CSPs, have proven to have broad 
enantioselectivities for most types of neutral, acidic, and basic compounds including amino 
acids and peptides, derivatized amino acids, alcohols, sulfoxides, etc (15,36-44). They can be 
used effectively not only in the reversed-phase and polar organic phase modes, but also in the 
normal phase mode without any irreversible change in enantioselectivity or denaturation. 
However, the enantioselectivity usually is different in each mode. They can be used in 
preparative scale separations as well. 
One of the greatest advantages of the glycopeptide CSPs is that native, underivatized amino 
acids can be effectively separated on the teicoplanin-based CSPs (41-43). The separations 
can simply be done with an alcohol-water mobile phase (Figure 5c) in which ethanol is the 
preferred organic modifier. In addition, somewhat different selectivities can also be obtained 
with the ristocetin A CSP. 
Besides the unique selectivity characteristics for each of these four CSPs, they have also been 
found to offer "complementary" separations (37,45). That means if a partial separation is 
obtained on one CSP, in most cases, a baseline separation can be obtained on one of the other 
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related glycopeptide CSPs without dramatically changing the separation conditions. The 
reason for this is thought to be due to the subtle differences in diastereomeric binding sites 
between the four phases. 
Figure 5. Structural diagrams showing the chiral selector and interaction for the (a) ligand-exchange, 
(b) Chiral crown ether, and (c) teicoplanin chiral stationary phases. (From Ref. 18) 
Chiral Crown Ethers 
Cram and co-workers first introduced chiral crown ether CSPs (46,47). They attached the 
synthetic chiral crown ether to the polymeric support and used it to separate amino acid 
enantiomers chromatographically. This method works only for primary amines and amino 
acids, and the separations must be performed with an acidic mobile phase. This is because 
the primary amine functional group must be in the ammonium ion form, which is necessary 
for inclusion complex formation with the chiral crown ether (Figure 5b). Ions such as 
potassium that are comparable in size to the ammonium ion should be excluded from the 
mobile phase because these species compete with ammonium ion for inclusion in the crown 
ether. However, in certain cases, some inorganic modifiers, such as ammonium acetate, 
(a) (b) (c) 
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potassium chloride, etc, were deliberately added to the aqueous mobile phase in order to 
reduce the retention in resolving some primary amino compounds (48,49). 
In general, perchloric acid has been widely and successfully used as an acidic modifier in the 
resolution of primary amino compounds (50-52). However, the addition of perchloric acid to 
the mobile phase can cause problems especially when performing preparative separations 
because evaporating the solvent can leave an explosive mixture of perchlorate and organic 
chemicals. 
So far, several chiral crown ether CSPs have been developed. They can be chiral crown 
ethers incorporating a chiral binaphthyl unit (46-48, 50), or chiral crown ethers based on 
tartaric acid units (53, 54). The performances of all these CSPs were found to be quite 
dependent on the composition of mobile phases. The structural characteristics of selected 
crown ether-based CSPs, analyte characteristics, and several separation factors were recently 
reviewed by Hyun (55). Among the various factors, the column temperature and the 
inorganic modifier in the mobile phase equally influence the chiral separations for the 
selected crown ether-based CSPs. In contrast, the organic and acidic modifier used in the 
aqueous mobile phase caused different behaviors in the enantioseparations. 
Although a primary amino group had been believed to be the essential functionality of 
analytes resolvable on crown ether-based CSPs, recently, Steffeck, et al. first reported the 
enantiomeric separation of racemic secondary amines including /^-blockers on (+)- or (-)-(18-
crown-6)-2,3,11,12-tetracarboxylic acid CSP (56). It is thought that the separation 
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mechanism is based on the secondary amine forming a complex that includes crown ether 
coordination and electrostatic interaction of the positively charged amine with a carboxylate 
anion of immobilized crown ether (56). These findings are expected to further expand the use 
of crown ether-based CSPs in the future. 
POLYMERIC STATIONARY PHASES 
Polymeric chiral stationary phases can be classified as natural polymers, synthetic polymers, 
and the widely used semi-synthetic polymers. Proteins can be thought as naturally occurring 
chiral polymers, and they were among the important CSPs in the mid to late 1980s and early 
1990s. Although academically interesting, synthetic polymer CSPs have not played a 
significant practical role in HPLC enantioseparations. However, they demonstrated the 
feasibility of coated-type CSPs. This approach was widely used for other derivatized 
polysaccharides (semi-synthetic polymers), which later became one of the most important 
and effective polymeric CSPs. 
Carbohydrates 
Cellulose and amylose are among the most common naturally occurring chiral polymers. 
They are very poor chiral selectors in their native state. However, they become highly 
effective chiral selectors when their hydroxyl functional groups are derivatized, particularly 
with aromatic moieties through ester or carbamate linkages. The first derivatized 
polysaccharide CSP was microcrystalline triacetylcellulose (MCTA), which was made by 
Hesse and Hagel in 1973 (57). Several groups reported the enantiomeric separation of many 
aromatic and aliphatic racemates based on this type of CSP (58, 59). Despite its reasonable 
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applicability and the high loading ability of this material, it had limited mechanical and 
physical properties as a HPLC stationary phase. In 1984, Okamoto and co-workers (60, 61) 
and Ichida, et al. (62) improved these CSPs by adsorbing polysaccharide derivatives onto 
macroporous /-aminopropyl silanized silica. This resulted in stable and highly efficient CSPs 
with broad applicability, especially in the normal phase mode of separation. Now CSPs based 
on the derivatized polysaccharides are widely used in enantiomeric separations. Table 3 
shows the structures of the derivatized polysaccharide polymers that are available as 
commercial CSPs. Nowadays, the most widely applicable CSPs are the 3,5-dimethylphenyl 
derivatives (Chiralcel OD and Chiralpak AD, Daicel). They seem to be capable of resolving 
almost as many compounds as all of the other carbohydrate-based CSPs combined (18). 
The polysaccharide derivatized CSPs are most often used in the normal phase mode. 
However, some versions of these columns have been conditioned for the reversed-phase 
mode as well (63) (e.g. the Chiralcel OD-R and Chiralcel OJ-R). Although they basically 
consist of the same packing materials, it should be noted that one should not use the same 
column in both normal phase and reversed-phase modes as they were conditioned differently. 
The mobile phase can alter the configuration of chiral polymers, often irreversibly. Hence, a 
column should be dedicated to either the normal phase mode or the reversed-phased mode. 
Nowadays, polysaccharide-based CSPs have become some of the most popular CSPs, and 
they can be used to separate a wide range of racemates including aliphatic and aromatic 
compounds as well as many drugs from analytical to preparative scale (64). 
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Table 3. Coated chiral stationary phases consisting of derivatives of cellulose and amylose 
Type of derivatives Derivative Trademark 
Amylose Derivatives 
OR 
RO 
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The main drawback of these CSPs is related to the solubility of the chiral selectors in a 
number of solvents, which limits their applicability and compromises their stability. Because 
most of the commercially available polysaccharide derivatives were coated onto silanized 
wide-pore silica gel, they are only compatible with a limited choice of solvents. In order to 
increase the column durability, chemically bonded-type polysaccharide-based stationary 
phases can be prepared (14,65). Derivatized polysaccharides can be bonded to silica gel 
using 4,4-diphenylmethylene as a spacer to improve durability (66), through radical 
polymerization of allyl groups of silica gels and a polysaccharide derivative bearing vinyl 
groups (67), or using a cross-linking technique (68). The bonded-type polysaccharides CPSs 
show greater durability in a wide variety of organic solvents including tetrahydrofuran (THF) 
and chloroform. However, these bonded CSPs show slightly lower chiral recognition than the 
coated-type CSPs because much of the bonding process may occur through some functional 
groups of the polysaccharides, which will cause structural alteration of the polysaccharides. 
Proteins 
Proteins are naturally occurring chiral polymers, but not all the proteins have the ability to 
separate a wide range of enantiomeric molecules or make effective CSPs. Protein-based 
CSPs developed thus far include bovine serum albumin (BSA) (22), human serum albumin 
(HSA) (69), «i-acid glycoprotein (AGP) (23), ovomucoid from chicken egg whites 
(OMCH1) (70), and avidin (AVI) (71), cellobiohydrolase I (CBH I) (72), pepsin (73), 
ovotransferrin (74) and (3-lactoglobulin (75). Most of these CSPs are commercially available 
(Table 4). Different versions of BSA and HSA CSPs have also been commercially available 
with differences in the type of silica used and the amount of protein crosslinking. Therefore, 
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these CSPs differ in the enantioselectivity as well as in stability. The AGP CSP can 
successfully separate secondary amines, cyclic amines, some acids and neutral molecules 
(23). Bovine serum albumin (BSA) has also been proven to be able to separate certain acidic 
compounds including some aromatic amino acids and amino acid derivatives (22). In 
addition, the enzyme cellobiohydrolase prefers amine-containing compounds such as /3-
blocking agents (76). It was found that electrostatic, hydrophobic, and hydrogen-bonding 
interactions were responsible for chiral recognition on protein-based CSPs. 
Table 4. Representative Proteins used as HPLC Chiral Stationary Phases 
Proteins Molecular Isoelectric Trade Name 
Weight point 
Albumins 
BSA 66,000 4.7 CHIRAL BSA; RESOLVOSIL 
BSA-7, BSA-7PX; USTRON ES-
BSA 
HSA 69,000 4.8 CHIRAL HSA; CHIRAL -HSA 
Glucoproteins 
a!-Acid glycoprotein (AGP) 41,000 2.7 CHIRAL-AGP 
Ovomucoid (OMCHI) 55,000 4.1 ULTRON ES-OVM 
Ovoglycoprotein (OGCHI) 29,700 4.1 N/A 
Avidin (AVI) 66,000 1.0 Bioptic AV-1 
Enzymes 
Cellobiohydrolase 1 (CBH I) 64,000 3.9 CHIRAL-CBH 
Pepsin 34,600 < 1.0 ULTRON ES-PEPSIN 
Others 
Ovotansferrin 77,000 6.1 N/A 
The advantages of protein-based CSPs generally include the use of an aqueous mobile phase 
(good for biological systems), wide enantioselectivity, and direct analysis without 
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derivatization. However, the application of protein-based CSPs has declined in the past few 
years because they can only be used in the reversed-phase mode and also they are less stable 
than most other CSPs. In addition, they have the least capacity because of the large size of 
the chiral selector, so that they are not useful for preparative separations. They are among the 
most expensive CSPs as well. Recently, CSPs based on a protein fragment or protein domain 
have been prepared (77, 78). These CSPs might provide higher capacity because only the 
active protein mass is used, however, the results showed that these CSPs often possessed 
inferior chiral recognition abilities compared to the parent proteins. Nevertheless, in the 
future, a protein fragment or protein domain could be prepared by over-expression with 
genetic technology, which makes it possible to produce the most suitable protein fragment or 
protein domain based-chiral selector for a specific target molecule (79). 
Synthetic Polymers 
Chiral stationary phases based on synthetic polymers were first developed by Okamoto and 
co-workers (80, 81). They succeeded in making synthetic helical vinylpolymer with a 
predominantly one-handed screw-sense by asymmetric polymerization of triphenylmethyl 
methacrylate with chiral catalysts. Depending on the catalysts used, they can form either a 
right-hand or left-hand helical coil (82, 83). They found when the resulting optically active 
poly(triphenylmethyl methacrylate) ((+)-PtrMA) was adsorbed on the wide-pore silica gel to 
form a CSP, it was capable of resolving some specific racemic compounds with aromatic 
groups (81,84-85). Since the development of the helix-sense-selective polymerization of 
TrMA, various TrMA-analogue CSPs have been synthesized. However, only PtrMA and 
poly (diphenyl-2-pyridylmethylmethacrylate (poly (D2PyMa) (85) thus far have shown 
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reasonable resolving power towards racemic compounds. Therefore, most of the research still 
emphasizes the enhancement in the performance and durability of these CSPs (86-88). 
Although the CSPs made from chiral synthetic polymer have never played a significant 
practical role in enantiomeric separations, they demonstrated the usefulness of coated-type 
CSPs. This approach was used with derivatized polysaccharides, which became popular and 
effective CSPs. 
Recently, enantioselective imprinted polymers, first introduced by Wulff (89), have become 
very attractive because people can create specific enantioselective binding sites with well-
defined shapes and functionalities in a prearranged fashion (90,91). Generally speaking, 
molecular imprinting is a technique of creating three-dimensional networks that have a 
memory of the shape as well as functional groups at specific positions of the template 
molecule. Therefore, the resulting molecular imprint polymers (MIPs) can selectively 
recognize the template molecules used in the imprinting process, even in the presence of 
compounds with structure and functionality similar to those of the template. In addition, the 
elution order is often predicable because the isomer used as a template for the preparation of 
the MIP is always the one that is more strongly retained. Therefore, MIP based CSPs usually 
provide predetermined selectivity and can be custom-made. Now the chirally imprinted 
polymer CSPs have shown enantiomeric separations for some amino acids, amino acid 
derivatives, peptides and amino alcohols (91-93). But these kinds of CSPs suffer from 
limited lifetime, low loading capacity and binding site heterogeneity problems. With the 
formation of more stable template-functional polymer complexes and application of 
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multifunctional cross-linking strategies, chirally imprinted polymer CSPs may become 
important for target molecules by creating specific binding sites. 
7I-7I INTERACTION CHIRAL SELECTORS 
The earliest successful CSPs utilized n-n association (94-97) and the first commercialized n-
n interaction CSP was ionically bonded (-) 3,5-dinitrobenzylphenylglycine (a Tt-electron 
acceptor type) (20). Clearly, enantiomeric separations using these CSPs require the n-n 
association between the chiral selector and analyte of interest. Other simultaneous 
interactions must occur as well such as hydrogen bonding, dipole-dipole interaction, and 
steric repulsion. Since the addition of polar solvents lessens n-n, hydrogen bonding, and 
dipolar interaction, these CSPs are generally used in the normal phase mode. The binding 
sites of these CSPs can be Tt-electron donor types (7t-basic) or ^-electron acceptor types (ti-
acidic). If the chiral selector is a n electron donor, the analyte has to be a n electron acceptor, 
and vice versa. But not all compounds of interest contain rc-acid or Tt-base moieties. 
Therefore, an achiral derivatization step may be necessary in order to achieve the 
enantiomeric separation. 
Various n-n interaction chiral selectors (Figure 6) have been developed in recent years (98-
110), and most of these CSPs provide good enantioselectivity to derivatized amino acids, 
amino alcohols, amines, other acidic racemates, etc. Many of the n-n interaction CSPs 
developed by a variety of research groups are still closely related to the original stationary 
phases developed by Pirkle and co-workers (99), based on amino acid derivatives carrying n-
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acidic and/or n-basic sites (100-102). The ^-complex CSPs that contain both n-acid and n-
base moieties tend to be more widely applicable (103-105). Some other chiral selectors of 
this class were assembled around a 1,3,5-triazine skeleton (106, 107). Chiral stationary 
phases with selectors derived from tartaric (108), cholic (109) and deoxycholic acids (110) 
were also described. Most of the n-n interaction CSPs are useful in the normal phase mode, 
however, a chiral stationary phase containing an alkaloid was prepared and shown to be 
effective in the resolution of acidic compounds in buffered aqueous solutions (111). As 
mentioned previously, aromatic functionalized cyclodextrins (i.e. Cyclobond RN and SN) 
can also be used as 7r-complex CSPs, and tend to be more widely used as well (28). 
Most of the 71-71 interaction CSPs are based on low-molecular-mass chiral selectors; hence, 
they usually have good loading ability, which make them good for preparative separations. If 
both enantiomers of the chiral selectors are available, one can obtain the opposite 
chromatographic retention order when needed. This will allow for the use of one CSP in 
determining the enantiomeric purity if the late eluting enantiomer exhibits poor efficiency. In 
addition, novel synthetic n-n interaction CSPs that incorporate highly pre-organized, 
receptor-like chiral selectors have also been described recently (98). They have 
demonstrated to be powerful tools in the study of enantiorecognition processes characterized 
by high degrees of selectivity (98). 
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(b) Naproxen-derived CSP 
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(c) Amino-acid-derived CSPs 
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(d) CSP with selector assembled around 1,3,5-triazine 
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R—O 
(e) Tartaric acid-derived CSP 
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Figure 6. Examples of n-complex chiral stationary selectors that have been immobilized on silica gel 
to form chiral stationary phases. 
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LIGAND EXCHANGE CHIRAL SELECTORS 
Chiral ligand exchange chromatography was invented by Davankov and co-workers in the 
early 1970s (112,113). This was the first liquid chromatographic technique successfully 
applied for the resolution of amino acids and other solutes, which are able to form 
coordination compounds with metal ions. These CSPs consist of a chiral bidentate ligand 
such as proline or hydroxyproline attached to a solid support. A transition metal such as 
copper (II) must be added to the mobile phase. The copper serves as a bridge to connect the 
chiral selector on the stationary phase and the free amino acid analyte to form transient 
diastereomeric tertiary complex (Figure 5 a). The observed enantioselectivity of the 
chromatographic system depends on the surface coverage of the CSPs, the kind of anchor 
molecule used to attach the chiral ligand to the support surface, and the concentration of 
metal ion and other modifiers in the mobile phase (114, 115). In addition, the chiral selectors 
can also be used as chiral mobile phase additives (116,117), the diastereomeric complexes 
are formed in the bulk of the mobile phase and then they are adsorbed on the achiral 
stationary phase. Several papers reviewed the history of the discovery and some benchmark 
achievements of enantioselective ligand exchange chromatography (118,119). The most 
popular chiral selectors are a-amino acids and their N-substituted derivatives. Recently, six 
N-substituted (5)-phenylglycinol chiral selectors (120) and N- (1-carboxyalkyl) chitosan 
CSPs were also reported (121). 
Ligand exchange chromatographic methods have some limitations. For example, it only 
works for analytes that can act as bidentate ligands, including amino acids, a-
hydroxycarboxylic acids, some diamines, etc. Additionally, because copper (II) or other 
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transition metal ions need to be added to the mobile phase, there is some background signal if 
using UV detection. Also, those transition metal ions should be removed when doing 
preparative separations. 
MISCELLANEOUS/HYBRID CHIRAL SELECTORS 
The classification about the chiral selectors is not absolute. In some cases, a chiral selector 
can contain the characteristics of more than one class. For example, the (R) or (S)-
naphthethylcarbamate derivative of /?-cyclodextrin (Cyclobond RN or SN) is clearly a 
macrocyclic chiral selector and can form inclusion complex in the reversed-phase mode, but 
it acts as a n-n interaction CSP in the normal phase mode (28). In addition, a side chain-
modified analog of Whelk-O-1, the polyWhelk-O, was obtained by the incorporation of the 
same selector into a polysiloxane backbone. This CSP has a fairly similar application 
spectrum but exhibits higher selectivity with less retention and efficiency than its brush-type 
analog (122,123). Although polyWhelk-0 CSP is still a n-n interaction CSP, it is also a 
synthetic polymer. 
Recently described stationary phases having tert-butylcarbamoylated quinine (an anion-
exchanged stationary phase based on derivatized 7t-acidic, or n basic moieties) linked to 
mercaptopropylsilica were able to separate the enantiomers of N-3, 5-dinitrobenzoylated 
leucine and phenylalanine with a-values of 15.87 and 10.78, respectively, in buffered 
aqueous solution (124). 
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3. Supercritical Fluid Chromatography 
Supercritical fluid chromatography (SFC) is now a well-established enantiomeric separation 
technique both analytically and preparatively for a wide range of compounds. Chiral 
separations in SFC are generally divided into open tubular and packed column approaches. 
Open tubular columns, designed for SFC, have the internal diameters in the range of 50 -100 
/an. Cyclodextrin derivatives and n-complex types of columns are among the most widely 
used CSPs for open tubular SFC (125-127). Flame ionization detection (FID) has often been 
used in conjunction with open tubular SFC for chiral separations (128). Because most of the 
organic modifiers are not compatible with FID detection, the mobile phase for open tubular 
SFC is usually pure carbon dioxide. The eluent strength is often changed by modifying the 
density of the supercritical carbon dioxide through changing the temperature and pressure. 
However, these changes cannot satisfy the solvent strength necessary to elute most polar 
compounds, which limits the application of open tubular SFC. In addition, the low sample 
capacity and lack of commercially available CSPs resulted in open tubular SFC never 
becoming a mainstream method. 
Chiral separations by packed column SFC was first proposed for the separation of chiral 
phosphorous-containing derivatives by Mourier et al. in 1985 (129). Since then, packed 
column SFC has become a promising chiral separation technique that is increasingly used in 
industrial applications (8,9,130-133). Because the applicability and selectivity of SFC are 
very similar to those of normal phase HPLC, nowadays, SFC is more frequently being used 
as a replacement for normal phase HPLC separations (134,135). Among all the HPLC chiral 
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selectors, suitable chiral stationary phases for SFC separations include bonded cyclodextrins, 
bonded antibiotics, derivatized cellulose and amylose, helical polymers and ^-complex-type 
stationary phases (Table 1). Other HPLC stationary phases based on proteins, ligand 
exchange and chiral crown ethers are either unstable or ineffective under SFC conditions. 
The following section will focus on the chiral selectors that work well in packed column SFC 
separations. Comparisons with normal phase HPLC also will be discussed. 
MACROCYCLIC CHIRAL SELECTORS 
Cyclodextrins and their Derivatives 
Most cyclodextrin columns have not been extensively used in SFC because these CSPs are 
generally used in the reversed phase mode or polar organic mode in HPLC. Only a few early 
papers reported the enantiomeric separations based on the native or derivatized cyclodextrins 
(136,137). Nowadays, the most widely used cyclodextrin-based CSPs in SFC are the 
aromatic functionalized cyclodextrins (i.e. Cyclobond RN and SN) because these 
cyclodextrins can be used as rc-complex CSPs (138,139). Interestingly, Williams, et al. 
demonstrated that compounds previously resolved not only on the normal-phase, but also on 
reversed-phase or polar organic modes on the Cyclobond RN or SN CSPs in HPLC can also 
be resolved in SFC using a simple carbon dioxide-alcohol eluent (139). Furthermore, the 
SFC separations tended to provide rapid optimization of selectivity and improved resolution 
compared to HPLC separations. 
33 
Glycopeptide/Antibiotic CSPs 
The macrocyclic glycopeptide chiral stationary phases have been widely used with SFC 
mobile phases. A vancomycin based CSP was able to separate the enantiomers of jS-
adrenergic blocking agents and other pharmaceuticals (140). Cyclic ketones and dioxalene 
derivatives were separated by chiral SFC using teicoplanin and vancomycin-based CSPs 
(141). The ristocetin A CSP was tested with SFC mobile phases and found to resolve 
enantiomers of acidic drugs (142). Forty-four racemates were evaluated for separations on 
teicoplanin and vancomycin CSPs with SFC mobile phases (143). Recently, we reported an 
in-depth evaluation of the capabilities of macrocyclic glycopeptide-based CSPs with SFC 
mobile phases (144). The 111 compounds separated included heterocycles, analgesics 
(nonsteroidal anti-inflammatory compounds), ^-blockers, chiral sulfoxides, N-protected 
amino acids, and native amino acids (144). In addition, twenty-four chiral 
dihydrofurocoumarin derivatives and structurally related compounds were also separated on 
macrocyclic glycopeptide CSPs (145). Generally speaking, the teicoplanin aglycon and 
teicoplanin CSPs seem to have better enantioselectivity than ristocetin A and vancomycin 
CSPs. It is also worthwhile to point out that most of the separations were done in less than 15 
minutes and over 70 % of separations were achieved in less than 4 minutes (with a flow rate 
at 4.0 ml min"1) (145). 
POLYSACCHARIDE CHIRAL SELECTORS 
Various derivatives of cellulose and amylose adsorbed on silica gel have proven to have wide 
applicability in normal phase HPLC separations, as well as in SFC separations. The 
derivatized cellulose and amylose stationary phases are stable under SFC conditions even 
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though the selector is coated and not bonded to the silica support. Antifungal drugs were 
separated based on derivatized polysaccharides with different substituent groups such as 3,5-
dimethylphenylcarbamate and (R)-phenylethylcarbamate (146). Bernai, et al. further 
evaluated the enantiomeric separations of several compounds including an antifugal drug and 
several of its precursors on Chiralpak AD and Chiralcel OD CSPs using both HPLC and SFC 
(147). The results showed that the separations obtained by SFC were better, in terms of 
higher resolution and shorter analysis times, than those obtained by HPLC. Separations of /?-
blockers on Chiralcel OD have been reported by several groups (148, 149). Other compounds 
separated on derivatized polysaccharide CSPs by packed column SFC include enantiomers of 
diltiazem hydrochloride (150), phenylpropanols and related compounds (151). Medvedovici, 
et al. evaluated polysaccharide CSPs along with other commercially available CSPs for the 
enantiomeric separation of a wide variety of compounds using the modifier (methanol 
containing 0.1 % trifluoroacetic acid and 0.1 % triethylamine) varied from 5 % (5 min) to 30 
% at 5 % min"1 (143). Chiralpak AD provided the best enantioselectivity with 70 % of the 44 
tested chiral compounds separated followed by Chiralcel OD (66 %). Recently, separations 
of albendazole sulfoxide enantiomers by SFC were also studied using Chiralpak AD and 
Chiralcel OD columns (152). 
71-71 INTERACTION CHIRAL SELECTORS 
As mentioned previously, the first demonstration of packed column chiral SFC was done 
using (R)-N-(3,5-dinitrobenzoyl)-phenylglycine, a n-n interaction CSP (129). Separations of 
chiral phosphine oxides were obtained using alcohols or alcohol-water mixtures as modifiers. 
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Since then, enantiomeric separations on Tt-complex types of CSPs using SFC have been 
widely reported (143,153-157). The chiral selector (5)-indoline-2-carboxylic acid combined 
with (R)-1 -( a-naphthyl) ethylamine via a urea linkage (Chirex 3022) was developed and used 
to separate some underivatized /^-blockers and /^-agonists (153). The newest TT-complex CSPs 
containing both %-acid and 7i-base moieties tended to be more widely applicable (154,155). A 
variety of enantiomers with different functional groups were resolved on Whelk 0-1 column 
(154). Pirkle, et al. further modified the Whelk-O-1 and analogous chiral selectors by 
incorporating them into polysiloxanes, which was then immobilized on silica (122, 155). The 
resulting CSPs are stable to normal and reversed-phase conditions and throughout a wide 
range of temperatures, mobile phases and additives. These CSPs often afforded greater 
enantioselectivity, better band shapes and reduced capacity factors in SFC. In addition, these 
CSPs separated a variety of chiral compounds, such as underivatized amines, alcohols, 
carboxylic acids, and heterocyclic atropoisomers, etc. High-speed separations of /^-blockers 
were also successfully obtained (analysis times less than 2 min) using a short column packed 
with ChyRoSine-A CSP (tyrosine-derived CSPs) by Bargmann, et al. (156). Recently, 
Schurig, et al. described the use of complexation SFC for enantiomeric separations of Lewis 
bases on chiral nickel (II)- and zinc (II)-bis[(3-heptafluorobutanoyl)-10-methylene-(lR)-
camphorate] chemically bonded to poly(dimethylsiloxane) (Chirasil-nickel and Chirasil-zinc) 
and employed as Lewis acid selectors (157). This method is especially well suited for less 
volatile and configurationally labile racemates. 
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OTHER CHIRAL SELECTORS 
Other chiral polymers also can be used as chiral selectors for SFC separations. Kromasil 
CHI-TBB, an acylated N, N'-diallyl-l-tartardiamide network polymers covalently bound to 
functionalized Kromasil silica, produced the best separation properties for ibuprofen among 
eleven different CSPs tested (158). It may be the most suitable CSP for scaling to preparative 
(I) 
(a) HPLC 
Metoprolol 
(ii) 
(a) HPLC 
—A— I I • n i " I • "~r 
10 
Clenhuterol 
(b) SFC 
4 8 
Time (min) 
(b) SFC 
JlA 
r-" 
10 20 
Time (min) 
Figure 7. Comparison of LC and SFC enantiomeric separations. 
(I). Enantioseparations of metoprolol on the Chiralcel OD CSP. Chromatographic conditions: (a) 
hexane-2-propanol-diethylamine (80:20:0.1, v/v/v), 0.5 ml min UV detection at 280 nm; (b) carbon 
dioxide-methanol-isopropylamine (80:20, v/v), 2.0 ml min"1, 30 °C, 15 MPa, UV detection at 280 nm. 
(II) Enantiomeric separations of clenbuterol on the Chirex 3022 CSP. Chromatographic conditions: 
(a) hexane-1,2-dichloroethane-ethanol-TFA (50:35:15, v/v/v), 1.0 ml min UV detection at 254 nm; 
(b) carbon dioxide-methanol (85:15, v/v), 2.0 ml min _1, 30 °C ,15 MPa, UV detection at 254 nm 
(FromRef. 153.) 
separations of ibuprofen. Wu investigated the enantiomeric separation of pharmaceutical 
compounds using supercritical and subcritical fluid ion-pairing chromatography (159). 
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Several chiral counter ions such as quinine, quinidine, and (+)-10-camphorsulfonic acid were 
chosen as chiral selectors for the separation of amino acids and amino alcohols. The effect of 
counter-ion's binding functions and structural features on the stereoselectivity was discussed. 
COMPARISON WITH NORMAL PHASE HPLC 
One of the most important advantages of the use of SFC compared to normal phase HPLC is 
the speed of separation. The low viscosity of supercritical fluids produces a low-pressure 
drop and allows the use of high flow rates (up to 6.0 ml min"1). In addition, the optimum 
linear velocity is shifted to higher values in SFC than in LC, because solutes have higher 
diffusion coefficients in supercritical fluids than in liquids (160). Therefore, higher flow rates 
often can be used in SFC to reduce analysis time without excessively compromising 
efficiency (161). But analysis times are not always shorter in SFC than in HPLC (Figure 7). 
Williams, et al. compared three different types of commercially available CSPs for 
enantiomeric separations (153). Faster separations were usually obtained on derivatized 
polysaccharide-based CSPs and cyclodextrin-based CSPs with SFC mobile phases. 
Macrocyclic glycopeptide CSPs also normally demonstrated faster enantioseparations in SFC 
(144). However, for Chirex 3022, a %-donor CSP, most of the compounds examined were 
strongly retained on the CSP in SFC compared to HPLC (Figure 7B, 153). Similar results 
have also been reported for comparisons of HPLC and SFC on other n-n interaction CSPs 
(155). The diminished eluent strength in SFC also highlights the fact that solute-mobile phase 
and mobile phase-stationary phase interactions are not equivalent for HPLC and SFC (162). 
Although SFC is often compared with normal phase HPLC, the similarities in 
enantioselectivity between the two techniques are not absolute, but are compound specific 
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(153). In addition, studies of the Cyclobond I RN and SN CSPs demonstrated that separations 
achieved under reversed phase or polar organic LC modes could also be duplicated in SFC 
with carbon dioxide-methanol eluents (139). 
Another key advantage in the use of supercritical fluid chromatography is that it is often 
possible to simplify the operation conditions relative to conventional HPLC. Overall, SFC 
provides rapid method development due to its relatively short analysis time, rapid column 
equilibration, and simple mobile phase composition. In addition, SFC is advantageous for 
preparative separations with its easy solute recovery and solvent disposal. As a result, SFC 
will likely continue to have significant impacts on analytical and preparative methodologies 
for chiral separations. Further improvements in commercial instruments will also help to 
solidify the position of SFC in analytical laboratories. 
4. Capillary Electrophoresis 
The inherent advantages of capillary electrophoresis (CE), including small sample size, fast 
analysis times, plug flow, and low solvent consumption, make it an attractive alternative to 
LC for enantiomeric separations. In general, capillary electrophoresis separates compounds 
by their mass-to-charge ratio via an applied voltage across a capillary. Anions migrate 
towards the anode while cations travel toward the cathode. Neutral molecules traverse the 
capillary with the bulk solution by means of an electroosmotic flow (EOF). This EOF is 
produced as a result of the build-up of positive buffer ions along the negatively charged 
silanol groups of the capillary wall. These cations, being more highly solvated by the 
aqueous solution than the buffer anions, produce a net flow of solution towards the negative 
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electrode. pH and ionic strength of the buffer solution can affect the magnitude of the EOF. 
Acidic pHs can decrease the EOF by protonating these silanol groups, and can effectively 
suppress the EOF below pH 2.5. High ionic strengths also diminish the EOF by reducing the 
double layer thickness at the capillary wall. Additives may be used in the run buffer to act as 
pseudo-phases to further separate analytes. 
Many of the chiral selectors used in LC can be easily transferred to capillary zone 
electrophoresis (CZE) as run buffer additives, enabling a wide variety of analytes to be 
separated. However, unlike LC, these additives are free within the buffer solution instead of 
statically bonded or coated to a stationary phase. While this totally dynamic system can limit 
run-to-run reproducibility, it also allows considerable control over the factors that determine 
selectivity. The most common chiral selectors used in CE include the macrocyclic chiral 
selectors (cyclodextrin, chiral crown ethers, and antibiotics), chiral surfactants, and acyclic 
carbohydrates (163). 
MACROCYCLIC CHIRAL SELECTORS 
Cyclodextrins 
Cyclodextrins and their derivatives are clearly the dominant class of chiral selectors used in 
CE enantiomeric separations. Over 50 different derivatized CD are available commercially, 
providing a wide variety of selectors from which to choose (164). Because of this diverse 
selection, a majority of chiral compounds can be separated with these selectors. Compared to 
other chiral selectors, cyclodextrins are relatively inexpensive. In addition, cyclodextrins are 
UV transparent allowing absorbance detection to be easily applied. Both native and 
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derivitized cyclodextrins are commonly used. Numerous reviews have been written 
concerning the use of cyclodextrins in CE (165-168). Before choosing a cyclodextrin for a 
specific separation, the charge of both the analyte and the chiral selector must be examined. 
Neutral cyclodextrins, such as the native forms, hydroxypropyl cyclodextrin (HP-CD), and 
dimethyl cyclodextrin (DM-CD), travel with the EOF. In order to achieve enantiomeric 
separation, the analyte must have a different mobility than the chiral selector. Therefore, 
neutral cyclodextrins are generally only useful for charged analytes. However, neutral 
analytes may be separated with neutral cyclodextrins by use of a charged secondary pseudo-
phase, such as an ionic micelle or another charged cyclodextrin (169). This secondary 
pseudophase may or may not be chirally selective. 
Cyclodextrins with ionizable groups, such as sulfated-CD and carboxymethyl-CD, are 
usually charged when in aqueous or hydroorganic solution, allowing neutral analytes to be 
easily separated. In addition, oppositely charged species are attracted to these cyclodextrins 
via electrostatic interactions, thus increasing their level of interaction with the chiral selector. 
This feature, however, may increase or diminish separation depending on the magnitude of 
the interaction. The hydrophobic cavity of CDs is particularly beneficial when separating 
enantiomers of aqueous-insoluble or weakly soluble analytes. The presence of the CD 
increases the analyte solubility considerably by providing a hydrophobic micro-environment 
(163). However, if the inclusion complex is so strong that the analyte virtually never leaves 
the cyclodextrin, an organic additive may be added to the run buffer in order for the analyte 
to achieve equilibrium between the cyclodextrin and the bulk solution. The percentage of 
organic content in the buffer solution can effectively control the level of selectivity by 
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shifting the equilibrium constant. Methanol and acetonitrile are common organic modifiers 
that are used for this purpose. 
Overall, cyclodextrins are a highly versatile class of chiral selectors. Numerous racemates 
have been separated with cyclodextrins including organic acids (170), amino acids (171-173), 
various pharmaceuticals and drugs (174), and highly hydrophobic compounds (175). 
Several other factors can alter the selectivity of separations involving cyclodextrins. These 
conditions include cyclodextrin concentration, the degree of substitution of derivitized 
cyclodextrins, buffer pH and ionic strength. In CE, selectivity is highly dependent on the 
concentration of chiral selector in the run buffer. Generally, increasing the CD concentration 
leads to an increase in resolution by effectively forcing more frequent analyte complexation 
with the cyclodextrin. However because separation requires a difference in interaction 
between the two enantiomeric analyte moieties, an excessive level of additive will reduce the 
selectivity since both enantiomers will be nearly always complexed. The advantage of this 
phenomenon is that great control over selectivity can be achieved by merely modifying the 
additive concentration. Moderately selective cyclodextrins can produce satisfactory 
resolutions by using a significantly higher concentration. Increased viscosity of the buffer 
solution can also be experienced with CD concentrations above 10 mg/mL, resulting in 
longer migration times and lower separation currents for neutral CDs. 
The solubility of the cyclodextrin in water must be taken into account, due to the aqueous 
nature of CE. The selectivity of many CDs is limited by their solubility in the run buffer. 
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Derivitized cyclodextrins tend to have an increased solubility as compared to their native 
forms, with the exception of those with highly hydrophobic substituants. For example, native 
(3-CD has a solubility of -20 mg/mL while DM-(3-CD is soluble up to ~330mg/mL (163). 
High concentrations of Urea may be added to increase the solubility of CD in the run buffer. 
Concentrations up to 7 M have been utilized in many cases (176-178). The exact mechanism 
of this effect is not totally understood. 
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Figure 8. The effect of degree of substitution of methylated-jS-CD on the separation of dansyl-DL-
leucine. All separations performed with 0.1M borate-0.05M sodium phosphate buffer at pH 9.0, and 
lOmM (A) /3-CD, (B) 3-MM-/3-CD, (C) 2.3-DM-/3-CD, and (D) 2,3,6-TM-jS-CD. 72cm capillary 
(50cm effective length) was used with 50/xm I D. Voltage run at 20kV. (From Ref. 172.) 
The degree of substitution (DS) and position of the functional groups on derivatized CD can 
greatly affect their selectivity as well. The 2- and 3-hydroxyl groups on the outer rim as well 
as the 6-hydroxyl on the smaller opening are available for derivitization on free CD, allowing 
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up to three substituents per glucose unit. Due to the significant contribution of these 
substituents on chiral selectivity, the difference in capabilities between a mono- and tri-
substituted CD can be dramatic. Figure 8 shows the effect of the DS and position of 
substitutents in methyl-[3-CD on the separation of dansyl-DL-leucine (172). Most 
commercially available derivitized CDs contain a mixture of compounds of varying degree 
and position of substitution (179). For example, a sample of DM-yS-CD may have an average 
DS of 1.8, with a varying blend of 2,3- and 2,6-substitution. Trace impurities of 2,3,6-
trimethyl-/?-CD and monomethylated form may also be present. As a result, different 
batches of supposedly identical CD may produce significantly different results (Figure 8). In 
fact, in some cases the mixture of CD isomers may produce better results than the pure form. 
Reproducibility, therefore, relies on the ability to use a single CD batch for every separation, 
possibly requiring large quantities to be ordered at one time. 
In addition to affecting the magnitude of the EOF, changes in pH and ionic strength of the 
run buffer may affect the enantiomeric separation as well. In cases involving analytes and 
cyclodextrins with ionizable substituents, the pH of the bulk solution can dictate the charge 
of these species. These charges directly correlate with the difference in electrophoretic 
mobility between the analyte and the chiral selector, therefore affecting the resolution of the 
separation (180). For separations involving electrostatic attraction between the analyte and 
cyclodextrin, the level of ionic strength of the run buffer can modify the intensity of these 
interactions. High ionic strength solutions can solvate ionic species and mask them from 
other oppositely charged molecules, effectively reducing interaction between the analyte and 
the chiral selector. 
Chiral Crown Ethers 
Utilizing crown ethers as chiral selectors in CE was first accomplished by Kuhn et al. with 
the separation of simple aromatic amino acids enantiomers (181). Currently, 18-crown-6 
tetracarboxylic acid (I8C6H4) is the only chiral crown ether that has been used effectively in 
CE (182). Due to its ability to complex cations within its polyether cavity via electron 
donating oxygen atoms, crown ethers are particularly useful for the separation of racemates 
with a primary amine group near its chiral center. Amino acids and their analogues are 
separated most frequently with this class of additive, as well as peptides and other amines 
(183-185). The theory behind this mechanism in CE is currently being studied. 
The concentration of crown ether in the bulk solution directly correlates with the 
enantiomeric resolution, in a manner analogous to what occurs with cyclodextrins. However, 
migration times are generally not increased as greatly as when cyclodextrins are used (186). 
This phenomenon may be due to the weaker, yet selective, analyte-crown ether 
complexation. 
The four carboxylic acid groups on 18-crown-6 tetracarboxylic acid have pKas of -2.1, 2.8, 
4.3, and 4.9 (187). Therefore, small pH changes in the acidic range can significantly modify 
the mobility of the crown ether. The magnitude of the negative charge on the crown ether 
increases with increasing pH. This factor must be controlled carefully, especially when 
separating negatively charged analytes to ensure that the chiral selector and analyte have 
sufficiently different mobilities. 
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In addition to pH, the composition of the buffer solutions must be examined. Crown ethers 
are known to complex with many alkali and alkali earth metal ions, particularly K+, as well 
as ammonium ions. Therefore it is necessary to avoid the use of these ions in the run buffer 
as they may compete with the analyte for crown ether inclusion. In fact, the stabilities of 
these ion complexes are almost ten times higher than that of primary amines (188). Other 
buffer additives, such as Tris or secondary and tertiary amines, are suitable for use in the bulk 
solution due to their lower inclusion stability. Various studies have been performed 
concerning the effect of buffer composition on chiral separations (189). 
A combination of cyclodextrin and crown ether has been shown in some cases to produce 
more efficient separations than with either additive alone. A dual complexation mechanism 
between both chiral selectors and the analyte (CD-analyte-18C6H4) is a likely cause for these 
results (190). This effect is magnified as the concentration of both selectors is increased 
beyond 10 mM (191). 
Macrocyclic Glycopeptides (Antibiotics) 
First demonstrated by Armstrong et al. in chiral separations with TLC, HPLC, and CE, 
macrocyclic glycopeptide antibiotics are a highly selective and useful class of chiral selectors 
(36). Several recent reviews cover these macrocycles as enantiomeric selectors, and discuss 
their use in detail (15, 166, 192, 193). A wide range of both anionic and cationic 
enantiomers have been separated in CE with these additives. The glycopeptides ristocetin A, 
vancomycin, and teicoplanin have been particularly beneficial for the separation of anionic 
analytes (194-196). This effect and their affinity towards compounds containing carboxylic 
acid groups can be traced to the protonated amine groups on the antibiotic at low pHs. The 
ansamycin, rifamycin B, has been applied as a negatively charged selector for the resolution 
of cationic compounds with up to two aromatic rings, while rifamycin SV is normally neutral 
and used for anionic samples of two or more aromatic rings (197, 195). 
The large number of stereogenic centers on macrocyclic antibiotics allows for broad 
selectivity. High efficiency is also maintained due to fast analyte complexation kinetics. As 
a result, many separations utilizing antibiotics as a chiral selector surpass the resolution by 
cyclodextrins (198). In addition, the large molecular weight of these antibiotics limits their 
rate of diffusion, thus further enhancing the separation efficiency. Figure 9 shows the high 
selectivity and efficiency of vancomycin for the anionic derivative of pyrroquinoline 
quinone. 
Each of these macrocyclic antibiotics is highly soluble in aqueous and polar aprotic 
environments, easily allowing application to CE. Teicoplanin exhibits the unique 
characteristic of micelle formation, due to the possession of a hydrophobic side chain 
attached to its 2-amino-2-deoxy-(3-D-glucopyranolsyl group (CMC of ~0.18mM) (35). As 
with many other chiral selectors the pH of the run buffer can affect the charge and mobility 
of the antibiotic and analyte by modifying their ionizable groups. Generally, a pH between 4 
and 7 is used to prevent hydrolysis of amide bonds and minimize conformational changes. 
The pKas of the antibiotic functional groups must be examined in order to determine the 
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Figure 9. Enantiomeric separation of the acetone adduct of pyrroquinohne quinone. Buffer is 0.7 
mM vancomycin in 50 mM MOPS-Tris buffer at pH 7. -8.5kV applied voltage, on 50 /xm I D., 37.8 
cm capillary (30cm effective length). (From Ref. 198) 
proper pH for a given separation system. The use of organic modifiers and additional 
pseudo-stationary phases can also enhance resolution in some cases. Micelles present in the 
run buffer may interact with both the analyte and the antibiotic, and result in a reversal of the 
enantiomer migration order by changing the mobility of the antibiotic. SDS in solution can 
also prevent adsorption of the antibiotic to the capillary wall, which is one difficulty of 
utilizing these chiral selectors in CE (199). 
Untreated silica capillaries allow many of these antibiotics to adsorb, resulting in reduced 
efficiency and resolution, and diminished EOF. Vancomycin adsorbs most strongly of the 
group, while teicoplanin adsorbs least due to its aggregate formation (35). Organic additives 
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and coated capillaries can also be implemented to alleviate this obstacle, as well as running at 
a pH near the pi of the antibiotic. 
Macrocyclic antibiotics are strong absorbers in the UV region, which is commonly used for 
detection in CE. However under low concentrations of antibiotic, a wavelength of 254 nm 
can be used for direct detection due to its decreased absorbance above 250 nm. Because of 
the high selectivity of this class of chiral selectors, a sufficient separation can usually still be 
performed even at lower concentrations. Otherwise, a counter-current partial-filling method 
can be performed, in which the antibiotic and the analyte migrate in opposite directions 
(192). A plug of antibiotic can be inserted into the capillary that travels away from the 
detector, while the analyte travels toward the detector. Therefore, the antibiotic never 
reaches the detection window. 
CHIRAL SURFACTANTS 
Chiral surfactants are another class of additives commonly used in CE for the separation of 
optically active compounds. Micellar and pseudo-phase liquid chromatography was first 
developed by Armstrong during the late 70's and early 80's (200-204), and its principles 
were easily transferred to CE (205) for chiral separations. These chiral selectors are usually 
low molecular weight compounds that contain a hydrophilic chiral head group and a large 
hydrophobic tail. In aqueous solution, surfactant monomers aggregate to form micelles when 
above their critical micelle concentration (CMC). The polar head groups align to form a 
surface in contact with the water, while the hydrophobic groups form a nonpolar environment 
in the interior of the micelle. Generally, chiral recognition is achieved via interactions with 
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the chiral head groups, while partitioning within the hydrophobic region. This mechanism is 
particularly useful for compounds that are weakly soluble in aqueous solution. Chiral 
surfactants can be divided into two categories: natural surfactants such as bile salts, and 
synthetic surfactants (206). 
Natural Surfactants 
Bile salts are the most popular chiral surfactants for CE. These compounds consist of a four 
ring steroidal structure with hydroxyl groups, and a carboxylic group bonded to glycine or 
taurine substituent (Figure 10). The micelle is formed by the hydrophobic attraction of the 
bulky nonpolar ring faces, resulting in a low aggregation number of only between 4 and 10 
(207). The most widely used bile salt is sodium taurodeoxycholate (STDC), due to its good 
aqueous solubility and high enantioselectivity of a wide range of compounds. Bile salts 
without taurine groups require a pH > 7 for proper solubility. Bile salts have the ability to 
resolve simple compounds such as amino acid derivatives (208), or more complicated 
polycyclic compounds (209). 
Digitonin and saponins are other natural surfactants that may be used for chiral recognition, 
however they are much less popular due to several drawbacks. Digitonin contains no 
ionizable groups, and is therefore mostly insoluble in water. However, mixed micelles with a 
charged surfactant, such as SDS, can be formed allowing this surfactant to be used in 
aqueous separations with CE (210). When SDS is added to saponins though, a gel-like 
mixture may form (163). Therefore saponins can be very difficult to utilize in mixed micelle 
systems. 
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Synthetic Surfactants 
Synthetic surfactants are constructed with a chiral polar head group attached to a long 
hydrophobic alkyl chain. Head groups are often chiral amino acids (211, 212), sugar 
derivatives (213), or other acids (Figure 10). These surfactants are highly soluble in aqueous 
solution when compared to natural surfactants. Amino acid and glucosidic surfactants have 
been used for a variety of enantiomeric separations (211-213), as well as mixed micelle 
systems (214). 
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Figure 10. Structures of various natural and synthetic chiral surfactants used in CE: (A) Steroid 
skeleton of bile salts, (B) dodecyl-amino acid ester derivatives, (C) dodecyl-glucopyranosyl 
derivatives, and (D) 2-undecyl-4-thiazolidine carboxylic acid. 
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As with any additive with ionizable functional groups, chiral surfactants are dependent on pH 
to determine their charge and mobility in aqueous solution. Amine groups in particular are 
affected by this trend, while most carboxylic groups will be deprotonated unless an extremely 
low pH is implemented. The CMC of a surfactant, however, is independent of the pH of the 
surrounding solution, as it is a function of the solvation properties of the surfactant monomer 
by the solvent. 
Organic modifiers may be used in the buffer solution to allow highly hydrophobic analytes to 
achieve equilibrium between the micelle and the bulk solution. But based on the type and 
amount of organic additive, the micellar aggregation may be disrupted by the polarity change 
of the environment. These changes may increase or decrease the selectivity depending on the 
analyte and the surfactant used. 
Polymeric Surfactants 
Polymeric chiral surfactants have been discovered to be highly effective for enantiomeric 
separations in CE as well. Work performed by Warner and co-workers in 1994, utilized 
surfactant polymers for the first time in CE with the chiral separation of naphthol and 
laudanosine derivatives (215). Polymeric chiral surfactants have several advantages over 
traditional non-polymerized micelles. Micelles are highly dynamic systems in which 
surfactant monomers are in constant equilibrium between the micelle and free solution. This 
phenomenon can often limit the micelle's ability to adequately discriminate enantiomers, due 
to the small difference in interaction between the two moieties. Polymeric micelles, being 
covalently bound, eliminate this dynamic system and are therefore able to distinguish 
enantiomers more effectively. In addition, these additives exhibit higher stability, structural 
rigidity, and more controllable aggregate size than non-polymerized micelles (206). 
Spectroscopic studies indicate that polymeric micelles generally have a more compact 
structure than normal micelles, limiting the depth of analyte interaction within the micelle 
(216). As a result, faster mass transfer is observed with polymeric micelles allowing higher 
efficiencies to be obtained. These chiral selectors have also been used for separating various 
acidic, basic, and neutral drugs (217). Other reviews and publications further describe the 
factors and methods for polymeric chiral surfactants in CE (206). 
POLYMERIC CHIRAL SELECTORS 
Linear Carbohydrates 
In addition to cyclic carbohydrates, such as cyclodextrins, linear carbohydrates are effective 
additives for enantioselectivity in CE (Figure 11). The use of oligosaccharides as chiral 
selectors in CE was first demonstrated by D'Hulst and Verbeke, by the separation of various 
anti-inflammatory and anticoagulant drugs (218, 219). Several classes of oligo- and 
polysaccharides are now commonly used in CE. Maltodextrins are neutral polymers 
consisting of D-glucose units linked by a (1-4) linkages. Dextrin, a common maltodexrin, 
shows a wide range of selectivity towards charged analytes (220, 221). Dextran possesses a 
similar structure to maltodextrins, however units are linked via a (1-6) linkages (221). A 
charged derivative of dextran, dextran sulfate, may be applied to separations of neutral 
enantiomers. Three sulfate groups exist at the 2, 3, and 4 positions of the glucose sub unit, 
providing a strong negative charge at most pHs used in CE. Chondroitin sulfate A, B, and C 
(221) may also be used as charged additives for chiral resolution, and differ only by the 
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position and orientation of its sulfate and carboxylic functional groups. Heparin, another a 
(1-4) linked polysaccharide, is composed of variably sulfonated D-glucosamine with either 
L-iduronic or D-glucuronic acids. This highly anionic linear carbohydrate shows excellent 
resolution for both cationic and amine containing chiral analytes (222, 223). More recently, 
pentosan polysulfate has been found to be quite effective for the separation of analytes with 
one or more basic functional groups. Its structure, primarily of D-xylopyranose units 
connected by (3 (1-4) linkages, contains numerous ionizable groups per subunit, allowing 
strong electrostatic interactions with cationic analytes (224). 
The selectivity of linear carbohydrates is similar to that of cyclodextrins, and efficiency 
increases with the length of the polysaccharide chain (220). Obviously only carbohydrates 
with good aqueous solubility may be utilized in CE. Therefore, it is important to note that as 
the length of the polysaccharide increases, its solubility decreases. With most commercially 
available polysaccharides, the size of the polymer chain is characterized by its degree of 
polymerization (DP). For maltodextrins, the dextrose equivalent value (DE) indicates the 
level of hydrolyzed glucose units in a given mixture, and is related to extent of polymer 
fragmentation. In general, higher DP and lower DE values (longer, less fragmented chains) 
produce better enantioseparation (225). 
Linear carbohydrates with a (1-4) linkages are thought to exist in aqueous solutions in a 
segmented helix conformation, leading to the creation of an interior hydrophobic region. At 
least 6 glucose units are required for a full helix (226). Upon interaction with an analyte, the 
chain may contort to include the compound. The flexibility of the polymer allows a wide 
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range of molecules to interact, making them relatively versatile (163). a (1-6) linkages limit 
the carbohydrate's ability to form helical structures, resulting in their inability to resolve 
some compounds that are separated with a (1-4) polysaccharides (218). 
Dextrin 
Dextran 
CH,OH 
Heparin 
Chondroitin Sulfate A 
CH20S03" CH2OSO3-
COOH COOH CH.OH CHiOH 
NHCOCH, NHCOCH, 
Figure 11. Examples of linear polysaccharide structures used as chiral selectors in capillary 
electrophoresis: dextran, dextrin, heparin, and chondroitin sulfate A. 
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The buffer composition and pH have a large impact on the selectivity of linear carbohydrates. 
Changes in the conformation of the polymer can be induced by modifying the buffer, which 
can affect analyte interaction. For charged polysaccharides, pH can also change its mobility 
by protonating or deprotonating ionizable functional groups. 
Proteins 
Another class of polymeric chiral selectors that are less frequently used in CE is proteins. 
These large biopolymers, consisting of amino acid residues, form complicated conformations 
based on the interactions between the amino acid functional groups and the formation of 
hydrophobic regions inside the protein. This elaborate structure enables a wide range of 
molecules to be resolved. Numerous sites for chiral recognition are available on a single 
protein, utilizing H-bonding, hydrophobic and electrostatic interactions, and steric effects. 
The conformation of the protein is highly important to its selectivity and is significantly 
dependent on the conditions of the run buffer. 
The most commonly studied proteins in CE are bovine serum albumin (BSA) (227) and 
human serum albumin (HSA). Others include ai-acid glycoprotein, ovomucoid (228), 
conalbumin, and pepsin. Pharmaceutical drugs are often common analytes for this class of 
chiral selectors (229, 230). 
The interactions between proteins and racemic analytes are generally very strong, as well as 
highly selective. Binding constants tend to be within the 103-106 range (231). This effect is 
especially pronounced for hydrophobic analytes that include strongly within the protein. As 
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a result, proteins produce highly selective separations with relatively low efficiency in pure 
aqueous environments. Organic modifiers are an extremely effective method of tuning the 
separation system. Increasing the level of nonpolar character of the buffer will lower the 
effective binding of hydrophobic analytes to the protein. In addition, nonpolar solvents 
greatly induce conformational changes to the protein, which in turn affects selectivity. 
Proteins, like many other chiral additives, are highly UV absorbing due to their UV active 
residues, such as tryptophan. As a result, a partial filling technique is often used when 
utilizing an absorbance detector. Many proteins also adsorb onto uncoated capillary walls 
easily due to their high number of functional groups. As a result, proteins are not used as 
widely as other chiral selectors in CZE. Several recent reviews cover the protein types and 
separation conditions used in CE more in depth (232, 233). 
5. Capillary Electrochromatography 
Most of the discussed chiral selectors, with the exception of chiral surfactants, may be 
applied to capillary electrochromatography (CEC) as an alternative method of separation. By 
immobilizing the chiral additive onto a stationary phase within the capillary, problems such 
as aqueous solubility and high UV absorption can be alleviated. This stationary phase may 
be either a chemically bonded coating on the inner capillary wall or particles packed 
throughout the capillary. The resulting system therefore parallels closely to reversed phase 
LC. Micelles, however, may be used additionally as a third phase within the run buffer, in 
order to increase enantiomeric resolution. Numerous examples of capillary 
electrochromatography are available in literature utilizing proteins (234), native (235) and 
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derivitized cyclodextrins (236, 237), cellulose derivatives (238), and macrocyclic 
glycopeptides (239, 240). While electrochromatographic systems allow higher sample 
capacities than some of the chiral selectors mentioned previously (such as surfactant 
micelles), the slow mass transfer between the stationary phase and the liquid mobile phase in 
capillaries >50 /xm I.D. can significantly limit efficiency (241). Another difficulty of CEC is 
the strong EOF dependence on the composition of the stationary phase. As a result, the 
magnitude and direction of the EOF can be unpredictable and unreliable (166). However, 
with further development of methodologies and instrumentation, the use of CEC for 
enantiomeric separations may increase greatly. 
6. Conclusions 
There is no doubt that chromatography can be considered a powerful tool for enantiomeric 
separations for wide varieties of compounds at both analytical and preparative scales. 
Nowadays, numerous chiral stationary phases have been developed, of which, over 200 CSPs 
have been commercialized. However, since there is no universal CSP available, most 
pharmaceutical companies often use high throughput chiral screening technologies to meet 
the need of enantiomeric separations at the analytical scale. Therefore, elucidation of the 
chiral discrimination mechanism on CSPs at the molecular level becomes essential for further 
developments in chiral separations. Several approaches to clarify the chiral recognition 
mechanism on CSPs for HPLC have been attempted by means of chromatography, NMR, 
and computational methods. The results will serve to develop more effective CSPs. Overall, 
with the better understanding of the molecular principles/mechanisms governing chiral 
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recognitions, one day people may choose and create suitable chiral selectors for given 
enantiomers. 
With increasing environmental concern, SFC has also become a popular enantiomeric 
separation technique because of its easy solvent disposal and low waste generated. In 
addition, SFC provides fast separation because high flow rates can be used. With all the 
aforementioned advantages, enantioseparations by SFC will maintain and even gain a higher 
importance in the future not only at the analytical scale, but at the preparative scale as well. 
Recently, CE has become a useful complimentary chiral separation technique. Although CE 
is more often used by academic researchers, it provides fast separation, high efficiency with 
low waste generated. These characteristics best meet the future demands in terms of speed 
and cost. However, CE can only be used for analytical scale separations because of its small 
sample capacity. With the better understanding of CE instrumentation and methodology, as 
well as the further development of microchip CE devices, chiral separation based on CE may 
become more routine in the future. 
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CHAPTER 2 
SUPER/SUBCRITICAL FLUID CHROMOATOGRAPHY CHIRAL 
SEPARATIONS WITH MACROCYCLIC GLYCOPEPTIDE 
STATIONARY PHASES 
A paper published in Journal of Chromatography A 
Ying Liu, Alain Berthod, Clifford R. Mitchell, Tom L. Xiao, Bo Zhang, William S. Jenks, 
Daniel W. Armstrong 
Abstract 
The chiral recognition capabilities of three macrocyclic glycopeptide chiral selectors, namely 
teicoplanin (Chirobiotic® T), its aglycone (Chirobiotic TAG) and ristocetin (Chirobiotic R), 
were evaluated with supercritical and subcritical fluid mobile phases. A set of 111 chiral 
compounds including heterocycles, analgesics (nonsteroidal anti-inflammatory compounds), 
^-blockers, sulfoxides, /V-b locked amino-acids and native amino-acids was separated on the 
three chiral stationary phases (CSP). All separations were done with an outlet pressure 
regulated at 100 bar, 31°C and at 4 mL/min. Various amounts of methanol ranging from 7 to 
67% v/v were added to the carbon dioxide along with small amounts (0.1 to 0.5 % v/v) of 
triethylamine and/or trifluoroacetic acid. The Chirobiotic TAG CSP was the most effective 
closely followed by the Chirobiotic T column. Both columns were able to separate, partially 
or fully, 92% of the enantiomers of the compound set. The ristocetin chiral selector could 
partially or baseline resolve only 60% of the enantiomers tested. All separations were done 
in less than 15 min and 70% were done in less than 4 min. The speed of the separations is 
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the main advantage of the use of SFC compared to normal phase HPLC. In addition, SFC is 
advantageous for preparative separations with easy solute recovery and solvent disposal. 
2.1 Introduction 
The use of supercritical fluids as eluents for chromatographic separations was first proposed 
by Klesper et al. in 1962 [1]. The advantages of supercritical fluids were numerous: reduced 
viscosity giving low pressure drop and allowing high flow rates or long columns, high solute 
diffusion coefficients giving fast mass transfer and high efficiency, ease of disposal and 
solute recovery in preparative modes, and the ability to use GC-type detectors. 
Unfortunately in the 1980s, studies greatly overestimated the solvent strength of supercritical 
CO2 and led to some disappointment in applicability of supercritical fluid chromatography 
(SFC) [2]. It was rapidly realized that the polarity of supercritical CO2 was similar to 
pentane. It was necessary to add significant amounts of polar solvents to the CO2 eluent to 
obtain a useful solvent strength. These solvent additions greatly limited the advantages of 
pure CO2, and the use of capillary SFC never became a mainstream method. 
With the increased environmental concerns, SFC with packed columns recently saw a rebirth 
as a potential replacement for normal-phase liquid chromatography [3], The use of packed-
column SFC grew relative to capillary SFC, which also had limited sample capacity and 
lacked preparative capabilities. Instrumentation for packed-column SFC was made more 
reliable using many of the same components as traditional LC [2]. A LC pump with a chilled 
head is used to measure CO2 in the liquid state and a second LC pump dispenses the organic 
modifier. The composition of the eluent is controlled by varying the flows delivered by each 
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pump as in any LC gradient system [3], A backpressure regulator is required at the system 
outlet to control the pressure and prevent expansion of the eluent into a gas in the detector 
cell. This implies that the detector cell, which is similar to a LC UV detector, must be 
capable of withstanding elevated pressure. 
Chiral SFC with packed columns was first proposed for the separation of chiral phosphorous-
containing derivatives by Mourier et al. in 1985 [4], The properties of supercritical fluids are 
especially useful in chiral separations that use almost exclusively subcritical mobile phases 
containing large amounts of modifier and mild conditions [5]. Using SFC for chiral 
separations, it is expected that the increased diffusivity will lead to sharper peaks and 
increased resolution. The low viscosity of SFC eluents should allow faster separations and 
rapid method development. The last point is essential. With rapid column equilibration, 
simple mobile phase composition and a reduced number of columns to evaluate, SFC is 
selected as the first try for chiral separations in some industrial cases [6]. 
The macrocyclic glycopeptide chiral stationary phases has been found to be extremely useful 
in the chiral separation of native amino acids [7-9], food flavors [10], so-called 
enantiomerically pure reagents and catalysts [11,12], and a wide variety of compounds of 
various polarities [13-15], Macrocyclic antibiotic columns were used with SFC mobile 
phases. A vancomycin based CSP was able to separate the enantiomers of ^-adrenergic 
blocking agents and other pharmaceuticals [16]. Cyclic ketones and dioxalene derivatives 
were separated by chiral SFC using teicoplanin and vancomycin based columns [17]. A 
ristocetin CSP was tested with SFC mobile phases to resolve the enantiomers of acidic drugs 
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[18]. 44 racemates were evaluated for separation on teicoplanin and vancomycin CSPs with 
SFC mobile phases [19]. 
An in depth evaluation of the capabilities of macrocyclic glycopeptide-based CSPs used with 
SFC mobile phases has not been reported to our knowledge. In this work a set of 111 chiral 
compounds with widely differing functionalities, acids, bases, heterocyclic compounds, j3-
blockers, chiral sulfoxides, derivatized and native amino-acids, was tested with three 
commercially available macrocyclic based CSPs: teicoplanin (T), ristocetin (R) and the 
recently introduced teicoplanin aglycone (TAG) [20]. Experimental conditions were 
deliberately chosen to favor fast (high flow rates) rather than efficient (high plate number) 
separations. The results obtained on the three CSPs are compared and discussed in terms of 
enantiorecognition capabilities. 
2.2 Experimental 
SFC Chromatograph 
A Berger Instrument SFC with a flow control module, an automatic injector, a diode array 
detector and a Berger Instruments ChemStation (Berger Instruments, Newark, DE, USA) was 
used. The chromatograph had two reciprocating pumps, one with a refrigerated head was 
dispensing the liquid CO2, the second one controlled the organic modifier. A personal scale 
was placed under the CO2 cylinder as a gauge indicating the amount of CO2 remaining in it. 
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Chiral Stationary Phases 
Three different 25 cm x 4.6 mm i.d. columns were obtained from Astec, Whippany, NJ, 
USA. They were Chirobiotic® T, Chirobiotic R and Chirobiotic TAG whose chiral selectors 
were, respectively, the teicoplanin, C88H97CI2N9O33, m.w. 1878, and ristocetin, 
C95H110N8O44, m.w. 2066, macrocyclic glycopeptides and the aglycone core of teicoplanin, 
C58H45CI2N7O18, m.w. 1197. These chiral stationary phases (CSPs) were extensively 
described in previous articles [8-14]. 
The Solutes 
111 solutes of a wide variety of functionalities were evaluated on the three Chirobiotic CSPs. 
They were sorted in 6 classes referred to by letters A to F. Class A contains a variety of 
heterocyclic compounds that are mainly amides (oxazolidinone or imidazolidinone) and 
esters (lactone, furanone). Three compounds of this class, hydrobenzoin (A15), N,S-
dimethyl-S-phenylsulfoximine (A16) and norgestrel (A 18) are not heterocyclic compounds. 
Class B is made of chiral acids, especially anti-inflammatory molecules (the "profen" family) 
and propionic acid derivatives. Class C is the ^-blockers compounds. Class D is made of 31 
chiral sulfoxides, many of them especially synthesized by the group of Dr. Jenks at Iowa 
State University. Class E compounds are dinitrophenyl (DNP), dinitropyridyl (DNPyr) or 
carboxybenzyl (CBZ) TV-derivatized amino-acids. Class F gathers underivatized amino-
acids. 
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Other Chemicals 
Only SFC grade CO2 (Matheson Gas, Chicago, IL, USA) in 17.7 kg cylinders was used. 
Triethylamine (TEA) and dimethylamine (DMA) were purchased from Aldrich (Milwaukee, 
WI, USA). Methanol, trifluoroacetic acid (TFA) and glycerol were from Fisher Scientific 
(Fairlawn, NJ, USA). The chiral sulfoxides were synthesized by the Jenks' group at Iowa 
State University (Ames, IA, USA). All the other chiral compounds were obtained from 
Sigma (St Louis, MO, USA). 
Protocol 
The solutes were dissolved in methanol (concentration between 1 and 5 mg/mL) except 
native amino-acids that were dissolved in water (pH 1). All separations were done in 
isocratic condition at 31°C and regulating the pressure at the detector outlet at 100 kg/cm2 
(100 bar, 10 MPa or 1430 p.s.i.). The organic additive pump was fed by the methanol + TFA 
and/or TEA mixture. Small amounts of glycerol and/or water were added to elute native 
amino-acids. Three wavelengths, 214, 220 and 254 nm, were continuously monitored. 
2.3 Results and Discussion 
Selecting the experimental conditions 
All previous studies using SFC and macrocyclic glycopeptide CSPs have shown that the 
enantioselectivity factors decreased as the temperature increased [17-19]. So a constant and 
low temperature, 31°C, was selected for all separations. Similarly, it was found that raising 
the pressure decreased the enantioresolution factors [17]. A constant outlet pressure of 100 
bar (10 MPa or 1430 p.s.i.) was used in all cases. The SFC instrument controls the mobile 
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phase pressure at the column outlet, after the detector cell (see Experimental). This means 
that the actual inlet pressure is not the same for all experiments although it is constant during 
a given isocratic separation. The inlet pressure depends on the column permeability and on 
the mobile phase composition. Since the mobile phase viscosity increases when the 
methanol percentage increases, the inlet column pressure is higher, at constant flow rate, 
when a high percentage of methanol is added to CO2. 
It can be argued that the mobile phases used are not all supercritical fluids. However, it was 
demonstrated that the changes in viscosity and solute diffusion coefficients between 
supercritical and subcritical or liquid mobile phases were continuous [2,21]. The mobile 
phase compositions used in this work contained between 4 and 60% v/v methanol as organic 
modifier. When 60% methanol is "added" to CO2, it can clearly be considered that it is 
actually 40% CO2 that is "added" to liquid methanol. At 31°C and more than 100 bar of 
pressure, the physico-chemical properties of the methanol-C02 mixtures change gradually 
from a pure supercritical state (no methanol) to a pure liquid (100% methanol) through the 
subcritical state. No phase separation occurs [3,21]. So, all CCh-methanol mixtures will be 
called SFC mobile phases, the S standing for "supercritical" in CO2 rich mobile phases and 
for "subcritical" in methanol-rich mobile phase. 
Trifluoroacetic acid (TFA) and/or triethylamine (TEA) were also added to the SFC mobile 
phases. Obviously, addition of TFA will protonate the solute and/or stationary phase basic 
sites and TEA additions will neutralize analyte and/or stationary phase acid sites. These 
ionization changes greatly affect the solute retention behavior and enantioselectivity. A 
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milliliter of TFA and TEA correspond respectively to 13.5 and 7.2 millimoles. Then, when 
equal volumes of TFA and TEA are added to a mobile phase, it remains acidic. The amount 
of TFA and TEA added to the SFC mobile phases depends on the solutes studied. 
Overall CSP Effectiveness 
Compound D27, methyl hexyl sulfoxide, is the only compound whose enantiomers could not 
be separated at all (Rs = 0). The enantiomers of all other 110 compounds could be fully 
separated (Rs > 1.5) by at least one of the macrocyclic glycopeptide CSPs. Table 1 lists the 
results. By chance, the two teicoplanin based chiral selectors were able to resolve fully (Rs = 
1.5 or greater) or partially (0.4 < Rs < 1.5) the enantiomers of exactly the same number of 
compounds: 63 compounds (57%) were baseline separated by the two Chirobiotic T and 
TAG columns and 39 (35%) were partially separated. The enantiomers of 9 compounds only 
(8%) could not be resolved. These identical numbers do not correspond to the same 
compounds. The Chirobiotic T column was the only one able to separate the enantiomers of 
compounds  A8 ,  A16 ,  D2  and  D16  (Tab le  1 ) .  S imi la r ly ,  t he  enan t iomers  o f  compounds  CI ,  
C2, C7 and F11 were separated only with the Chirobiotic TAG column. 
The Chirobiotic R column was significantly less successful. It could separate, with baseline 
return between peaks, the enantiomers of 25 compounds (22%, Table 1). 42 more 
compounds (38%) were partially resolved and there were no separations for the 44 remaining 
compounds (40%). However, the enantiomers of D17 and D20 could be separated only by 
the ristocetin CSP. 
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0.9 
All compounds A B C D E F 
Figure 1. Most effective CSP in the separation of the enantiomers of the 6 classes of compounds. A 
= heterocyclic compounds, B = chiral acids, C = |3-blockers, D = chiral sulfoxides, E = vV-blocked 
amino acids, F = native amino-acids. 
Table 1 shows that the resolution factors obtained for the same compound with the 3 
different columns may differ widely. Figure 1 shows the number of best enantioseparations 
obtained for each class of compounds and each CSP. Clearly, the Chirobiotic TAG column 
shows a better effectiveness except in the separation of ^-blockers enantiomers (Class C) 
where the Chirobiotic T column is clearly superior. Of the whole set of enantiomers, 55% 
(61 compounds) are best separated by the Chirobiotic TAG column, 35% (38 compounds) by 
the Chirobiotic T column and 10% (11 compounds) by the Chirobiotic R column (Figure. 1). 
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Class A, Heterocyclic Compounds 
Most of the compounds in this class have a stereogenic center that is part of a heterocyclic 
ring. This structural configuration introduces some rigidity in and around the stereogenic 
center and renders the two enantiomers easier to differentiate compared to stereogenic 
centers with four freely rotating substituents [22]. This may be the reason why the three 
highest resolution factors obtained with Chirobiotic T and TAG columns correspond to the 
Class-A compounds. For Chirobiotic T, the Rs values for Compounds A6, Al 1 and A3 were 
12.2, 9.0 and 6.2, respectively (Table 1). For Chirobiotic TAG, the Rs values were 9.1, 8.0 
and 6.9 obtained for Compounds All, A2 and A6, respectively. A Rs value of 8.0 was also 
obtained on the Chirobiotic R column for the A6 compound. Compounds A15 and A16 are 
not heterocyclic compounds. They were included with the Class A compounds to compare 
the enantioresolution obtained with two chiral compounds with a free stereogenic center and 
compounds with ring-blocked stereogenic centers. A15 and A16 are significantly less 
enantioresolved by the three CSPs, compared to most other Class-A compounds. 
The speed of these enantiomeric separations should be noted. With the standard 
experimental conditions used, 100 bar, 31°C and 4 mL/min, and different methanol content 
as listed in Table 1, all heterocyclic compounds were eluted in less than 10 min. 18 class-A 
compounds (70%) were eluted in less than 5 min. Several compounds of this class were 
separated by HPLC with similar resolution factors, but the duration of analysis was 
commonly three times higher [13]. 
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Class B, Chiral Acids 
The ristocetin chiral selector is not able to separate the enantiomers of the Class B chiral 
acids as well as the teicoplanin and its aglycone analogue do. All 12 acids are resolved, at 
least partially by the Chirobiotic T and TAG columns. The Chirobiotic R column could 
separate only three. 
From a mechanistic point of view, it should be noted that the enantiomers of the acid 
compounds are separated with two very different mobile phase compositions. They are 
either acidic SFC mobile phases containing low amounts of methanol (15% v/v or less) or 
basic SFC mobile phases with a high methanol content (more than 40% v/v) (Table 1). With 
TFA containing mobile phases, the class-B solutes are in their molecular form and the CSPs 
are positively charged since their carboxylic acid groups are neutral and their amine groups 
are protonated. Acidic polar organic mobile phases are used to separate these compounds by 
HPLC [11,12]. With basic mobile phases, the acid solutes are negatively charged and so are 
the CSPs. Table 1 shows that good separation of enantiomeric pairs could be obtained in 
these conditions with methanol rich SFC mobile phases. Figure 2 illustrates this point with 
the Chirobiotic T column. Figure 2A shows the separation of Compound B12 with a SFC 
mobile phase containing 7% added methanol. The enantiomers are partially separated with 
tailing peaks in less than 5 min. If a small amount of TFA (0.1 % v/v) is added, the 
enantioseparation is lost (Figure 2B). With an equal 0.1% amount of TEA and TFA added to 
the 7 % methanol, the SFC mobile phase is still acidic and one tailing peak is still obtained 
(Figure 2C). When 0.1% v/v TEA is added to the mobile phase, the enantiomers are 
separated but the retention times increased to over 20 min. Increasing the methanol content 
85 
to 40%, with the 0.1 % v/v TEA allows baseline resolution (Rs = 1.6) to be obtained in less 
than 3 min (Fig. 2D). 
MeOH 7% 
200 
175 
150 
B mAU _ MeOH 7% + 0.1% TFA 
400 
200 
mAU 
MeOH 7% 
+ 0.1% TEA +0.1% TFA 200 
too 
mAU 
200 MeOH 40% + 0.1% TEA 
100 
Figure 2. Effect on additives on the separation of the enantiomers of B12, 2-(4-chlorophenoxy) 
propionic acid. A: C02 + 7% v/v methanol, 4 mL/min, 100 bar outlet pressure, 31°C; B: Same as A 
except 0.1% trifluoroacetic acid were added to methanol; C: Same as A except 0.1% trifluoroacetic 
acid and 0.1% triethylamine were added to methanol; D: Same as A except 40% methanol and 0.1% 
triethylamine were added to C02. 
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Class C, /3-blockers 
The /3-adrenergic blockers are all secondary amines with very similar molecular structures 
(i.e., R-0-CH2-C*H0H-CH2-NH-CH(CH3)2). The R substituent is always aromatic. It was 
necessary to use high amounts of methanol (more than 20% v/v) and to add 0.1% v/v of both 
TEA and TFA to most SFC mobile phases. These mixtures are acidic since 0.1% v/v TEA 
(7.3 mM) is completely neutralized by 0.1% v/v TFA (13.5 mM). It means the ^-blockers 
are in their protonated cationic form when separated by the glycopeptide-based CSP 
columns. 
The ristocetin chiral selector was unable to resolve enantiomers of any Class C compounds. 
Teicoplanin was the best chiral selector for this set of compounds. The teicoplanin aglycone 
was able to approach the results obtained with teicoplanin for three compounds (C3, C4 and 
C5) and to match them for C6 (propanolol, Table 1). All successful chiral separations were 
obtained with more than 40% v/v methanol. 
Class D, Chiral Sulfoxides 
Trivalent sulfur compounds such as sulfoxides have non-planar geometries and, when 
asymmetrically substituted, can be found as stable enantiomers at room temperature [23]. 
Traditionally, the sulfoxide group has been represented in illustrations as S=0, implying the 
existence of a second bond between the two atoms. A more modern understanding is that the 
S-0 bond is more ylide-like, i.e. the molecule bears no overall charge but has a negatively 
charged oxygen atom bonded to a positively charged sulfur atom [24]. The sulfur 
stereogenic center is pyramidal, with a lone pair occupying the fourth position of the 
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pseudotetrahedral center. We demonstrated in recent work that the Chirobiotic T, TAG and 
R were very effective in separating sulfoxide enantiomers in the normal phase mode (hexane-
ethanol 90-10 % v/v mobile phases) [25]. It was then logical to try SFC conditions to 
separate these compounds with the same Chirobiotic CSPs. 
No additive other than methanol in small amounts (7% or 15% v/v) was needed to obtain the 
enantioseparation^. Fig. 1 shows that the TAG CSP was the most effective stationary phase 
for this class of compounds. The Chirobiotic TAG column could separate the enantiomers of 
28 sulfoxides (90%) of which 17 sulfoxides (55%) were baseline separated. The teicoplanin 
based CSP could separate 25 compounds (80%) and 15 (48%) with baseline return. The 
Chirobiotic R column could separate 16 compounds (52%) with only 6 (20%) at baseline. 
Compounds D2 and D16 were separated by the TAG CSP only. Similarly, Compounds D17 
and D20 showed enantioresolution with the R CSP only. 
These results correspond to what was obtained with the same columns and hexane-ethanol 
90-10 % v/v or hexane-isopropyl alcohol 90-10 % v/v normal mobile phases [25]. Figure 3 
compares the enantioselectivity factors obtained with SFC and HPLC (hexane-ethanol 90-10 
% v/v normal mobile phase) for the ortho, meta and para isomers of the methyl, chloro and 
bromo methyl-phenyl sulfoxides, Compounds D2-D4, D6-D8 and D9-D11, respectively. 
The similarity of the results is striking. The enantioselectivity factor on the TAG CSP and 
teicoplanin CSP shows a maximum for all meta isomers, in SFC as well as in HPLC in the 
normal-phase mode. The enantioselectivity factors obtained with HPLC are slightly 
(teicoplanin) or significantly (TAG) higher than those obtained with SFC (Fig. 3). D27, the 
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only compound that was not separated in SFC, was also not separated in HPLC with the 
same three CSPs and normal-phase mobile phases. Though, D27 was baseline separated by 
the teicoplanin and TAG columns with a methanol-pH 4.1 buffer 20-80 % v/v reversed 
mobile phase [25]. It seems that the chiral recognition mechanism for the sulfoxides is very 
similar with CC^-methanol mobile phases and normal phase hexane-alcohol mobile phases. 
SFC teicoplanin aglycone 
ortho para 
ortho meta para 
2.2 
• 
» 
- . 
HPLC normal phase -teicoplanin aglycone 
ortho para 
SFC teicoplanin 
1 - • - Br 
• CI 
" —A—CK3 
• * 
# 
sf v 
* X 
V 
HPLC normal phase • teicoplanin 
ortho para 
Figure 3: Comparing SFC and HPLC enantioselectivity for ortho, meta and para substituted phenyl 
methyl sulfoxides. Top figures: column Chirobiotic TAG. Bottom figures: column Chirobiotic T. 
Left figures: SFC with 7 %v/v methanol, 100 bar, 31°C, 4 mL/min. Right figures: HPLC with 
hexane-isopropyl alcohol (90-10 % v/v), 1 mL/min, data from [25]. 
The similarities between the HPLC findings and the SFC results were not absolute. For 
example, the ristocetin chiral selector was least effective for sulfoxide enantioresolution; it is, 
however, the only one that separated the enantiomers of compounds D17 and D20 and the 
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most effective selector for compounds D18 and D19 with SFC mobile phases. All four 
compounds are derivatives of phenyl benzyl sulfoxides. With HPLC normal-phase mobile 
phases, compound D19 was the only one that matched the SFC results. It was partially 
resolved by the ristocetin CSP only [25]. D17, D18 and D20 were better resolved by the 
Chirobiotic T and TAG CSPs. Compound D17 was partially separated by the TAG CSP 
only; compounds D18 was partially resolved by the three CSPs, and compound D20 was 
partially separated by the teicoplanin and TAG CSPs, and not by the ristocetin CSP, an 
opposite result compared to SFC. 
Class E, N-blocked Amino-Acids 
TV-blocked amino-acids are acidic compounds. So they should be separated using conditions 
similar to the ones used for Class B acidic compounds. It turned out that the 7% v/v 
methanol 0.5% TFA SFC mobile phase was not useful in separating the enantiomers of these 
compounds. The methanol rich SFC mobile phases were much more successful. Most 
baseline separations were obtained with 40% or 60% methanol in the SFC mobile phases. 
Addition of 0.1% v/v TEA was often needed to obtain the enantioseparation, which means 
the solutes and the stationary phase were in negatively charged forms. 
Figure 4 illustrates the additive effect with the Chirobiotic T column and Compound E4 
(DNPyr-leucine). Figure 4A shows that a baseline separation is obtained with 15% methanol 
and no other additives. The peaks are tailing somewhat. The separation is lost when 0.1% 
TFA is added (Figure 4B). Adding both TEA and TFA (0.1%) partially restores the 
enantioseparation (Figure 4C). Adding only 0.1% TEA produced an excellent separation but 
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retention times greater than 25 min (not shown). Increasing the methanol content to 40% v/v 
decreased the retention times below 4 min as shown by Figure 4D with enantioselectivity and 
resolution factors as high as 2.3 and 5.4, respectively. 
mAU . 
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lOO-
B 
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SO 
o 
n 
mAU 
—7— 
2 
"T 
2 
2 
MeOH 15% 
MeOH 15% + 0.1% TFA 
\ A 
MeOH 15% + 0.1% TFA 
MeOH 40% + 0.1% TEA 
Figure 4. Effect on additives on the separation of the enantiomers of E4, DNPyr-leucine. A: C02 + 
15% v/v methanol, 4 mL/min, 100 bar outlet pressure, 31°C; B: Same as A except 0.1% 
trifluoroacetic acid were added to methanol; C: Same as A except 0.1% trifluoroacetic acid and 0.1% 
triethylamine were added to methanol, separation is partially restored (compare with Fig. 2C); D: 
Same as A except 40% methanol and 0.1% triethylamine were added to C02. 
The enantiomers of the DNPyr or CBZ derivatives of alanine (E3 and El7, respectively) 
were extremely well separated on all three CSPs without any optimization. The 
enantioselectivity factors were higher than 1.6 and the enantioresolution factors were higher 
than 2.5 (Table 1). This is due to the natural antibiotic property of the three CSPs that bind 
to the D-Ala-D-Ala terminal group of the terminal dipeptide of the microbial cell wall of 
Gram+ bacteria [26]. The chiral selectors have a high affinity for the D-Ala amino-acid and 
the L-Ala form is much less retained. Since the amine group of alanine is derivatized, it 
shows that the carboxylic acid group is essential in the recognition mechanism [8-12]. 
Changing the methyl group attached to the stereogenic center of alanine for other groups 
produces the other amino acids that are also enantiodifferenciated by the CSPs, but somewhat 
less well than alanine (Table 1). 
Figure 5 compares the separation of El9 (CBZ-norvaline) in HPLC with a classical 
methanol-pH 4.1 buffer (20-80 % v/v) and the SFC separation with 40 % methanol on both 
the Chirobiotic T and R columns. In all cases, the enantiomers were baseline separated. The 
peak shape obtained with the classical reversed phase mobile phases is better than the one 
obtained with the SFC mobile phases. But the HPLC separations that needed 18 min or 13 
min on ristocetin or teicoplanin CSPs, respectively, were performed in less than 3 min with 
SFC mobile phases (Fig. 5). 
Class F, Native Amino Acids. 
It was mentioned in the introduction that SFC is a useful substitute to normal phase 
chromatography. In this work, polar compounds such as native, underivatized amino acids, 
that require reversed phase polar mobile phases in HPLC, were tested to see if they could be 
enantioresolved by SFC. Two problems were encountered: 1) native amino acids lacking an 
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aromatic substituent poorly absorb UV light making them difficult to detect. Only the 214 
nm detector wavelength gave some absorbance. 2) Following the example of Medvedovici et 
al., small amounts of water and/or glycerol can be added to the mobile phase to enhance the 
solubility of polar analytes and to improve peak shape [19]. 
HPLC 
t 
o 
1 1 \ 
10 
+ 0 20 min 15 min 
Ristocetin A Teicopianin 
Ristocetin A Teicoplanin 
Figure 5: Comparison of HPLC (top) and SFC (bottom) enantiomer separations of E19 (CBZ-
norvaline) on Chirobiotic R (left) and Chirobiotic T (right) columns. HPLC: pH 4.1 buffer-methanol 
(80:20 % v/v) mobile phase, 1 mL/min, room temperature. SFC: C02-methanol-TEA (60:40:0.1 % 
v/v) mobile phase, 4 mL/min, 31°C, 100 bar. 
All 24 underivatized amino-acids were enantioseparated almost always to baseline by the 
three macrocyclic glycopeptide CSPs with mobile phase containing more than 47.5% v/v 
methanol, 2 % or more water, 0.1% or more TEA, 0.1% or more TFA and 0.3 % glycerol. 
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Figure 6 shows the separation of F7 (phenylalanine) on the Chirobiotic T and R columns, 
comparing the SFC and classical reversed phase mobile phases. It can be seen that the 
reversed phase HPLC separation of phenylalanine is as good as or even better than the 
corresponding separation by SFC. The retention time is slightly lower with SFC but the peak 
shape is significantly poorer as well. 
HPLC 
i—i—r V 
0 4 8 min 0 
Ristocetin A 
2 4 6 min 
Teicoplanin 
2 4 
Ristocetin A Teicoplanin 
Figure 6: Comparison of HPLC (top) and SFC (bottom) enantiomer separations of F7 
(phenylalanine) on Chirobiotic R (left) and Chirobiotic T (right) columns. HPLC and ristocetin: 
water-methanol (50:50 % v/v) mobile phase; HPLC and teicoplanin: water-ethanol (50:50% v/v) 
mobile phase, 1 mL/min, room temperature. SFC: C02-methanol-water-glycerol-TEA-TFA 
(49.5:48:2:0.3:0.1:0.1 % v/v) mobile phase, 4 mL/min, 31°C, 100 bar. 
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Elution Order 
It is often of great interest to know the enantiomeric elution order of chiral separations. A 
change in the elution order of some compounds was observed with the same mobile phase 
when changing the chiral selector [27]. Pure enantiomers are needed to identify the 
compounds and determine the elution order. It was not possible to have such pure 
enantiomers for all 111 compounds. Table 2 lists the compounds for which the elution order 
could be determined. 
Table 2. Elution order of the compounds eluted by SFC on the three CSPs 
Compound teicoplanin TAG ristocetin 
A1 (R), (S) no separation 
A2 (R), (S) (R), (S) (R),(S) 
A3 (R),(S) (R), (S) (R), (S) 
A4 (R), (S) (R),(S) (R), (S) 
A5 (4S,5R), (4R,5S) (4R,5S), (4S,5R) (4S,5R), (4R,5S) 
A6 (4S,5R), (4R,5S) (4S,5R), (4R,5S) (4S,5R), (4R,5S) 
A7 (4R,5S), (4S,5R) (4R,5S), (4S,5R) no separation 
A9 (S),(%) (S),(R) (S),(R) 
C6 (S),(%) (S), (R) (S),(R) 
D compounds* (S), (R) (S),(R) (R), (S) 
E compounds* (L,D) (L, D) (L,D) 
F compounds* (L, D) (L, D) (L,D) 
* for the separated enantiomers 
In most cases, the same elution order was obtained with the three CSPs. For the compounds 
that were tested for elution order, only A5 and C6 showed inversion of the elution order with 
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the TAG column compared to the T and R columns (Table 2). The sulfoxide compounds 
(Class D) are exceptions. All chiral sulfoxides showed the (S)-(+) as the first eluting 
enantiomer on the teicoplanin and TAG columns. The (R)-(-) sulfoxide enantiomer was first 
eluted with the ristocetin A column. The high affinity of the natural chiral selector for the D-
form (R) of the amino-acids makes this enantiomer always more retained than the L-amino 
acid (S form). 
2.4 Conclusions 
The separation time factor is the greatest advantage of the SFC mobile phases. As can be 
seen in Table 1, all separations done with subcritical mobile phases were performed in less 
than 15 min, 70% of the separations being done in less than 4 min. The peak shape is not as 
symmetrical as that obtained in the corresponding HPLC separations. It should also be 
pointed out that the column equilibrates much faster with COi-containing mobile phases than 
in normal phase HPLC. This work also showed that the macrocyclic based CSPs are able to 
separate enantiomers of widely different compounds with various functionalities and 
polarities. The teicoplanin aglycone and teicoplanin CSPs seem to be the most effective 
stationary phase with SFC mobile phases. 
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Table 1. Enantiomeric separations on three chirobiotic CSPs by subcritical fluid chromatography 
Code Compound name and formula CSP ti a Rs MeOH Other 
% v/v additive 
Class A: heterocyclic compounds 
A1 R,S-(+/-)-4-benzyl-2-oxazolidinone T 3.73 1.39 2.3 40 
TAG 3.76 1.55 3.9 50 
R 1.64 1.02 0.3 40 
A2 5,5-dimethyl-4-phenyl-2-oxazolidinone T 1.87 1.56 4.0 40 
A TAG 2.30 2.94 8.0 40 
"3CU 1 R 1.19 1.08 0.8 40 
A3 R,S-(+/-)-4-benzyl-5,5-dimethyl-2-oxazolidinone 
A4 R,S-(+/-)-4-diphenylmethyl-2-oxazolidinone 
JL 
T 2.01 2.96 6.2 40 
TAG 2.52 1.87 4.1 40 
R 1.23 1.36 1.6 40 
T 2.61 1.82 4.1 40 
TAG 2.83 1.52 3.0 40 
R 1.49 1.23 1.4 40 
A5 (4R5S/4S5R)-(+/-)-cis-4,5-diphenyl-2- T 2.11 1.74 4.3 40 
oxazolidinone TAG 4.09 1.23 1.6 40 
NH R 1.38 1.25 1.8 40 
A6 (4R,5S/4S,5R)-(+/-)-4-methyl-5-phenyl-2- T 1.96 3.17 12.2 40 
oxazolidinone H,C^_n„ TAG 3.62 2.53 6.9 40 
R 1.28 3.26 8.0 40 
A7 (4R,5S/4S,5R)-(+/-)-l,5-dimethyl-4-phenyl-2- T 1.27 1.14 1.3 40 
imidazolidinone TAG 1.65 1.42 3.3 40 
N NH 
H3C\n/\o 
R 6.25 1.04 0.9 7 
A8 
CH3 
l-benzyloxycarbonyl-2-tert-butyl-3-methyl-4- T 1.73 1.00 0.0 7 
imidazolidinone 
°» nCH3 TAG 3.69 1.05 0.8 10 
\f^CCCH3 f^YcH2°c CH3 
R 2.80 1.00 0.0 5 
A9 
v ° 
4-hydroxy-2-pyrrolidinone T 2.47 1.05 0.5 40 
TAG 3.53 1.16 1.7 40 
R 2.42 1.08 0.9 40 
Table 1 continued 
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Code Compound name and formula CSP Rs MeOH Other 
% v/v additive 
T 2.47 1.20 1.5 40 
TAG 3.61 1.22 1.6 60 
R 2.32 1.05 0.7 40 
T 2.32 1.05 0.7 40 
TAG 3.20 3.87 9.1 40 
R 2.00 1.39 2.2 40 
T 6.97 1.16 1.4 40 
TAG 4.58 1.38 2.0 60 
A10 RS(-/-)-5-(hydroxymethyl)-2-pyrrolidinone 
Al 1 5-methyl-5-phenylhydantoin 
A12 5-(3 -hydroxyphenyl)-5 -phenyl-hydantoin 
A13 DL-5 -(4-hydroxyphenyl)-5 -phenylhydantoin 
A14 Chlorthalidon 
A15 (R,R/S,S)-(+/-)-Hydrobenzoin 
A16 (R,S)-(+/-)-AfS-dimethyl-S-phenylsulfoximine 
H3C/N 
A17 1. methyl-a-phenyl-succinimide 
A18 Norgestrel 
A19 (lR,5S/lS,5R)-(+/-)-2-Oxabicyclo[3,3,0]-oct-6-
en-3-one 
R 4.14 1.18 0.9 40 
T 8.27 1.16 1.3 40 
TAG 6.14 1.08 0.6 60 
R 4.35 1.12 0.7 40 
T 3.61 1.37 2.9 40 
TAG 4.72 1.82 3.6 45 
R 8.65 1.08 1.0 30 
T 6.70 1.04 0.6 7 
TAG 6.59 1.04 0.7 10 
R 4.75 1.00 0.0 10 
T 4.41 1.00 0.0 5 
TAG 4.80 1.06 0.6 7 
R 3.98 1.00 0.0 5 
T 1.60 1.26 3.0 2 
TAG 2.83 1.47 4.5 15 
R 4.58 1.03 0.6 7 
T 11.92 1.05 1.0 7 
TAG 8.08 1.08 0.9 15 
R 10.49 1.02 0.6 7 
T 
TAG 
R 
1.11 
1.63 
0.90 
1.51 
1.53 
1.20 
2.9 
2.7 
1.0 
40 
30 
40 
0.1 TEA 
TFA 
0.1 TEA 
TFA 
0.1 TEA 
TFA 
0.1 TEA 
TFA 
Table 1 continued 
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Code Compound name and formula CSP Rs MeOH Other 
% v/v additive 
A20 (R,S)-(+/-)-Dihydro-5-(hydroxymethyl)-2(3H)- T 1.31 1.11 0.8 40 
furanone 
j \ TAG 1.63 1.12 0.7 20 
R 1.21 1.00 0.0 40 
A21 (R,S)-(+/-)-5-hydroxymethyl-)-2-(5H)-furanone T 5.25 1.13 1.3 40 
TAG 4.93 1.14 1.2 15 
R 4.72 1.00 0.0 10 
A22 y-nonanoic lactone T 1.53 1.14 1.1 7 
H3C(H2C)3H / o TAG 1.35 1.13 0.8 15 
R 2.79 1.11 0.8 5 
A23 y- phenyl-y-butyrolactone T 2.35 1.29 1.8 7 
TAG 1.75 1.54 2.4 25 
R 5.16 1.03 0.6 5 
A24 DL-pantolactone T 1.67 1.11 1.5 15 
H3C. r-OH 
TAG 2.13 1.23 2.3 15 
R 7.85 1.00 0.0 5 
A25 (+/-) P-butyrolactone T 2.65 1.12 0.8 7 
rf TAG 3.04 1.18 1.4 5 
R 2.48 1.00 0.0 5 
class B, chiral acids 
T 4.05 1.07 1.2 5 0.5 TFA 
TAG 6.44 1.06 1.2 5 0.5 TFA 
R 2.93 1.00 0.0 7 0.5 TFA 
T 3.95 1.07 1.2 5 0.5 TFA 
TAG 5.73 1.05 1.1 5 0.5 TFA 
R 2.90 1.00 0.0 7 0.5 TFA 
T 6.99 1.11 1.9 15 0.5 TFA 
TAG 8.60 1.14 1.6 20 0.5 TFA 
R 6.63 1.00 0.0 15 0.5 TFA 
B1 Flurbiprofen 
B2 Fenoprofen 
B3 Indoprofen 
B4 Ibuprofen T 1.89 1.13 1.5 7 0.5 TFA 
TAG 2.25 1.14 2.2 7 0.5 TFA 
R 2.25 1.14 2.2 7 0.5 TFA 
B5 DL-tropic acid T 8.45 1.07 1.3 7 0.5 TFA 
HO' OH TAG 3.95 1.07 1.3 15 0.5 TFA 
/L R 5.85 1.00 0.0 7 0.5 TFA 
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Table 1 continued 
Code Compound name and formula CSP Rs MeOH Other 
% v/v additive 
T 3.90 1.04 0.5 7 0.5 TFA 
TAG 8.47 1.09 1.2 5 0.5 TFA 
R 3.47 1.24 1.8 7 0.5 TFA 
T 6.84 1.04 0.9 5 0.2 TFA 
TAG 4.28 1.06 1.1 5 0.5 TFA 
R 3.17 1.04 0.8 5 0.2 TFA 
T 2.09 1.10 1.5 7 0.5 TFA 
TAG 2.64 1.12 1.5 7 0.5 TFA 
R 2.11 1.00 0.0 7 0.5 TFA 
T 134 1.09 0.6 7 0.1 TFA 
TAG 1.50 1.72 2.6 60 0.1 TEA 
R 2.43 1.00 0.0 7 0.5 TFA 
T 2.01 1.51 1.7 40 0.1 TEA 
TAG 2.05 1.61 1.6 40 0.1 TEA 
R 2.74 1.00 0.0 7 0.5 TFA 
T 2.02 1.53 0.9 40 0.1 TEA 
TAG 2.88 1.37 1.7 40 0.1 TEA 
R 2.42 1.00 0.0 7 0.5 TFA 
T 2.07 1.59 1.8 40 0.1 TEA 
TAG 2.45 1.74 2.3 40 0.1 TEA 
R 2.44 1.00 0.0 7 0.5 TFA 
B6 a-Methyoxyphenyl acetic acid 
o 
B7 a-phenylcyclopentaneacetic acid 
B8 2-phenyl-propionic acid 
B9 2-phenoxyl-propionic acid 
BIO 2-(2-chlorophenoxy) propionic acid 
B11 2-(3-chlorophenoxy) propionic acid 
B12 2-(4-chlorophenoxy) propionic acid 
Class C, j8-blockers 
CI Atenolol 
i 
T 10.63 1.15 1.5 70 0.1 TFA 
TEA 
<) 0 TAG 4.93 1.00 0.0 60 0.1 TFA 
OH TEA 
R 10.62 1.00 0.0 40 0.1 TFA 
TEA 
C2 Oxprenolol T 4.75 1.14 1.8 60 0.1 TEA 
TAG 3.75 1.00 0.0 40 0.1 TFA 
TEA 
R 6.61 1.00 0.0 20 0.1 TFA 
TEA 
C3 Metoprolol T 2.67 1.14 1.5 40 0.1 TFA 
TEA 
TAG 3.97 1.07 0.8 60 0.1 TFA 
TEA 
R 7.99 1.00 0.0 20 0.1 TFA 
TEA 
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Table 1 continued 
Code Compound name and formula CSP ti a Rs MeOH 
% v/v 
Other 
additive 
C4 Alprenolol 
C5 Acebutolol 
C6 DL-propranolol 
C7 Pindolol 
T 
TAG 
R 
T 
TAG 
R 
T 
TAG 
R 
T 
TAG 
R 
2.06 1.15 
5.19 1.08 
4.89 1.00 
8.90 1.10 
12.49 1.11 
4.14 1.00 
3.08 1.16 
2.89 1.38 
9.35 1.00 
4.41 1.12 
8.11 1.00 
8.71 1.00 
1.5 
1.0 
0.0 
1.1 
1.0 
0.0 
1.8 
2.0 
0.0 
1.4 
0.0 
0.0 
40 
30 
20 
60 
40 
40 
40 
50 
20 
40 
40 
30 
0.1 TFA 
TEA 
0.1 TFA 
TEA 
0.1 TFA 
TEA 
0.1 TEA 
0.1 TFA 
TEA 
0.1 TFA 
TEA 
0.1 TFA 
TEA 
0.1 TFA 
TEA 
0.1 TFA 
TEA 
0.1 TFA 
TEA 
0.1 TFA 
TEA 
0.1 TFA 
TEA 
class D, chiral sulfoxides 
D1 
D2 
D3 
D4 
D5 
D6 
T 
TAG 
R 
T 
TAG 
R 
T 
TAG 
R 
T 
TAG 
R 
T 
TAG 
R 
T 
TAG 
R 
5.14 
8.52 
4.17 
5.37 
9.54 
3.97 
4.37 
318 
156 
4.90 
3.77 
188 
4.3 
7.28 
3.4 
4.81 
8.86 
4.0 
1.03 
1.14 
1.06 
1.00 
1.12 
1.00 
1.22 
1.29 
1.03 
1.00 
1.10 
1.06 
1.15 
1.32 
1.00 
1.19 
1.28 
1.00 
0.4 
0.9 
0.9 
0.0 
1.2 
0.0 
3.1 
3.2 
0.5 
0.0 
1.1 
0.9 
2.4 
3.6 
0.0 
1.9 
2.3 
0.1 
7 
7 
7 
7 
7 
7 
7 
15 
7 
7 
15 
15 
7 
7 
7 
7 
7 
7 
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Code Compound name and formula CSP Rs MeOH 
% v/v 
T 4.31 1.18 2.8 7 
TAG 143 1.31 3.4 15 
R 3.93 1.00 0.0 7 
T 137 1.12 1.8 7 
TAG 3.06 1.20 1.8 15 
R 2.86 1.00 0.0 7 
T 5.75 1.18 2.6 7 
TAG 11.21 1.30 3.5 7 
R 4.62 1.03 0.8 7 
T 4.98 1.22 3.0 7 
TAG 4.04 1.37 4.0 15 
R 4.52 1.00 0.0 7 
T 4.09 1.16 1.8 7 
TAG 3.91 1.22 2.3 15 
R 3.41 1.00 0.0 7 
T 2.65 1.04 0.8 7 
TAG 3.65 1.10 1.3 7 
R 2.2 1.00 0.0 7 
T 9.3 1.12 1.7 7 
TAG 8.09 1.06 0.8 15 
R 7.19 1.00 0.0 7 
T 2.73 1.07 1.0 7 
TAG 1.95 1.19 1.8 15 
R 2.66 1.11 1.4 7 
T 132 1.11 2.0 7 
TAG 2.68 1.18 2.7 15 
R 3.21 1.00 0.0 7 
T 5.25 1.00 0.0 7 
TAG 10.62 1.02 0.4 7 
R 5.25 1.00 0.0 7 
T 5.63 1.00 0.0 7 
TAG 4.22 1.00 0.0 15 
R 4.89 1.11 1.7 7 
T 4.79 1.05 0.8 7 
TAG 4.15 1.04 0.7 15 
R 4.70 1.24 2.6 7 
Other 
additive 
D7 
D8 
D9 
D10 
D l l  
D12 
D13 
D14 
D15 
D16 
D17 
D I S  
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Code Compound name and formula CSP Rs MeOH 
% v/v 
T 8.55 1.03 0.6 7 
TAG 5.89 1.07 1.0 15 
R 7.1 1.21 1.8 7 
T 5.07 1.00 0.0 7 
TAG 10.01 1.00 0.0 7 
R 4.87 1.01 0.4 7 
T 5.98 1.19 3.1 7 
TAG 11.73 1.19 2.4 7 
R 2.39 1.20 2.1 15 
T 4.8 1.05 0.6 7 
TAG 3.39 1.10 1.1 15 
R 4.14 1.05 1.0 7 
T 3.63 1.17 2.1 7 
TAG 5.94 1.22 1.9 7 
R 3.59 1.23 3.7 7 
T 3.69 1.07 1.2 7 
TAG 6.03 1.15 1.5 7 
R 3.67 1.05 0.9 7 
T 7 1.29 4.5 7 
TAG 5.21 1.35 3.8 15 
R 4.98 1.00 0.0 7 
T 155 1.37 5.7 7 
TAG 2.53 1.52 4.7 15 
R 2.61 1.00 0.0 7 
T 3.59 1.00 0.0 7 
TAG 2.37 1.00 0.0 15 
R 2.79 1.00 0.0 7 
T 8.29 1.03 0.7 15 
TAG 6.55 1.05 0.7 25 
R 7.12 1.02 0.5 15 
T 6.81 1.06 1.0 15 
TAG 5.74 1.05 0.7 25 
R 5.96 1.00 0.0 15 
T 8.06 1.24 2.8 7 
TAG 6 62 1.36 2.9 15 
R 5.88 1.08 0.9 7 
Other 
additive 
D19 
D20 
D21 
D22 
D23 
D24 
D25 
D26 
D27 
D28 
D29 
D30 
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Code Compound name and formula CSP t, a Rs MeOH Other 
% v/v additive 
D31 T 9.18 1.05 0.9 7 
TAG 7.23 1.11 1.4 15 
R 8.54 1.11 1.5 7 
class E, N-blocked amino-acids 
El 
E3 
E4 
E5 
E6 
E7 
E8 
N-3,5-DNPyr-DL-serine 
HOH2C—HC—N 
E2 N-3,5 -DNPyr-DL-phenylalanine 
—H2C—HC—N 
N-3,5-DNPyr-DL-alanine 
NO, 
"Q 
NO2 
N-3,5 -DNPyr-DL-leucine 
NO2 
^OOH-/a( (H3C)2HC-H2C—HC—N ^ 
^ \ NO2 
N-2,4-DNP-DL-ethionine 
H3CH2C—S(H2C)2—HC—I 
N-2,4-DNP-DL-norvaline 
H3C-(CHJ)^—N-TA / 
N-2,4-DNP-DL-methionine 
H3C—S-(CHJ)P—N TTA/  
N-2,4-DNP-DL-norleucine 
02N 
COOH 
H3C-(CH#F—N (\ Z) N02 
E9 N-2,4-DNP-DL- a-amino-n-caprylic acid 
H3C<H2C)5 HC—N-
E10 N-2,4-DNP-DL-a-amino-n-butyric acid 
iOOH }=\ 
H3C—H2C—HC—N^—4 NO2 
E l l  N - C B Z - D L - p r o l i n e  
A F N C — O—H2C-
T 4.09 1.74 3.1 25 
TAG 4.36 1.52 1.5 40 
R 5.83 1.30 1.5 40 
T 1.44 1.50 1.5 40 
TAG 2.51 1.29 0.9 40 
R 3.00 195 6.9 40 
T 1.80 107 4.2 25 
TAG 3.49 1.80 2.6 25 
R 2.36 1.61 3.3 40 
T 1.82 125 5.4 40 0.1 TEA 
TAG 2.86 1.47 1.9 15 
R 2.87 1.52 2.9 25 
T 1.91 1.62 2.0 40 
TAG 4.33 1.72 2.0 40 
R 2.28 1.05 0.5 40 0.1 TEA 
T 2.22 1.57 2.4 25 
TAG 4.76 1.46 1.6 25 
R 4.66 1.00 0.0 40 0.1 TEA 
T 1.94 1.89 2.4 40 
TAG 4.96 2.06 2.5 40 
R 6.53 1.06 0.8 40 0.1 TEA 
T 2.14 1.41 2.2 25 
TAG 4.28 1.29 1.0 25 
R 179 1.00 0.0 40 0.1 TEA 
T 3.03 1.48 2.8 40 0.1 TEA 
TAG 5.13 1.21 1.0 40 0.1 TEA 
R 3.08 1.00 0.0 40 0.1 TEA 
T 5.78 1.28 1.8 40 0.1 TEA 
TAG 4.61 1.12 0.7 60 0.1 TEA 
R 5.85 1.31 2.4 40 0.1 TEA 
T 6.56 1.06 0.8 7 
TAG 196 1.10 1.0 15 
R 1.82 1.00 0.0 40 0.1 TEA 
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Table 1 continued 
Code Compound name and formula CSP Rs MeOH 
% v/v 
Other 
additive 
E12 N-CBZ-DL-phenylalanine 
E13 N-CBZ-DL-serine 
?OOH II 
HOH2C—HC—HN—C—O—H2C 
E14 N - CBZ-D L-leucine ÇOOH ° 
(H3C)2HC—H2C—HC—HN—c—0-H2C-
El 5 N-CBZ-DL-tryptophan 
~"CH2—CH—NH—C—O—CH2—u ,} 
"2 \ / 
E16 N-CBZ-DL-Norleucine 
ÇOOH O 
H3C—(H2C)2—HC—HN—C—O—H2C 
El 7 N-CBZ-DL-alanine 
H3C—HC—HN—C—O—H2C ^ ^ 
El 8 N-CBZ-DL-valine 
çooH 0 (CHHC-HC-HN-C-0-H2C^x a 
3)2 ^ ^ 
E19 N-CBZ-DL-norvaline 
ÇOOH o 
H39H2C)2—HC—HN—C—O—H2C 
E20 N-CBZ-DL-methionine 
ÇOOH o 
H3C—S-(CHtig—HN—C—0-H2C — 
E21 N-CBZ-DL-asparagine 
C ÇOOH O , 
H2N—C—H2C—HC—HN—C—O—H2C—^ \ 
E22 DL-alanine-2-naphthylamide hydrochloride 
-NH—C—CH—NH2HCl II I O CH3 
T 2.41 1.25 1.0 40 0.1 TEA 
TAG 3.06 1.27 1.2 40 0.1 TEA 
R 316 1.53 2.2 40 0.1 TEA 
T 4.05 1.39 1.0 40 0.1 TEA 
TAG 1.87 1.66 1.8 60 0.1 TEA 
R 5.69 1.25 1.7 40 0.1 TEA 
T 6.15 1.29 2.2 15 0.1 TEA 
TAG 3.03 1.24 1.7 15 
R 156 1.12 0.9 15 
T 4.31 1.15 0.7 40 0.1 TEA 
TAG 7.24 1.25 1.2 40 0.1 TEA 
R 5.39 1.39 2.1 40 0.1 TEA 
T 1.43 1.45 1.4 40 0.1 TEA 
TAG 1.60 1.76 2.5 40 0.1 TEA 
R 1.55 1.20 1.0 40 0.1 TEA 
T 1.89 1.66 2.4 40 0.1 TEA 
TAG 2.43 2.32 3.3 40 0.1 TEA 
R 2.34 1.51 2.8 40 0.1 TEA 
T 1.42 1.18 0.8 40 0.1 TEA 
TAG 1.61 1.37 1.3 40 0.1 TEA 
R 1.61 1.22 1.1 40 0.1 TEA 
T 1.51 1.54 1.6 40 0.1 TEA 
TAG 1.69 1.90 2.6 40 0.1 TEA 
R 1.68 1.33 1.6 40 0.1 TEA 
T 2.21 1.50 1.8 40 0.1 TEA 
TAG 2.70 1.82 2.8 40 0.1 TEA 
R 2.61 1.35 2.1 40 0.1 TEA 
T 2.72 1.19 0.8 60 0.1 TEA 
TAG 4.06 1.16 0.8 60 0.1 TEA 
R 4.07 1.11 0.8 60 0.1 TEA 
T 4.51 1.00 0.0 40 0.1 TFA 
TEA 
TAG 5.09 1.11 0.9 40 0.1 TFA 
TEA 
R 188 1.19 1.8 40 0.1 TFA 
TEA 
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Table 1 continued 
Code Compound name and formula CSP ti a Rs MeOH Other 
% v/v additive 
class F, Native amino-acids 
F1 Alanine T 2.60 1.94 3.1 48 0.1 TEA TFA 
H3C—HC—COOH 2 H20 0.3 gly 
TAG 4.41 2.06 5.0 47.5 0.15 TEA 
TFA 
2.5 H20, 0.3 
gly 
R 2.80 1.39 1.3 48 0.1 TEA TFA 
2 H20 
F2 Serine T 3.20 1.40 1.8 46.5 0.1 TEA TFA 
HOH2C—HC—COOH 3.5 H20 
TAG 
— — — 
Not detected 
R 4.32 1.17 1.1 48 0.1 TEA TFA 
2 H20 
F3 Asparagine T 4.02 1.54 1.6 57.6 0.15 TEA 
0 NH2 
H2N — C—HJC—HC—COOH TFA 
2.4 HzO 
TAG 218 2.24 3.8 67.2 0.15 TEA 
TFA 
2.8 H20 
R 4.06 1.36 1.8 47.5 0.15 TEA 
TFA 
2.5 H20 0.3 
gly 
F4 Glutamine T 4.06 1.36 1.8 57.6 0.15 TEA 
0 NH2 
H2N—C—(H2Q2—HC—COOH TFA 
2.4 H20 
TAG 2.07 1.50 1.5 67.2 0.15 TEA 
TFA 
2.8 HzO 
R 3.37 1.21 1.2 47.5 0.15 TEA 
TFA 
2.5 HzO 0.3 
gly 
F5 Methionine T 2.55 2.14 3.0 48 0.1 TEA TFA 
NH2 
H3C—S (H2C)2 HC—COOH 2 H20 0.3 gly 
TAG 2.25 4.09 3.7 48 0.1 TEA TFA 
2 HzO 0.3 gly 
R 2.59 1.32 1.1 48 0.1 TEA TFA 
2 H20 
F6 Tryptophan T 3.61 1.71 1.8 48 0.1 TEA TFA 
2 H20 0.3 gly 
L jL/ r 
^5/ —CH2—CH—COOH TAG 133 102 2.3 48 0.1 TEA TFA 
2 H20 0.3 gly 
R 4.10 1.20 0.7 48 0.1 TEA TFA 
2 H20 0.3 gly 
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Table 1 continued 
Code Compound name and formula CSP t, a Rs MeOH Other 
% v/v additive 
F7 Phenylalanine 
H2C—HC—COOH 
F8 Threonine 
4]C—HC—HC—COOH 
F9 Tyrosine 
HO / \ H2C—HC—COOH 
F10 Histidine 
CH2—CH—COOH 
Fl l  Lys ine  
H2N(H2C)4—HC—COOH 
F22 Arginine 
NH NH2 
H2N—C—HN(H2C)3—HC—COOH 
T 2.72 1.89 
TAG 2.24 2.55 
R 2.90 1.37 
T 2.97 1.52 
TAG 2.30 2.18 
R 3.45 1.27 
T 2.87 1.77 
TAG 2.40 2.63 
R 3.18 1.31 
T 3.18 1.31 
TAG 3.51 1.64 
R 7.95 1.09 
T 1.85 1.60 
TAG 
R — — 
T 4.71 1.80 
TAG 
R 4.04 1.50 
2.2 48 0.1 TEA TFA 
2 H20 0.3 gly 
2.4 48 0.1 TEA TFA 
2 H20 0.3 gly 
1.2 48 0.1 TEA TFA 
2 H20 0.3 gly 
2.0 48 0.1 TEA TFA 
2 H20 0.3 gly 
3.8 47.5 0.15 TEA 
TFA 
2.5 H20 0.3 
gly 
1.2 48 0.1 TEA TFA 
2 H20 0.3 gly 
1.4 48 0.1 TEA TFA 
2 H20 0.3 gly 
2.4 48 0.1 TEA TFA 
2 H20 0.3 gly 
1.1 48 0.1 TEA TFA 
2 H20 0.3 gly 
1.1 48 0.1 TEA TFA 
2 H20 0.3 gly 
1.7 67.2 0.15 TEA 
TFA 
2.8 H20 
0.4 47.5 0.15 TEA 
TFA 
2.5 H20 0.3 
gly 
2.7 67.2 0.15 TEA 
TFA 
2.8 H20 
Not detected 
Not detected 
3.4 57.6 0.15 TEA 
TFA 
2.4 H20 
Not detected 
1.8 47.5 0.15 TEA 
TFA 
2.5 HzO 0.3 
giy 
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Table 1 continued 
Code Compound name and formula CSP ti a Rs MeOH 
% v/v 
Other 
additive 
F23 Norvaline T 2.62 1.66 1.7 48 0.1 TEA TFA 
NH2 
H30(H2CH—HC—COOH 2 H20 0.3 gly 
TAG 2.42 2.10 1.9 48 0.1 TEA TFA 
2 H20 0.3 gly 
R 2.73 1.38 1.2 48 0.1 TEA TFA 
2 HzO 0.3 gly 
F24 DL-4-chlorophenylalanine T 1.82 1.80 2.0 60 0.1 TEA TFA 
/"A i"' CI </ V—H2C—HC—COOH TAG 1.51 2.17 2.1 60 0.1 TEA TFA 
R 2.22 1.25 0.7 60 0.1 TEA TFA 
Chromatographic conditions: pressure 100 bar, temperature 31C, flow rate 4 mL/min; UV detection at 254 nm, 
220 nm and 214 nm with a diode array detector. TEA = triethylamine, TFA = trifluoroacetic acid, gly = 
glycerol. 
110 
CHAPTER 3 
FAST SUPER/SUBCRITICAL FLUID CHROMATOGRAPHY 
ENANTIOMERIC SEPARATIONS OF DIHYDROFUROCOUMARIN 
DERIVATIVES WITH MACROCYCLIC GLYCOPEPTIDE 
STATIONARY PHASES 
A paper published in Chromatographia 
Ying Liu, Roman V. Rozhkov, Richard C. Larock, Tom Ling Xiao, Daniel W. Armstrong 
Abstract 
Twenty-four chiral dihydrofurocoumarin derivatives and structurally related compounds 
were separated using super/subcritical fluid chromatography (SFC) on three macrocyclic 
glycopeptide chiral stationary phases (CSPs). All the dihydrofurocoumarin derivatives could 
be resolved on at least one of the macrocyclic glycopeptide CSPs, and the Chirobiotic T 
column showed the best enantioselectivity for 21 of the dihydrofurocoumarins studied. The 
Chirobiotic TAG and Chirobiotic R CSPs separated similar numbers of chiral 
dihydrofurocoumarin derivatives (16 on Chirobiotic TAG and 15 on Chirobiotic R), but the 
Chirobiotic TAG column baseline resolved more samples than the Chirobiotic R column 
under similar experimental conditions. All separations were done isocratically with an outlet 
pressure regulated at 100 bar, a column temperature of 31 ° C, and a flow rate of 3.0 
mL-min"1. Various amounts of methanol ranging from 2 to 25% (v/v) were added to the 
supercritical carbon dioxide in order to optimize the enantiomeric separations. All of the 
I l l  
separations were completed in less than 15 min, and 81 % of the separations were done in 
less than 10 min. The separation speed is one of the main advantages of SFC. 
3.1 Introduction 
Drug chirality continues to be extremely important in the pharmaceutical industry because 
various health problems have been associated with the use of an impure drug or an undesired 
enantiomer. Strict guidelines, set forth by the U.S. Food and Drug Administration, require 
compounds developed by pharmaceutical companies to meet special qualifications related to 
purity and other physical and chemical properties [1]. To meet this requirement, there has 
been a substantial increase in research and development related to drug chirality over the last 
twenty years [2-5]. 
Chiral separations by packed column SFC was first proposed for the separation of chiral 
phosphorous-containing derivatives by Mourier et al in 1985 [6], Today, supercritical fluid 
chromatography has become a promising chiral separation technique that is increasingly used 
in industrial applications [7-15]. Its advantages include the low viscosity of the supercritical 
fluid, which provides low pressure-drops, which in turn permit the use of high flow rates and 
long columns. The applicability and selectivity of SFC is very similar to that of normal 
phase HPLC. Hence, it is more frequently being used as a replacement for normal phase 
HPLC separations [16]. 
Macrocyclic glycopeptide CSPs were first introduced by Armstrong et al in 1994 [17], and 
soon were found to be extremely useful in chiral separations of underivatized amino acids 
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[18,19], food flavors [20], and a wide variety of compounds with different polarities and 
different functionalities [21-23], Chiral separations employing macrocyclic glycopeptide 
CSPs with SFC mobile phases have been reported recently [11-14], Forty-four racemates 
have been evaluated on six CSPs, including Chirobiotic V and Chirobiotic T, with SFC 
mobile phases [14]. Recently, we reported an in-depth evaluation of the capabilities of 
macrocyclic glycopeptide-based CSPs with SFC mobile phases based on a set of 111 chiral 
compounds [10]. 
Dihydrofurocoumarin derivatives occur commonly in plants and fruits and are an important 
class of pharmacologically active compounds. In addition to anti-coagulant properties [24], 
other coumarin derivatives have been found to have antibacterial [25], anti-parasitic [26], 
anti-HIV [27,28], anti-inflammatory [29], anti-platelet [30], and anti-allergic properties [31]. 
Clearly, the potential pharmaceutical applications of dihydrofurocoumarin derivatives are 
significant. Since many of these derivatives are chiral, the elucidation of possible 
pharmacological differences of the two enantiomers becomes essential. So far, no successful 
asymmetric syntheses have been reported for this class of compounds. A very effective 
general synthesis of racemic dihydrofurocoumarins has been reported recently [32]. A few 
papers have reported the enantiomeric separation of coumarin-type anticoagulants, such as 
warfarin and warfarin analogues, using liquid chromatography on several CSPs [14,33,34], 
However, these compounds are very different in their size, charge and action from the 
substituted tetrahydrofurocoumarins. This paper first reports rapid and successful SFC 
enantiomeric separations of chiral dihydrofurocoumarin derivatives based on macrocyclic 
glycopeptide chiral stationary phases. 
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3.2 Experimental 
A Berger analytical SFC with a Berger Instruments Chemstation (Berger Instruments, 
Newark, DE, USA) was used. The Berger SFC chromatography used was equipped with a 
fluid control module, a thermal control module, an automatic liquid sampler, a photodiode 
array detector (Agilent Technologies, Palo Alto, CA), a column selection valve and a solvent 
selection valve (Valco Instruments co. Inc., USA). The automated column selection valve 
and cabinet allow up to 6 analytical columns to be used. Additionally, the solvent switching 
valves allow the pumping of six different organic solvents one at a time. 
Three different macrocyclic glycopeptide chiral stationary phases, Chirobiotic R, Chirobiotic 
T, and Chirobiotic TAG (25 cm x 4.6 I.D. mm columns, 5 jjM particle size) were obtained 
from Advanced Separation Technologies Inc. (Whippany, NJ, USA). 
SFC grade CO2 (Air Products and Chemicals, Inc. Allentown, PA) was used. HPLC grade 
methanol was purchased from Fisher Scientific (Fairlawn, NJ, USA). All chiral 
dihydrofurocoumarin derivatives were synthesized by Rozhkov et al at Iowa State University 
[32] (Ames, LA, USA) via the palladium-catalyzed annulation of 1,3-dienes by o-
iodoacetoxycoumarins. These samples were dissolved in methanol with a concentration from 
1 to 5 mg-mL"1. All separations were done under isocratic conditions at 31 °C and a flow rate 
of 3.0 mL-min"1, while regulating the pressure at the detector outlet at 100 bar. The organic 
solvent pump was fed by methanol. UV detection was carried out at 214 nm and 254 nm 
simultaneously with a photodiode array detector. 
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3.3 Results and Discussion 
Overall CSP effectiveness 
The enantioselectivity of three commercially available macrocyclic glycopeptide-based 
CSPs, teicoplanin (Chirobiotic T), Ristocetin A (Chirobiotic R), and the recently introduced 
teicoplanin aglycon (Chirobiotic TAG), was evaluated with a set of twenty-four chiral 
dihydrofurocoumarin derivatives. Experimental conditions were deliberately chosen to favor 
fast (short retention times), rather than highly efficient (high plate number) separations. All 
chromatograms were obtained within 15 min at a flow rate of 3.0 mL-min1. The results 
obtained on the three CSPs are listed in Table I. 
All of the twenty-four dihydrofurocoumarin derivatives could be baseline resolved on at least 
one of the macrocyclic glycopeptide CSPs, and 17 of these analytes were fully separated (Rs 
> 1.5) within 15 min. The Chirobiotic T column produced the broadest enantioselectivity (i.e. 
separated the most dihydrofurocoumarins) followed by the Chirobiotic TAG column (see 
Figure 1). The teicoplanin CSP shows enantioselectivity (a > 0.5) for 21 chiral 
dihydrofurocoumarin derivatives and baseline resolves (Rs > 1.5) 15 of those within 15 min. 
In addition, the teicoplanin aglycone and ristocetin A CSPs show enantioselectivity for an 
almost equal number of the dihydrofurocoumarin derivatives tested (16 on teicoplanin 
aglycone column and 15 on ristocetin A column). However, the Chirobiotic TAG column can 
baseline resolve more compounds (9 dihydrofurocoumarin derivatives) compared to the 
Chirobiotic R column (only 4 compounds) under similar experimental conditions. Although 
the Chirobiotic R column is the least enantioselective CSP for these dihydrofurocoumarins, it 
happened to be the most successful CSP for the class C compounds listed in Table I. All four 
115 
structurally related coumarin derivatives can be separated by the Chirobiotic R column. But 
the two teicoplanin-based chiral selectors only show enantioselectivity for one of these 
compounds. 
Figure 1. Overview of successful separation of 24 chiral substituted dihydrofurocoumarin separated 
on the three Chirobiotic CSPs: T (teicoplanin CSP); TAG (teicoplanin aglycon CSP); R (ristocetin A 
CSP). 
Selecting the experimental conditions 
All of the chiral dihydrofurocoumarin derivatives and related compounds analyzed in this 
study are neutral molecules. Experimental results showed that there were no pronounced 
differences in retention or in the enantioresolution factors when a small amount of acidic, 
basic or both additives were used in the mobile phases (data not shown). Occasionally, 
ionization of the CSP can affect the separation of neutral molecules [17], but that was not 
observed in this study. Because all of the neutral dihydrofurocoumarin derivatives tested are 
relatively nonpolar, only small amounts of methanol were required in order to elute these 
compounds (Table I). Based on the retention behavior of different compounds on different 
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CSPs, the percentage of methanol in the supercritical CO2 can be adjusted in order to achieve 
enantioseparation within a certain time range (i.e. within 15 min in this study). In most cases, 
less than 5 % of methanol was added when using the Chirobiotic R column. Up to 10 % 
methanol was needed for the Chirobiotic T column and up to 20 % methanol was used with 
the Chirobiotic TAG column. These results are consistent with those obtained for other 
compounds where it was reported that removing the sugar moieties from teicoplanin to 
produce the teicoplanin aglycon (i.e. Chirobiotic TAG) produced a CSP with increased 
retention properties [38]. 
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Figure 2. Effect of methanol concentration on the separation of the enantiomers of B4. 
Chromatographic conditions: Chirobiotic T column, 25 x 0.46 cm I.D., 3.0 mL • min 1 of indicated 
SFC mobile phases, 31 0 C, 100 bar, UV detection at 214 nm. 
Figure 2 shows the effect of methanol concentration on the separation of enantiomers of 
compound B4 on the Chirobiotic T column. With 10 % methanol present in the mobile 
phase, partial separation with resolution factor (Rs) 1.1 was observed around 5 minute, when 
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the methanol percentage was reduced to 5 %, baseline separation (Rs = 1.5) can be achieved 
but the retention time doubled. Basically, for these neutral chiral dihydrofurocoumarin 
derivatives, the enantioresolution can be improved simply by decreasing the percentage of 
organic modifier in the CO2 eluent. The trade-off is a concurrent increase in the retention 
time. 
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Figure 3. Effect of temperature on the separation of the enantiomers of All. Chromatographic 
conditions: Chirobiotic T column, 25 x 0.46 cm I.D., 3.0 mL • min"1, 5 % (v/v) methanol added to 
supercritical C02, 100 bar, UV detection at 214 nm. 
Effects of temperature and pressure were also investigated. The effects of temperature and 
pressure on these separations were very similar to previously reported results [10, 39]. Two 
different temperature (31 °C and 50 °C) were investigated for the enantiomeric separation of 
sample All on the Chirobiotic T column. Figure 3 shows that retention increases with 
increasing temperature at constant pressure 100 bar, which is different from HPLC. In HPLC, 
increasing temperature will decrease retention time because elevated temperature increases 
the solubility and diffusivity. But in SFC, the increased retention time with increasing 
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temperature is due to the lower mobile phase density and the associated reduction in its 
solubilizing power [3], Figure 3 also shows that the enantioresolution factor slightly 
decreases as the temperature increased, so a constant and low temperature 31 degree was 
selected for all separations. 
Pressure: IOC bar 
t 
V wx__ 
Time (min) 
90-
E 
Pressure: 200 bar 
\j v 
u Time (min) 
Figure 4. Effect of pressure on the separation of two enantiomers of compound Al 1. 
Chromatographic conditions: Chirobiotic T column, 25 x 0.46 cm I.D., 3.0 mL • min"1, 10 % (v/v) 
methanol added to supercritical C02, 31 ° C, UV detection at 214 nm. 
The effect of pressure on these SFC separations was also investigated. Figure 4 shows the 
enantiomeric separation of compound All performed at two different pressures. The 
retention time decreased as the pressure is increased from 100 bar to 200 bar, which 
consistent with literature reports [10, 39]. For a given column and temperature, retention 
generally decreases as the operating pressure is increased because the fluid density increases 
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at the high pressure. In addition, raising the pressure will slightly decrease the 
enantioresolution factors [10, 30]. Thus, a constant outlet pressure of 100 bar was used in this 
study. 
mAl 
150 
mAU 
150 H T 
Time (min) 
(c) 
! . 
Time (min) 
mAU (b) 
TAG 
Time (min) 
mAU 
60 
(d) 
TAG 
i l  S  
Time (min) 
Figure 5. Effect of structure on enantioselectivity: a comparison of separations on two teicoplanin 
based CSPs. Chromatographic conditions: 3.0 mL • min-1 with methanol additive of (a) 5 % (b) 10 
%, (c) 10 %, (d), 15 % (v/v) to supercritical C02, 100 bar, 31 °C, UV detection at 214 nm. 
Structure-enantioselectivity relationships 
The large number of structurally related compounds in this study provides a means to 
examine the effect of small structural changes on enantioseparation. In particular, structural 
differences near the stereogenic center had a significant effect on the enantiomeric separation 
of these compounds. Figure 5 shows the enantiomeric separations of compounds A2 and A3 
on the teicoplanin-based CSPs. These two compounds vary only in the substituent alpha to 
the stereogenic center. There is only a slight separation of compound A2 on the Chirobiotic 
T column. With the addition of a methyl group next to the stereogenic center, compound A3 
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can be baseline resolved on both columns. Clearly, the addition of the methyl group next to 
the stereogenic center greatly enhanced the enantiomeric separation. 
It is also interesting to compare the separation of compounds A4 and A3. They differ by a 
methyl substituent on the stereogenic center. No enantiomeric separations were observed for 
compound A4 on the Chirobiotic TAG and R CSPs, while only partial separation was 
observed on the Chirobiotic T column. When a methyl group is substituted for hydrogen on 
the stereogenic center (compound A3), the enantioresolution is greatly enhanced. Baseline 
separations were observed on both of the teicoplanin-based CSPs and a partial separation was 
also found with the Chirobiotic R column. Overall, the increase in steric bulk (methyl group 
compared to hydrogen) on the stereogenic center or alpha to it enhanced the enantiomeric 
separation. However, chiral recognition was affected differently if the bulky substituent is 
further from the stereogenic center. For example, comparing compounds A5 and A6, with 
A7, the substituents vary in size from a dimethyl group to an ethyl group to a phenyl group in 
the position beta to the stereogenic center. The enantioselectivity of the compound with the 
largest group, a bulky phenyl substituent (A7), dramatically decreased on the Chirobiotic 
TAG column, although the retention time increased. No significant difference in 
enantiomeric separation is observed between compounds A5 and A6, since the dimethyl and 
ethyl groups have comparable size. Similar results were found for compounds Bl, B2, and 
B5 as well. No enantiomeric separation was observed on the Chirobiotic TAG CSP for the 
phenyl-substituted compound (B2), although the retention time doubled under similar 
experimental conditions. 
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In these experiments, higher enantioresolution factors were obtained for compounds All, 
A12, and A13, compared to most other investigated dihydrofurocoumarins. This is, 
presumably, due to the greater rigidity of these compounds about their stereogenic centers 
(see structures in Table I). Most other compounds studied have free rotation of a hydrocarbon 
substituent attached to the stereogenic center by a single bond. The synthetic mechanism 
allows only formation of the cis-configuration giving one pair of enantiomers for this set of 
compounds. Compound A12, bearing a seven-member ring, displayed the highest 
enantioresolution factor of all the analytes on all three Chirobiotic columns. 
Comparison with Normal Phase HPLC separation 
Enantiomeric separations of the same series of compounds have also been done by normal 
phase HPLC using the same Chirobiotic columns [40]. When comparing the normal phase 
HPLC with SFC, the separation results for these two techniques tended to follow similar 
trends. When a high degree of enantioselectivity was achieved for a particular compound in 
HPLC, similar behavior was also observed in SFC. For example, in both cases, the 
Chirobiotic R column is the least effective chiral stationary phase tested, but it is the only 
column that can baseline separate compounds CI and C4 [40]. However, the similarities in 
enantioselectivity between the HPLC results and the SFC results were not absolute. For 
example, the Chirobiotic R CSP can be used to separate compound B7 using a SFC mobile 
phase, but no separation was observed using hexane/ethanol (98.5/1.5%) as the mobile phase 
in HPLC [40]. Oppositely, compound B2 can be separated with the Chirobiotic TAG column 
when using hexane/ethanol as the mobile phase in HPLC, but the enantioseparation is lost 
when COa-based mobile phases are used in SFC. 
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3.4 Conclusions 
The speed of the enantiomeric separations and solvent removal are advantages of using SFC 
compared to HPLC. Twenty-four coumarin derivatives can be separated individually in less 
than 15 min, and most in less than 10 min with subcritical mobile phases and Chirobiotic 
columns. Column equilibration is much faster with CO2 containing mobile phases than with 
normal phase HPLC. SFC is advantageous for preparative separations with easy solute 
recovery and solvent disposal. This work also shows that the macrocyclic based CSPs are 
able to rapidly and successfully separate enantiomers of dihydrofurocoumarin derivatives and 
structurally related compounds. In this case, the Chirobiotic T column showed the best 
overall enantioselectivity with SFC mobile phases, followed by the Chirobiotic TAG column. 
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Table I. Enantiomeric separations on three chirobiotic CSPs by subcritical fluid chromatography 
Code Structure CSP3 
(min) 
k' a Rs MeOH° 
(v/v%) 
Class A: dihydrofuroangelicins 
A1 I R 10.09 7.77 1.00 0.0 2 
C/JTTI'SD T 9.15 6.96 1.13 1.8 3 
TAG 7.56 6.34 1.12 1.4 7 
A2 I R 6.41 4.88 1.00 0.0 3 
T 9.63 7.37 1.03 0.7 3 
TAG 6.20 5.20 1.00 0.0 10 
A3 I R 3.93 2.85 1.03 0.5 5 
T 3.08 2.08 1.13 1.8 10 
TAG 3.48 3.00 1.15 1.6 15 
A4 _ 1 R 7.33 5.72 1.00 0.0 3 
O jT-O^O T 10.38 8.03 1.05 0.9 3 
TAG 9.58 8.30 1.00 0.0 7 1 < R 7.53 5.91 1.06 0.9 3 
o Y ^ o o  T 3.52 2.52 1.11 1.8 10 
f 
TAG 9.99 8.70 1.11 1.5 7 
A6 °fj R 7.46 5.84 1.00 0.0 3 
T 6.11 4.61 1.10 1.7 5 
/%/% 
TAG 8.95 7.69 1.07 1.0 7 
A 7  ° C j O  R 9.89 5.59 1.00 0.0 5 
T 9.81 7.92 1.03 0.8 7 
TAG 10.98 11.62 1.00 0.0 15 
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Table I (continued) 
Code Structure CSPa t7 k? a K MeOH3" 
(min) (v/v%) 
A8 R 
A9 
A10 
A11 
A12 
A13 o ^ o  
TAG 
R 
T 
TAG 
R 
T 
TAG 
R 
T 
TAG 
R 
T 
TAG 
R 
T 
TAG 
4.88 
5.74 
2.91 
3.28 
4.75 
5.60 
11.01 
6.77 
10.25 
7.88 
10.79 
9.37 
11.83 
3.30 
3.90 
8.12 
3.37 
6.98 
9.10 
3.78 
5.36 
3.48 
4.27 
1.65 
1.98 
3.61 
4.44 
9.79 
5.77 
10.78 
6.23 
8.38 
8.10 
9.29 
2.30 
3.48 
6.45 
2.37 
5.98 
7.35 
2.78 
5.16 
1.06 
1.07 
1.14 
1.18 
1.42 
1.57 
1.09 
1.18 
1.12 
1.05 
1.06 
1.11 
1.05 
1.11 
1.51 
1.10 
1.21 
1.50 
1.07 
1.11 
1.25 
0.8 
0.9 
1.3 
2.2 
4.4 
5.8 
1.5 
2.8 
1.2 
0.8 
1.4 
1.3 
0.8 
1.7 
2.3 
1.5 
3.2 
5.4 
1.3 
1.8 
2.6 
5 
10 
15 
3 
3 
7 
2 
10 
15 
3 
10 
10 
3 
10 
15 
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Table I (continued) 
Code Structure CSPa t«" 
(min) 
ki a MeOH 
(v/v%) 
Class B: dihydrofuropsoralens 
B1 
B2 
B3 
B4 
B5 
B6 
R 
T 
TAG 
R 
T 
TAG 
R 
T 
TAG 
R 
T 
TAG 
R 
T 
TAG 
R 
TAG 
8.78 
10.37 
9.97 
7.77 
8.53 
9.15 
6.72 
15.76 
8.00 
8.19 
10.25 
9.90 
8.60 
9.66 
9.36 
10.78 
12.68 
4.01 
4.27 
7.22 
8.16 
7.61 
8.51 
8.97 
6.77 
7.53 
9.76 
5.59 
12.70 
7.00 
7.03 
8.40 
8.90 
7.43 
7.86 
8.36 
8.89 
10.63 
3.01 
3.27 
6.22 
7.16 
1.00 
1.07 
1.04 
1.03 
1.10 
1.00 
1.00 
1.05 
1.00 
1.00 
1.08 
1.04 
1.00 
1.12 
1.05 
1.07 
1.04 
1.00 
1.14 
1.05 
1.14 
0.0 
1.5 
0.8 
0.6 
2.1 
0.0 
0.0 
0.9 
0.0 
0.0 
1.5 
0.7 
0.0 
2.1 
0.8 
1.1 
0.8 
0.0 
2.4 
0.8 
1.8 
5 
5 
10 
10 
10 
20 
5 
3 
10 
5 
5 
10 
5 
5 
10 
3 
10 
10 
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Table I (continued) 
Code Structure CSP" V k-T 
(min) 
R* MeOH 
B7 R 
TAG 
5.47 4.47 
7.71 
5.95 
6.01 
5.84 
1.11 2.0 
1.12 2.4 
1.09 1.0 
10 
7 
15 
Class C: Other structurally related coumarin derivatives 
C1 
C2 
C3 
o ^ o  
C4 
R 
T 
TAG 
R 
T 
TAG 
R 
T 
TAG 
R 
T 
TAG 
8.42 
7.65 
6.99 
5.05 
8.74 
9.40 
4.91 
6.76 
5.07 
10.01 
8.12 
8.93 
7.25 
6.65 
7.32 
3.95 
7.02 
8.40 
3.91 
5.76 
5.04 
8.18 
6.45 
7.93 
1.13 
1.00 
1.00 
1.04 
1.00 
1.00 
1.16 
1.07 
1.26 
1.09 
1.00 
1.00 
2.1 
0.0 
0.0 
0.8 
0.0 
0.0 
2.0 
1.4 
2.2 
1.3 
0.0 
0.0 
5 
10 
25 
5 
5 
10 
10 
10 
25 
3 
5 
10 
a Chromatographic conditions: pressure 100 Bar, temperature 31 °C, flow rate 3.0 mL-min"1, UV 
detection at 214 nm with a diode array detector. 
b Retention time for the first eluted enantiomer 
c Retention factor for the first eluted enantiomer (calculated using equation kt = (trrt0)/to, where t0 is 
dead volume) 
d Volume percentage of methanol added to the supercritical carbon dioxide. 
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CHAPTER 4 
ENANTIOSEPARATIONS OF DIHYDROFUROCOUMARIN 
DERIVATIVES BY VARIOUS SEPARATION MODES OF 
CAPILLARY ELECTROPHORESIS 
A paper published in Electrophoresis 
Matthew D. Egger, Ying Liu, Juraj Sevcik1, Eva Tesafovâ2, Roman Rozhkov, Richard C. 
Larock, Daniel W. Armstrong 
Abstract 
Chiral dihydrofurocoumarin compounds are currently the focus of industrial and 
pharmacological research. These derivatives have been shown to possess many physiological 
properties that could be medically beneficial. This work proposes four different chiral 
separation methods using capillary electrophoresis and micellar capillary electrophoresis 
(MCE). Several different cyclodextrin chiral selectors were examined to evaluate their 
effectiveness in the enantioseparation of dihydrofurocoumarins. In addition, the effects of 
the chiral selector concentration, the presence of an organic modifier, run buffer pH, and in 
two cases, the ratio between the chiral selector and an additional charged pseudophase were 
investigated. Overall, the best separations for this class of chiral compounds were achieved 
using sulfated /3-cyclodextrins at low pH in the reversed polarity mode. 
1 On leave from Department of Analytical Chemistry, Palacky University, 77146 Olomouc, Czech Republic 
2 On leave from Department of Phys. and Macromol Chemistry, Charles University, 128 43 Prague, Czech 
Republic 
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Abbreviations: MCE, micellar capillary electrophoresis, NPM, normal polarity mode, 
RPM, reverse polarity mode, S-/3-CD, sulfated /3-cyclodextrin, HP-/3-CD, hydroxypropyl /3-
cyclodextrin, CM-/8-CD, carboxymethyl /3-cyclodextrin, SBE-/S-CD, sulfobutyl ether /3-
cyclodextrin, SDS, sodium dodecyl sulfate, EOF, electroosmotic flow 
4.1 Introduction 
Coumarins and coumarin derivatives have been of great interest to researchers in both 
industry and medicine for many years. The anticoagulant activity of warfarin and its 
analogues has been known for decades [1], Other coumarin derivatives have been found to 
act as vasodilators [2], More recently, dihydrofurocoumarin analogues have been found to 
have several other beneficial physiological properties. There have been reports in which 
these compounds have shown antibacterial and anti-tumor activity [3,4]. Within the past few 
years, dihydro furocoumarin compounds isolated from natural sources have been shown to 
possess anti-HIV activity [5,6]. In addition, enzymatic studies have shown that some of 
these molecules possess protein kinase inhibition activity as well as cytokinase release 
activity [3,7]. Due to the wide array of biological properties attributed to 
dihydro furocoumarin derivatives, much effort has been made for the synthesis of these 
molecules. 
General synthetic routes for the production of dihydrofurocoumarins have been reported [8], 
However, these suffer from low yields and are limited in the range of compounds that can be 
produced. Recently, Rozhkov and Larock have proposed an approach for the synthesis of 
chiral dihydro furocoumarins by palladium-catalyzed annulation of 1,3-dienes by o-
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iodoumbelliferones [9], This approach typically offers high yields (-70-95%) of a broad 
range of chiral dihydrofurocoumarins [9], However, as with other synthetic approaches, only 
the racemate is produced. Thus far no successful asymmetric syntheses have been reported 
for this class of molecules. 
There have been several previous reports on the LC enantiomeric separation of the common 
coumarin derivatives of warfarin and its analogues [10-14], Several studies have reported the 
enantioseparation of warfarin, and warfarin analogues with capillary electrophoresis [15-19]. 
Unfortunately, the methods used in these studies were not as effective for the 
dihydrofurocoumarins analyzed in this work. Warfarin and warfarin analogues are somewhat 
soluble in aqueous solutions and have functional groups that may possess a charge. The 
dihydrofurocoumarin compounds analyzed in this study are all neutral molecules and very 
hydrophobic which greatly limits their water solubility (see structures in Table 1). In this 
work we report the use of both cyclodextrins and micelles to achieve the first CE 
enantiomeric separations of several dihydrofurocoumarin compounds. 
4.2 Experimental 
Materials 
Sulfated /3-cyclodextrin (S-/3-CD) and hydroxypropyl /3-cyclodextrin (HP-/3-CD) were 
purchased from the Aldrich Chemical Company (Milwaukee, WI, USA). Carboxymethyl /3-
cyclodextrin (CM-/3-CD) was purchased from American Maize Products (Hammond, IN, 
USA). Sulfobutyl ether /3-cyclodextrin (SBE-/3-CD) was obtained from CyDex, Inc. 
(Overland Park, KS, USA). Sodium dodecyl sulfate (SDS), sodium phosphate, HPLC-grade 
133 
methanol, HPLC-grade acetonitrile, hydrochloric acid, and sodium hydroxide were all 
obtained through Fisher Scientific (St. Louis, MO, USA). The racemic dihydro furocoumarin 
compounds were synthesized as reported previously [9]. The capillaries used in these 
experiments were purchased from Polymicro Technologies (Phoenix, AZ, USA). 
Methods 
The system used for all CE experiments was a P/ACE MDQ system from Beckman Coulter 
(Fullerton, CA, USA). The separation capillary had a 50 jim ID, a 30 cm total length and a 
20 effective length. A 3 mm portion of the polyamide coating of the capillary was burned off 
to create a window for detection. The MDQ instrument has a photodiode array detector, 
however all electropherograms obtained for this work were detected at a wavelength of 214 
nm. Samples were injected by pressure and rinsing was performed at a pressure of 20 psi. 
The capillary was conditioned first with water for 1 min, then with 1 M sodium hydroxide for 
5 min, and again with water for 5 min. In between every run, the capillary was rinsed with 
water for 0.5 min, 1 M sodium hydroxide for 0.5 min, water for 0.5 min, and finally rinsed 
with the run buffer for 2 min. The samples in this experiment were dissolved in methanol and 
diluted with run buffer. The optimized separation voltage applied was 15 kV. The MCE 
experiments were all performed on a P/ACE System 5000 from Beckman Coulter (Fullerton, 
CA, USA). The separation capillary had a 50 jttm ID, with a 40 cm length and an effective 
length of 32 cm. The applied voltage was also 15 kV. The analytes were detected at a 
wavelength of 214 nm with this instrument. Prior to use, the capillary was conditioned for 1 
min with water, 3 min with sodium hydroxide, and finally 3 min with water. Prior to every 
run, the capillary was rinsed with 0.1 M sodium hydroxide for 2 min, water for 2 min, and 
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the run buffer for 3 min. The samples in the MCE experiments were dissolved in the run 
buffer, with the exception of compounds 8 and 9 that had to be dissolved in a small volume 
of acetonitrile that was then diluted with the run buffer. Running buffer for the reversed 
polarity mode CE experiments were prepared by dissolving the required amount of the 
cyclodextrins in 50 mM sodium phosphate stock solution. Running buffers for MCE study 
were prepared by dissolving the required amount of the cyclodextrin and/or SDS in 10 mM 
sodium phosphate stock solution. The pH was adjusted by adding aqueous sodium hydroxide 
or aqueous hydrochloric acid. The buffers were degassed by sonication prior to use. The 
organic modifier was added on a volume-to-volume basis. 
4.3 Results and Discussion 
4.3.1 Enantioseparation of coumarins by CE 
The use of cyclodextrins to achieve enantioseparations in CE was originally borrowed from 
liquid chromatography [14, 20]. Subsequently, cyclodextrins and their derivatives have 
developed into the most prevalent and broadly useful class of chiral selectors in CE [17, 21-
25]. It is well understood that for separations to occur, either the analyte or the cyclodextrin 
must possess a charge otherwise the cyclodextrin-enantiomer complex will move with the 
electroosmotic flow (EOF) and no enantioseparation will be observed. In the case of the 
chiral dihydro furocoumarin derivatives (Table 1), the analytes are neutral, therefore the 
cyclodextrins used for this separation must be charged. 
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30 mqtn L Carboxvmethvt-B- C û 10rra*nlSBE-(3-CD 
+ 50 nrairiLHP-B-CO 
t1 (min) R, 
40 mpiriL SUf^ed-p-CD 
Structure 
t1 (min) t1 (min) 
1.07 1.01 1.05 3.43 1B 0.4 9.59 
4.2 13 0.8 1.02 1.06 7.15 8.21 
4 
3.14 1.15 1.02 5.64 7.84 1.06 
3j56 93 1.38 1.06 5.6 9.07 
2.47 18 1.05 5.51 0.9 1.01 12.54 2.7 
S 
238 32 1.18 1.03 5.5 8.2 1.12 
Table 1. Results of the enantioseparation of coumarins for each anionic chiral selector under 
optimized conditions 
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In the normal polarity mode, and at higher pHs, some negatively charged CDs produce poor 
enantioseparations of the racemic dihydrofurocoumarin analytes. At lower pHs, the 
electrophoretic mobility of the negatively charged CD towards the anode (at the inlet) can be 
higher than that of the EOF (directed to the cathode) and prevents the analyte/CD complex 
from reaching the detector. To overcome this problem, the separations were conducted in the 
reversed polarity mode (RPM). The EOF can be reduced significantly by using a running 
buffer at low pH. 
a ) ;  
! 
2 
B) — 
D ' 
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t (time) '(time) 
Figure 1. CE enantioseparation of a coumarin derivative using A) S-/3-CD, B) CM-/3-CD, C) SBE-/3-
CD, and D) SBE-/3-CD + HP-/3-CD. The background electrolyte was 50 mM phosphate buffer, at pH 
2.5. The applied voltage was -15 kV. Detection was performed at 214 nm. Sample: racemate of 
chiral coumarin derivative #7. 
Effect of Different Negatively Charged Derivatized Cyclodextrins on 
Dihydrofurocoumarin Enantioseparations 
The nature of the anionic functional group(s) on the derivatized /3-CD and their degree of 
substitution often affect enantiomeric separations. In this work, three different anionic CDs 
were examined: S-/3-CD, CM-/3-CD, SBE-/3-CD (see Materials and Methods section for 
further details). These anionic CDs showed very different enantioselectivities for the 
dihydrofurocoumarins listed in Table 1. In nearly every case, the sulfated-/3-cyclodextrin 
gave better resolution than either carboxymethyl-/3-cyclodextrin or the combination of 
sulfobutylether-jS-cyclodextrin with hydroxypropyl-jS-cyclodextrin (HP-j3-CD). The 
effectiveness of different derivatized cyclodextrins on the separation of enantiomers of 
dihydrofurocoumarin derivatives is shown in Figure 1. Note that the SBE-/3-CD rarely 
produced a separation by itself. It required the addition of the uncharged HP-/3-CD. The 
neutral HP-/3-CD provided the enantioselectivity while the negatively charged SBE-/3-CD 
provided electrophoretic mobility. 
Effect of Chiral Selector Concentration on Enantioseparation 
The concentration of the chiral selector can have a significant effect on the resolution and 
efficiency of the enantioseparation. As stated earlier, the enantiomers of these chiral, 
substituted dihydrofurocoumarins were best separated when using sulfated-/3-cyclodextrin as 
the chiral selector in the RPM. In this case, as the concentration of S-j3-CD increased, the 
migration time of the analyte decreased (Figure 2). This was due to an increase in the 
apparent electrophoretic mobility towards the outlet brought about by the presence of a 
greater amount of the anionic chiral selector (S-jS-CD) in the run buffer which, in turn, 
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resulted in a greater percentage of the analyte being complexed (Figure 2). At both 20 and 
40 mg/mL S-/3-CD, this approach produced good, efficient separations. However, due to the 
fact that the run times were typically shorter with a concentration of 40 mg/mL S-j3-CD, this 
was the concentration used for all subsequent separations. 
AU 
4 5 2 3 
t(min) 
Figure 2. CE enantioseparation of coumarin derivative with A) 60 mg/mL of S-/3-CD, B) 40 mg/mL 
of S-/3-CD, and C) 20 mg/ml of S-/3-CD. Other conditions are as described in Figure 1. 
The ratio of HP-/3-CD to SBE-/3-CD is also important for the separation of 
dihydrofurocoumarins. As discussed earlier, the SBE-/3-CD provides for the mobility, and 
the HP-/3-CD provides the enantioselective complexation. As the amount of the anionic 
SBE-j3-CD increases, the dihydrofurocoumarin analyte will have a greater interaction with 
the anionic pseudophase, decreasing the interaction with the enantioselective HP-/3-CD. This 
produced a faster analysis but a diminished separation. If the ratio were changed such that 
139 
there was a greater amount of HP-/3-CD, the analyte would have had less interaction with the 
anionic pseudophase, thus leading to an improved separation. From this work, it became 
apparent that it may be possible for other achiral anionic carriers, such as micelles 
(specifically SDS micelles), to provide the needed counter-current effect thereby eliciting a 
similar separation. This will be discussed in a subsequent section of this paper. 
Effect of Addition of Methanol to the Run Buffer 
In most cases using the normal electrode polarity mode in CE with cyclodextrins as chiral 
selectors, the addition of organic modifiers in the run buffer has an adverse effect on 
enantioselectivity. This is due to the fact that the organic additive will form a competing 
inclusion complex with the chiral selector, thus displacing the analyte [21-24], Figure 3 
shows the results of added methanol to an enantioseparation with S-jS-CD in the RPM. 
AU 
10 5 
t(min) 
Figure 3. CE enantioseparation of coumarin derivative with A) 0% methanol , B) 5 % methanol, C) 
10% methanol, and D) 15% methanol. All other separation conditions are as described in Figure 1. 
Note that the peak areas on electropherograms C and D are somewhat greater because a saturated 
solution of the sparingly soluble sample was used, and its solubility varied slightly with the 
composition of the running buffer. 
140 
The single most obvious effect is the significant increase in the migration times. This effect 
can be attributed to the previously mentioned competition of the analyte and methanol for 
inclusion into the cyclodextrin cavity. Also the increased viscosity and lower conductivity of 
the organic-aqueous run buffer can slow the migration of analytes. Interestingly, the 
selectivities (all a's -1.1), efficiencies (n's ~ 12,000 plates), and resolutions (all Rs ~ 2.3) do 
not change appreciably under these conditions. Based on these results, it appears that the 
best separation of these analytes is obtained when no methanol is added to the run buffer. 
Effect of Run Buffer pH 
By using the RPM under acidic conditions for the separation of coumarin derivatives, a 
decreased EOF will occur. This is desirable since it will result in shorter run times (Figure 
4). As discussed previously, these separations benefit from the counter-current movement of 
the analyte and chiral selector, as the EOF goes from the outlet to the inlet, and the 
electrophoretic mobility of the anionic cyclodextrin derivative is toward the detector. At 
lower run buffer pH values, the dominant motive force in the capillary is the electrophoretic 
mobility of the anionic cyclodextrin derivative. However, when the run buffer pH reaches 
approximately 6.5, the EOF becomes the main motive force in the capillary, and the effective 
mobility of the negatively charged analyte/cyclodextrin complex will be directed toward the 
inlet buffer vial, thus the analyte is never seen at the detector. In order to see the analyte 
signal at pHs >6.5, the normal electrode polarity must be used. Performing the separation in 
this mode produced little or no enantioseparation. 
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AU 
t(min) 
Figure 4. CE enantioseparation of coumarin derivative in the RPM at A) pH = 2.5, B) pH =3.1, C) 
pH = 4.2, D) pH = 5.0. The background electrolyte was 50 mM phosphate buffer at different pH 
values. The chiral selector used in this experiment was CM-/3-CD. The applied voltage was -15 kV. 
Detection was performed at 214 nm. Sample: racemate of chiral coumarin derivative #7. 
4.3.2 Enantioseparation of dihydrofurocoumarin derivatives using micellar capillary 
electrophoresis (MCE) 
The addition of micelles to the CE system as a pseudophase was borrowed from HPLC in 
1984 by Terabe et al. [26]. The addition of surfactant to the run buffer to produce micelles 
creates a negatively charged pseudophase. As discussed previously, for the enantiomeric 
separation of these neutral compounds to occur in CE, there must be a charged species in the 
run buffer for the analyte to interact with. This condition was previously illustrated in 
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Section 3.1.1 when separating dihydrofurocoumarins using a combination of HP- /3-CD with 
SBE-/3-CD. 
Optimum Concentration 
of SDS(mM) 
Optimum Concent raticn 
of HP-(3-CD(mg/hnL) t, (min) t,(min) 
250 38.1 39.0 250 1.02 
10.6 125 150 25.2 29.9 
150 14.9 6.4 1.06 150 14.1 
Table 2 Optimum conditions for the enantioseparation of coumarins by MCE 
SDS micelles can also provide an anionic pseudophase in the run buffer and thus permit the 
use of an uncharged cyclodextrin as the chiral selector. Hydroxypropyl-j3-CD was shown 
previously to yield efficient enantiomeric separations of dihydrofurocoumarins by HPLC 
[27]. Therefore, the same chiral selector was used in these experiments. Using MCE to 
separate the coumarin derivatives in the normal electrode polarity mode produced poor 
enantioseparations. For this reason, the RPM was used for these experiments. To decrease 
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the EOF, the run buffer was prepared with a pH of 2.5 so that the dominant motive force in 
the capillary was the electrophoretic mobility of the micelle. In addition to providing a 
negatively charged pseudophase, the presence of micelles also increases the solubility of the 
hydrophobic coumarin derivatives in the run buffer, thereby decreasing the need for organic 
co-solvents to dissolve the analyte. Similarly to the effects of the charged and uncharged 
cyclodextrins, described in 3.1.2, there was a certain concentration ratio of SDS to 
hydroxypropyl /3-CD that gave optimum separations (Table 2). It is obvious from Table 2 
that the concentration of SDS to HP-P-CD differs for different derivatives. If the amount of 
SDS were increased, the dihydrofurocoumarin compound would partition more extensively 
to the micelle and less to the HP-/3-CD. 
-X 
Figure 5. MCE enantioseparation of coumarin analogue. The background electrolyte was 10 mM 
phosphate buffer at pH 2.5 and 150 mM SDS. The chiral selector use in this experiment was 150 
mg/mL HP-j3-CD. The applied voltage was 15 kV. Detection was performed at 214 nm. Sample: 
racemate of chiral coumarin derivative #8. 
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Because the HP-/3-CD provides the enantioselectivity, these conditions yield diminished or 
no separations. If the relative amount of HP-/3-CD were increased, the analyte interaction 
with the chiral selector would increase, thus decreasing the interactions with the micellar 
pseudophase. Since the micelle provides the counter-current mobility in this system, a 
greatly diminished interaction with the micelle also yields diminished or no 
enantioseparation. The main drawback to separations with this method was the extended run 
times (Figure 5). However, this approach produced high enantioselectivities and good 
efficiencies for the chiral dihydrofurocoumarins (Table 2). 
4.4 Conclusions 
Several coumarin derivatives were analyzed using various systems of CE and MCE. When 
comparing the techniques, the optimum enantioseparation was obtained in the reversed 
polarity mode with sulfated-|3-cyclodextrin as the chiral selector. S-/3-CD gave better 
separations than the carboxymethyl-|8-cyclodextrin due to its greater enantioselectivity for 
these analytes. The S-/3-CD was also more successful than either the sulfobutylether-|3-
cyclodextrin in combination with hydroxypropyl-jS-cyclodextrin, and it produced shorter run 
times when compared to the micelle-based enantioseparation method. This work also 
showed that optimization of the pH, and chiral selector concentration had substantial effects 
on the enantioseparation of dihydrofurocoumarins. 
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CHAPTER 5 
BINDING CONSTANT STUDIES OF DRUGS AND PROTEINS USING 
FRONTAL ANALYSIS CAPILLARY ELECTROPHORESIS-
LASER INDUCED FLUORESCENCE 
Abstract 
Capillary electrophoresis has been recognized as an attractive analytical tool for examining 
the nature and strength of biological interactions between drugs and proteins. Various CE 
methods exist for measuring binding constants. Capillary electrophoresis-frontal analysis 
(FA) has been particularly used for measuring the interactions between drugs with plasma 
proteins, particularly when limited analytes of the pure substrates are available. Two 
drug/protein systems have been studied using the frontal analysis method. More sensitive 
laser induced fluorescence detection (LIF) was used in this assay, which overcame the 
problem of low sensitivity that is common when using UV detection for drug-protein studies. 
In addition, the use of a UV argon laser (Excitation at 257 nm) coupled with CCD camera as 
a frontal analysis detection method enabled the simultaneous observation of the drug 
fluorescence as well as the protein fluorescence. Also, this more sensitive detection method 
has demonstrated the potential usefulness of CE-FA for the study of a wide variety of drug-
plasma protein binding processes. 
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5.1 Introduction 
Drug-protein binding is an important process in determining the activity and fate of a drug 
once it enters the body. In biological systems, unbound drugs in plasma can easily reach the 
target organ, whereas bound drugs are hard to pass through the blood-capillary wall. 
Therefore, understanding the binding behavior between plasma proteins and drugs is 
essential for drug development because the concentration of unbound drugs shows a better 
correlation to the pharmacological activity than the total drug concentration [1], In addition, 
many pharmacokinetic properties such as hepatic metabolism rate, renal excretion rate, 
biomembrane partition rate and steady-state distribution volume are a function of the 
unbound drug fraction (unbound/bound concentration ratio) [2,3]. Therefore, a better 
understanding of drug-protein binding is also essential to pharmacokinetic studies and 
optimum therapeutic dosing regimens. 
Determining an individual analyte in complex biological samples often requires some type of 
separation as a prerequisite for their measurement. A number of separation techniques exist 
for the determination of binding constants, and most separation methods are done under 
equilibrium conditions [4-9]. Capillary electrophoresis (CE) has shown to be an attractive 
analytical tool for evaluating binding behavior. Its beneficial characteristics include short 
analysis times, high efficiency, high selectivity, high resolving power, low sample and 
reagent consumption, and ease of automation [4-10]. Various CE methods have been applied 
to determine the unbound (free) drug or the bound drug concentration in solution. It includes 
affinity capillary electrophoresis (ACE), the frontal analysis (FA) method, the Hummel-
Dreyer Method (HD), the vacancy peak (VP) and the vacancy affinity capillary 
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electrophoresis (VACE). With the exception of VACE, most of these methods were 
originally developed for high-performance liquid chromatography (HPLC) and then 
transferred to CE [11,12], 
Measuring binding constants using the ACE method can be done by adding a protein to the 
CE running buffer and measuring the change in electrophoretic mobility of an injected drug. 
This method requires that the drug's electrophoretic mobility undergoes a significant change 
upon complexation [6], In the Hummel-Dreyer method, the capillary is filled with running 
buffer containing a drug at varying concentrations, creating a high detector background 
response [4-6]. When a small amount of sample consisting of both protein and drug-
containing running buffer is injected, the complexed drug-protein migrates out of the 
injection plug, leaving a zone of reduced drug concentration behind. This zone is detected as 
a negative peak, and the area is directly related to the amount of drug bound to the protein. A 
positive peak corresponds to the drug-protein complex and the free protein [4-6]. Both 
internal calibration and external calibration methods can be used in this assay. 
In a vacancy peak (VP) experiment, the capillary is filled with running buffer consisting of 
both the protein and the drug. When a small amount of plain buffer is injected, two negative 
peaks were observed. One peak arises due to a vacancy in free drug, and another peak arises 
due to a vacancy in the drug-protein complex and the free protein. The free drug 
concentration can be determined by the peak area (or height). The binding constant is 
calculated for the free drug concentration as a function of protein concentrations. The 
vacancy affinity capillary electrophoresis is performed in an identical experimental set-up as 
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the VP method. However, the binding constant is calculated based on the change in 
electrophoretic mobility of the drug peak at varying concentrations of protein in the buffer, 
because the migration time of negative peaks is correlated to the fraction of free and 
complexed drug. 
(a) 
calibration drug [Dtot] 
(b) 
B 
sample mixture 
Pf] 
B_ 
A 
[Dtot] 
[Db] = [Dtot] - [Df] 
[Db] 
r = 
[P] 
Figure 1. Illustration of the calibration procedures for the capillary electrophoresis-frontal analysis 
method. 
Abbreviation: A, Peak height when only injecting calibration drug; B, Peak height when injecting 
drug-protein mixture; [Dtot], concentration of total drug; [Df], concentration of unbound drug; [Db], 
concentration of bound drug; [P], concentration of protein; r, fraction of bound drug per protein. 
In the FA, the capillary is filled with running buffer, and subsequently a large sample plug is 
injected [4-6]. This sample plug consists of both drug and protein in equilibrium. In this 
assay, the electrophoretic mobility of the free drug must be different from the mobility of the 
protein and the protein-drug complex. The protein and the protein-drug complex usually 
have same electrophoretic mobility because proteins are very large molecules, therefore, the 
mobility (depending on the size or charge) of proteins won't change when binding with a 
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small molecule drug. After injection of a large mixed sample plug, the free drug will migrate 
away from the protein, and equilibrium is maintained where the zones temporarily overlap 
[4-6]. The equilibrium free drug concentration is calculated from the height of the resulting 
plateau. The plateau height of free drug at [protein] = 0 is used as the standard. With the 
addition of protein to the injected sample plug, the height of the free drug plateau decreases 
due to the binding of the drug to the protein [4-7]. From the known total and the measured 
free drug concentration, the association parameters can be calculated. The calibration 
procedure is schematically presented in Figure 1. Varying drug concentrations with a fixed 
protein concentration in the large sample plug allows the determination of binding constant 
according to the following equation: r = n Kb [Df]/ {1+ Kb[Df]}, where r is the fraction of 
bound drug per protein; n is the number of binding sites; [D]f is the free drug concentration in 
the running buffer, and Kb is the binding constant between drug and protein. For 1: 1 binding, 
equation can be simplified to r/(l-r) = Kb [Df], and the binding constant can be easily 
determined from the slope. 
The CE methods for the determination of binding constants and their experimental setups are 
summarized in Table 1. In the ACE and VACE methods, the binding parameters can be 
calculated from the change in the electrophoretic mobility of the drug on complexation with a 
protein. In the frontal analysis and vacancy peak methods, the free drug concentration is 
measured, while in the Hummel-Dreyer method the amount of bound drug is measured. 
Overall, most of the CE methods require the addition of either drug or protein to the running 
buffer, as seen in Table 1. Therefore, relatively large amounts of either drug and/or protein 
are needed for these measurements since buffer vials are usually large. Although ACE was 
153 
found most useful for the measurement of binding constants, the frontal analysis method is 
the only method that requires a relatively small amount of sample (using plain buffer as the 
running buffer). Therefore, due to the sample limitation, frontal analysis method was chosen 
for the measurement of binding constants for the following two protein-drug systems. 
Method Sample injected Running buffer Estimation of K 
ACE D Buffer +P Changes in mobility of D 
VACE Buffer Buffer + D+P Changes in mobility of D or P 
(vacancy peak) 
VP Buffer Buffer + D+P Peak area of vacancy peak 
corresponding to [Df] 
FA Buffer+D+P Buffer Plateau height corresponding to 
[Df] 
HD Buffer+D+P Buffer + P (or D) Peak area of vacancy peak 
corresponding to [Db] 
Table 1. CE methods and their experimental setups for the estimation of binding constants. 
Abbreviation: ACE, affinity capillary electrophoresis; VACE, vacancy affinity capillary 
electrophoresis; HD, Hummel-Dreyer method; VP, vacancy peak method; FA, frontal analysis; D, 
ligand such as drug; P, receptor such as protein; [Db], concentration of bound drug; [Df], 
concentration of tree drug. (Revised from Table 1 in Ref. 7. Tanaka, Y., Terabe, S. J. Chromatogr. B, 
2002,768,81-92) 
5.2. Binding constant study between coumarin 153 and apomyoglobin 
Understanding a protein's dielectric response requires both a theoretical model and a well-
defined experimental system. The complex of coumarin 153 (C153) with apomyoglobin 
(ApoMb) provides a fruitful system for studying the protein dielectric response. C 153 has 
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been exhaustively studied and has proven to be an excellent probe of the solvation dynamics 
of polar solvents. Myoglobin is one of the most thoroughly studied proteins. In addition, the 
availability of mutant proteins with amino acid replacements near the heme-binding site of 
myoglobin will eventually permit a quantitative evaluation of local contributions of specific 
residues to the solvation dynamics of proteins. Because protein is clearly a heterogeneous 
environment with spatially dependent polarizability, a precise knowledge of where and how 
the fluorescence probe binds is crucial to any thorough analysis of the protein's response 
from that of the solvent. In this assay, equilibrium binding studies by capillary 
electrophoresis frontal analysis was used as one of the tools to demonstrate the existence of a 
robust C 153-ApoMb system. 
5.2.1. Experimental 
5.2.1.1. Apparatus 
The frontal analysis CE experiments were performed on a Beckman Coulter P/ACE MDQ 
capillary electrophoresis system equipped with 488 nm laser-induced fluorescence (LIF) 
detector. Untreated fused-silica capillary with 50 jam ID and 360 |im OD was purchased 
from Polymicro Technologies, Inc. (Phoenix, AZ). The capillary was 30 cm in length (20 cm 
to detection window). When a capillary was first used, it was rinsed for 1 min with water, 5 
min with 1 M NaOH, and 1 min with water at the pressure of 20 psi. Prior to each injection, 
capillary was washed for 0.5 min with water, 0.5 min with 1 M NaOH, and 0.5 min with 
water, followed by 2 min with running buffer. The premixed C 153-ApoMb samples were 
injected at 0.5 psi for 40 seconds to the capillary. Experiments were performed at 10 kV and 
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a temperature of 25 ° C. The emission of the sample was collected at 520 nm. Data were 
collected by P/ACE system MDQ software. 
5.2.1.2. Reagents and solutions 
Coumarin 153 was purchased from Aldrich Chem. Co. (Milwaukee, WI), and used without 
further purification. Apomyoglobin was prepared using the procedure described elsewhere 
[13]. Sodium phosphate and phosphoric acid were purchased from Fisher Scientific (Fair 
Lawn, NJ). 0.2 M Na-phosphate buffer at pH 9.0 was used. The phosphate buffer was filtered 
through 0.22 pm non-pyrogenic filter (Costar, Corp. Corming, NY). 
5.2.2. Results and Discussion 
5.2.2.1. Capillary electrophoresis-frontal analysis of coumarin 153 and apomyoglobin 
In the frontal analysis technique, CI53 and ApoMb were premixed and injected as a large 
sample plug after waiting sufficient time (45 min) to ensure the formation of an equilibrium 
complex. At pH 9, the apomyoglobin (pl= 8.72) is negatively charged. The electrophoretic 
mobility of the free CI53 is different from the mobility of the ApoMb and ApoMb-C153 
complex. Figure 2 shows the electropherograms for C 153-ApoMb system: the height of the 
free coumarin plateau decreases with the addition of apomyoglobin because of the binding of 
the coumarin to the protein. The plateau height of free coumarin at [ApoMb] = 0 pM was 
used as the coumarin standard. In this assay, a series of sample mixtures with a fixed 
ApoMb concentration and varying C 153 concentrations (0.2-4.0 p,M) were injected. Since 
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the ApoMb concentration used is about at least one order of magnitude higher than that of C 
153, we assume that the binding between ApoMb and C 153 is 1:1. 
RFU 
1.45 nM C153/11.4 (xM ApoMb" 
1.45 nM C153 
/•Vf f1* 
^ 
0 time (mimtes) 5.0 
Figure 2. Electropherograms obtained using the frontal analysis CE method with coumarin-
apomyoglobin. Experimental conditions: pressure injection at 0.5 psi for 40 s; separation voltage, 10 
KV; LIE detector with excitation at 488 nm and emission at 520 nm; 0.2 M Na- phosphate buffer at 
pH 9.0. 
Three individual experiments were carried out, and duplicate data were collected for each set 
of experiments. The calculated binding constant between C 153 and ApoMb is 7.7 x 104 M"1 
(STD, 0.011; RSD, 14.30%). This final result is based on the average of three individual 
experiments, and each experiment was done at different ApoMb concentrations (results 
shown in Figure 3 and Table 2). 
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5.2.2.2. Effect of injection time 
In CE, injection time is directly related to the injection volume. When the injection is small, 
the drug will be eluted as a normal CE peak followed by the protein peak. If the injection is 
large enough, the release of bound drug from the protein forms a plateau region. Therefore, 
the unbound drug concentration can be determined from the height of the plateau region. 
According to this principle, different injection times (in the range of 5 s to 60 s) were 
investigated with a sample solution that remained constant (1.6 pg/ml C 153 in 8.1 JJ.M 
ApoMb). 
0.3 
L. 
0 1 2 3 
[C153]f |j,M 
Figure 3. Plot of {r/(l-r)} against free coumarin, where r is the fraction of C153 bound per ApoMb. 
The slope of a linear fit to the experimental data points gives the binding constant (Kb) of CI 53 in the 
complex. (The value of Kb obtained from this figure is 8.6 x 104M '.) 
Figure 4 shows the effect of injection time on the migration profile. When the injection time 
is short, C153 is well separated from ApoMb. Only the C 153 peak was observed in this case, 
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Table 2. Repeatability of FA-CE method for the determination of binding constants between C 153 
and ApoMb. Abbreviation: Kb_ binding constant; Kd, dissociation constant. 
Results ApoMb concentration (jaM) Kd (pM) 
I 8.5 8.6 x 10* 11.6 
II 10.5 6.5 x 10* 15.4 
III 11.4 8.0 x 10^ 12.5 
Avg. 7.7 x 10^ 13.2 
10 s 
50 s 60s 
20 s 
35 s 40 s 
25 s 15 s 
Figure 4. The effect of injection time on migration profile of C 153-ApoMb mixed solution (1.6 
p,g/ml C 153 in 8.1 p.M ApoMb). Capillary: 50 x 30 (20) cm; running buffer: 0.2 M sodium 
phosphate buffer at pH 9.0; 10 KV; injection time: 5 s to 60 s. 
because ApoMb does not have strong fluorophores, therefore, it cannot be detected using a 
fluorescence detector. However, with an increase in the injection time, the CI53-ApoMb 
complex peak started to show up, and then produced a very strong signal when the injection 
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time was increased to 30 s. Further study of the fluorescence spectra explains this 
phenomenon. Figure 5 gives fluorescence spectra of C 153 both in neat water and in the 
presence of ApoMb. The fluorescence intensity of C 153 greatly increases (about three 
times) when the C 153 forms equilibrium complex with ApoMb. When the injection time is 
short, no complex is formed because coumarin 153 and ApoMb are well separated. 
Therefore, no signal was observed from ApoMb. With an increase in the injection time, the 
coumarin 153 zone and the ApoMb zone overlap, therefore, the ApoMb signal due to 
complexation appeared. In addition, when the injection time is above 35 s, a zonal profile 
with an obvious plateau appears. Further increasing the injection time hardly changes the 
peak height. Therefore, an injection time of 40 s was chosen for all the experiments. 
Figure 5. Fluorescence spectra of coumarin 153 in neat water (a) and in the presence of ApoMb (b). 
Excitation wavelength is 488 nm. 
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5.3. Binding constant study between BP-tetrols and Anti-PAH MAb 
Antibody-antigen complexation is believed to be one of the most specific biological events. 
The two pairs of chiral diastereoisomers tested are derived from benzo(a) pyrene (BP), 
namely (+) r-7,t-8,t-9,t-10-tetrahydroxy-7,8,9,10-tetrahydrobenzo(a) pyrene or cis-BP tetrol 
(c-BPT) and (±) r-7,t-8,9,c-10-tetrahydroxy-7,8,9,10-tetrahydrobenzo(a) pyrene or trans-BP 
tetrol (t-BPT) (Figure 6). While BP adduction (through its ultimate mutagenic diol epoxide 
9 
8 
OH 
HO. 
HO1 
OH 
HO/ 
HO1 
(-) cis-BPT °H (-) trans-BPT 
OH 
HO; 
HO 
OH 
HO; 
HO 
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Figure 6. Molecular structures of benzo(a)pyrene (BP), (+) r-7,t-8,t-9,t-10-tetrahydroxy-7,8,9,10-
tetrahydrobenzo(a) pyrene (cis-BPT) and (±)r-7,t-8,9,c-10-tetrahydroxy-7,8,9,10-tetrahydrobenzo(a) 
pyrene (trans-BPT). 
12 1 
7 6 5 
Benzo(a)pyrene (BP) 
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form, BPDE) to p53 tumor suppressor gene is claimed to be one of the reasons for the 
induction of certain types of chemically induced lung cancer [14, 15], BP tetrols are the final 
hydrolytic products of so formed BP-derived DNA adducts [16]. An anti-PAH monoclonal 
antibody (MAb) was used in this study, which cross-reacts with a number of polycyclic 
aromatic hydrocarbons (PAH), i.e. pyrene and benzo(a)pyrene. 
(-) c-BPT (+) c-BPT 
(-) f-BPT (+) f-BPT 
374 376 378 380 374 376 378 380 
Figure 7. High-resolution fluorescence spectra of free diastereomeric and immunocomplexed BP-
tetrols. Xexc=363.0nm, T = 4.2K, 40 ns delayed detection. Broken and solid lines represent spectra of 
free and immunocomplexed ligands, respectively. Frame A: (-) c-BPT, Frame B: (+) c-BPT, Frame 
C: (-) Z-BPT, Frame D: (+) f-BPT. 
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Figure 7 shows the high-resolution fluorescence spectra of free diastereomeric and 
immunocomplexed tetrols. Noticeable spectra changes in the fluorescence line-narrowing 
spectroscopy (FLNS) spectra (due to the shifts and/or alterations in relative intensities of 
vibrational frequencies) were observed for (+) enantiomers of both c-BPT and t-BPT 
complexes (broken line in Figure 7) when compared to the spectra of uncomplexed species 
(solid line in Figure 7) respectively. On the other hand, there were no significant spectra 
changes for (-) enantiomers when incubating with antibody molecules. Overall, upon 
incubation of enantiomeric ligands with anti-PAH MAb, variations in spectral features 
between immunocomplexed species are highly developed, enabling total resolution of the 4 
stereoisomers. In order to correlate the spectral behavior of ligands upon interaction with the 
antibody, binding constants for each ligand-antibody couple were determined using the 
frontal analysis method of capillary electrophoresis. 
5.3.1. Experimental 
5.3.1.1. Apparatus 
Capillary electrophoresis - frontal analysis (FA) experiments were performed on a modular 
capillary electrophoresis system (Crystal 300 series, Model 310, ATI Unicam, Boston, MA, 
USA) coupled with laser induced fluorescence detector. The detection system consisted of 
CW excitation at 257nm provided by Lexel 95-SHG laser operated at intensity of 100 mW. 
Fluorescence was collected with a reflecting objective (N.A. 0.28), dispersed by a 
monochromator, and detected by an intensified CCD camera. Electropherograms were 
generated by on-line integration of the 320 - 450 nm spectral region in fluorescence emission 
window. Excitation used and spectral region observed enabled simultaneous observation of 
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tetrol fluorescence as well as the native antibody fluorescence using WinSpec/32 software, 
Roper Scientific. UV-transparent capillaries (85 cm x 75 j-im i.d. and 365 jam. o.d.) were 
obtained from Polymicro Technologies with a length of 70 cm (55 cm to the detection 
window). Samples were hydrodynamically injected with 20-mbar for 60 s and separated at 
18 kV (resulting current 140.0 pA) at room temperature (25 0 C). When a capillary was first 
used, it was rinsed for 1 min with water, 5 min with 1 M NaOH, and 1 min with water. Prior 
to each injection, capillary was washed for 2 min with running buffer. 
5.3.1.2. Reagents and Solutions 
Purified Anti-PAH MAb was purchased from Strategic Biosolutions (Newark, DE, USA). 
Methanol (Aldrich, Milwaukee, WI) and glycerol (Spectrum Chemical MFG. Corp., 
Gardena, CA) were used as received. Sodium phosphate, and phosphoric acid were 
purchased from Fisher Scientific (Fair Lawn, NJ) and were used for preparation of a running 
buffer for capillary electrophoresis. The CE running buffer (50 mM Na-phosphate buffer at 
pH 8.8) was filtered through 0.22 pm non-pyrogenic filter (Costar, Corp.Corming, NY). All 
buffers and samples were prepared using water purified by a Milli-Q Water Purification 
System (Millipore). 
Racemic r-7, t-8,t-9,t-10-tetrahydroxy-7,8,9,10-tetrahydrobenzo(a) pyrene (c-BPT) and (±)r-
7,t-8,9,c-10-tetrahydroxy-7,8,9,10-tetrahydrobenzo(a) pyrene (t-BPT) were purchased from 
Midwest Research Institute, NCI Chemical Carcinogen Reference Standard Repository, 
Kansas City, Missouri. Enantiomers were obtained by HPLC separations of racemic 
standards on the 7-cyclodextrin chiral stationary phase (Cyclobond II, 250 x 4.6 mm, Astec, 
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Whippany, NJ, USA). Shimadzu HPLC system coupled with a UV detector (SPD-6A, 
Shimadzu) was used. Detection wavelength was set at 246 nm, which corresponds to the 
absorption maxima of the two compounds. The preparative separation conditions used to 
obtain milligrams of the pure enantiomers of c-BPT and t-BPT are as follows. Racemates 
were dissolved in methanol at a concentration of 32 mg/ml. 10 /zL of each sample were 
injected into a 7-cyclodextrin column and eluted with methanol/water, 20/80 (v/v). The 
enantiomers were collected manually and concentrated under vacuum at 60 °C. The mobile 
phase was degassed before use and the flow rate was 1.0 ml/min. The polarimetric detector 
(Chiralyser, Astec, Whippany, NJ, USA) was used to determine the elution order. The 
wavelength is 430 nm. For both compounds, the (-) enantiomer was eluted first, followed by 
the (+) isomer. 
5.3.2. Results and Discussion 
In the frontal analysis technique, the purified chiral tetrols and the anti-PAH MAb were 
premixed and injected as a large sample plug (20 mbar for 60 s) into the capillary column. At 
pH 8.8, the anti-PAH MAb is negatively charged. The electrophoretic mobility of the free 
tetrol is different from the mobility of the antibody and tetrol-antibody complex. After the 
injection of large mixed sample plug, the free tetrol will migrate away from the antibody. 
Equilibrium is maintained where the zones temporarily overlap. The equilibrium free tetrol 
concentration is calculated from the height of the resulting plateau. The height of the free 
tetrol plateau decreases with the addition of antibody because of the binding of tetrol to the 
antibody. The plateau height at [antibody] = 0 uM was used as the standard. In this assay, a 
series of sample mixtures with a fixed antibody concentration and varying tetrol 
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concentrations are injected. Repeating such experiments at different tetrol concentrations 
allows the determination of binding constant according to the simplified equation: r/(l-r) = 
Kb [Df], where r, fraction of bound drug per protein; [Df], concentration of free drug; Kb, 
binding constant. 
1.6 • (+) t-BPT 
X (+) c-BPT 
a (-) t-BPT 
o (-) c-BPT 
1.2 
0.8 
0.4 
0 
0 0.1 0.2 0.3 
Concentration of free tetrols (gM) 
Figure 8. Plot of {r/(l-r)} against free tetrol, where r is the fraction of tetrol bound per antibody. The 
slope of a linear fit to the experimental data points gives the binding constant (Kb) of tetrol in the 
complex. 
Figure 8 shows the plot of fraction of ligand bound to the antibody vs free tetrol 
concentrations for the series of CE injections of four antibody-ligand mixtures. The binding 
constant for each enantiomer can be calculated from the slope, and the numerical values are 
as follows: K (+) t-BPT = 6.0 x 10 6 M"1, K (-) t-BPT = 6.1 x 10 5 M"1, K (+) c-BPT = 2.4 x 
10 6 M"1 and K (-) c-BPT = 2.1 x 10 5 M"1. The (+)-enantiomers of the diastereomeric tetrols 
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have significantly larger binding constants (about one order of magnitude higher) compared 
to their enantiomeric counterparts. Higher binding constants correspond to noticeable 
spectral differences between free and immunocomplexed (+) species, while lower binding 
constants and the lack of spectral alterations in the case of free and complexed (-) 
enantiomers suggest weaker, external interactions with the protein molecule. Overall, it is 
evident from our data that the interaction of anti-PAH MAb with the optical isomers of cis-
and trans-BP tetrols involves different complex geometries. Therefore, these different ligand-
protein interactions result in different alterations in the vibronic structures of the FLNS 
spectra of these enantiomers. 
5.4. Conclusion 
Capillary electrophoresis-frontal analysis is applicable to the binding constant assay of both 
the apomyoglobin/coumarin 153 and the tetrol/anti-PAH Mab systems. Due to the rapid 
analysis and small injection volumes, the frontal CE method proved to be extremely useful 
for the binding study of plasma proteins since they are not suitable for the long-term 
preservation and large-scale separation. In addition, this method uses more sensitive laser 
induced fluorescence detection. Therefore, it overcame the low sensitivity problem, which 
commonly occurs when using UV detection for drug-protein studies. Also, this work first 
introduced the use of a UV argon laser (excitation at 257 nm) coupled with a CCD camera as 
a detection method for the FA-CE method. The excitation wavelength used and the spectral 
region observed enabled simultaneous observation of drug fluorescences as well as the 
protein fluorescences. 
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CHAPTER 6 
SEPARATION AND CHARACTERIZATION OF UNDERIVATIZED 
OLIGOSACCHARIDES USING LC AND LC-ESI-MS 
A paper submitted to Journal of Chromatography A 
Ying Liu, Daniel W. Armstrong 
Abstract 
Native cyclodextrin-based columns are particularly useful for the analysis of 
oligosaccharides because the retention of these carbohydrates is based mainly on the 
hydrogen bonding interactions of oligosaccharide hydroxyl groups with the stationary phase. 
Thus, the retention time predictably increases with the number of analyte hydroxyl groups, 
which corresponds to the elongation of the oligosaccharide chain. High-performance liquid 
chromatography (HPLC) coupled to electrospray ionization (ESI) mass spectrometry (MS) 
was used for the separation and characterization of underivatized oligosaccharide mixtures. 
With the limits of detection as low as 50 picograms, all individual components of 
oligosaccharide mixtures (up to 11 glucose-units long) were baseline resolved on a 
Cyclobond I 2000 column and detected using ESI-MS. Low flow rates and narrow ID 
columns increase the ESI-MS sensitivity significantly. The method showed potential 
usefulness for the sensitive and quick analysis of hydrolysis products of polysaccharides, and 
for trace levels of individual oligosaccharides or oligosaccharide isomers from biological 
systems. 
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6.1 Introduction 
The separation and characterization of underivatized oligosaccharides have continued to gain 
attention in recent years due to their ubiquity in nature and their significant roles and uses in 
industry, consumer products and biology where they are crucial for the development, growth, 
function or survival of an organism [1,2]. Identification of the carbohydrate substituents on 
glycoproteins and glycopeptides (which affect or control their function) is an important and 
often difficult endeavor [3,4]. A variety of chromatographic methods have been used to 
separate saccharides and oligosaccharides. They include ligand exchange chromatography 
[5,6]; chromatography based on size exclusion [7-9], and widely used hydrophilic 
chromatography on silica-based bonded polar stationary phases [10-12], Often the 
separations of underivatized carbohydrates require specific types of columns such as 
alkylated silica bonded phases [13-15], amino-bonded stationary phases [12, 16-18] or 
various ion-exchange media [19-22] in which specific counter ions are added to affect the 
separations. However, most of the columns have problems, particularly in terms of column 
stability, lifetime and separation reproducibility. Stable cyclodextrin bonded stationary phase 
columns were first introduced for oligosaccharide analysis by Armstrong and Jin [23] in 
1989. It has been shown that these native cyclodextrin bonded columns are particularly 
useful for the analysis of oligosaccharides [23-25]. In this paper, a native beta-cyclodextrin 
stationary phase (Cyclobond I 2000) was used to separate a variety of related 
oligosaccharides using MS compatible mobile phases. The retention of oligosaccharides in 
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high acetonitrile-containing mobile phases on cyclodextrin-bonded phases is based on the 
hydrogen bonding interactions between the oligosaccharide hydroxyl groups and the 
cyclodextrin hydroxyl groups that constitute part of the stationary phase. In this separation 
approach, the retention time predictably increases with the number of the hydroxyl groups 
possessed by the saccharide or oligosaccharide. Hence, longer/larger 
saccharides/oligosaccharides tend to be retained more than shorter/smaller ones. In addition, 
cyclodextrin-based stationary phases are stable, have good efficiency and good 
reproducibility, and do not react with reducing sugars/carbohydrates as do amine-type 
bonded stationary phases. Consequently, they are very good for quantitative analysis. 
Several LC detection methods have been used for carbohydrate analysis. Oligosaccharides 
have been labeled with a wide variety of derivatization reagents in order to enhance 
detectability during chromatographic analysis [26-29], However, most derivatization 
techniques require tedious procedures, and often suffer from poor reproducibility. Therefore, 
detection of underivatized oligosaccharides remains extremely important. 
Although underivatized oligosaccharides do not have strong chromophores, they are still 
detectable by UV absorption at low wavelengths, e.g., 195 ran, with detection limits in the 
microgram range [23]. Refractive index (RI) detection was frequently used with slightly 
higher sensitivity compared to UV detection. The limits of detection by RI have been 
reported to below 25 nanograms [30]. However, this detector has a major disadvantage, 
namely, that the signal is related to the solvent composition, which prevents the use of 
gradient elution. Also even greater sensitivity is desirable. Evaporative light scattering 
171 
detection (ELSD) is another preferred universal detector for carbohydrate analysis [31,32] 
because its response is independent of the spectral properties of the analyte and solvent. 
Therefore, ELSD is compatible with the solvent variations and it produces stable baselines. 
However, the non-linear response of ELSD limits the detector's use for high-accuracy 
quantitative analysis [33]. 
Recently, mass spectrometry has gained increasing importance as a detection method for 
oligosaccharide analysis and characterization. So far, several mass spectrometric techniques 
have been used for the determination of oligosaccharide structure. They are matrix-assisted 
laser desorption/ionization (MALDI) [34-37], fast-atom bombardment (FAB) [38,39], and 
electrospray ionization (ESI) mass spectrometry [40-43]. All of aforementioned MS 
techniques have an advantage over chemical or chromatographic methods in that they yield 
molecular mass information with relatively high sensitivity. Coupled mass spectrometry -
HPLC became the most widely used technique in proteomics and is now beginning to make 
an impact on the analysis of complex carbohydrates in many fields of biotechnology [44-47], 
However, the ionization and sensitive detection of carbohydrates via this approach is not as 
facile as it has been for proteins and peptides. So far, ESI-MS is known as one of the most 
suitable interfacing techniques for online LC/MS. 
Online-LC-ESI-MS analyses of underivatized oligosaccharides have so far been performed 
using graphitized carbon chromatography (GCC) [48], and a nanoscale amide-80 column 
[43]. We applied a native beta-cyclodextrin stationary phase to the online LC-ESI-MS 
analysis of a variety of underivatized oligosaccharides. This system is characterized by high 
172 
chromatographic resolution, high column stability, and low mass spectrometric detection 
limit at picogram (femtomole) sensitivity. In addition, this method showed potential 
usefulness for the sensitive and quick analysis of hydrolysis products of polysaccharides, and 
individual oligosaccharides from biological systems. 
6.2 Experimental 
Chemicals and reagents 
HPLC grade acetonitrile and water was purchased from Fisher (Pittsburgh, PA, USA), formic 
acid from J.T. Baker (Philipsburg, NJ, USA). Cellooligosaccharides, maltooligosaccharides, 
dextran, and all other underivatized oligosaccharides were all purchased from Sigma. Most of 
the oligosaccharides were dissolved in water at 1 mg/ml, and then further diluted before 
injection. 
Chromatography 
Three Cyclobond I 2000 columns with different IDs (250 x 4.6 mm i.d.; 250 x 2.0 mm i.d.; 
and 250 x 1.0 mm i.d.) were from Advanced Separation Technology (Astec, Whippany, NJ, 
USA). Most separations were performed at room temperature on the 250 x 4.6 mm ID 
Cyclobond 12000 column. Mobile phase compositions were acetonitrile-0.1 % formic acid in 
water at varying concentrations. Flow rates varied from 100 to 800 pi min"1 and 195 nm was 
used for UV detection. 
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Mass Spectrometry 
ESI Conditions for Shimadzu LCMS-2010 
Most LC-MS experiments were performed on a Shimadzu LCMS-2010 coupled with an 
electrospray (ESI) ion source. The single stage quadruple mass spectrometer provides an 
upper mass unit limit of 2000 dations and unit mass resolution. 
Nebulizer gas flow was 4.50 L/min and MS parameters were optimized to the following: 
probe bias = 4.5 KV, CDL = 25.0 V, aperture = 0 V, CDL temperature = 250 ° C, and block 
temperature was 200 0 C. 
ESI conditions for Thermo Finnigan LCQ Advantage MS 
The effect of column IDs on sensitivity experiments were performed on a Thermo Finnigan 
(San Jose, CA, USA) Surveyor LC system coupled to a Thermo Finnigan LCQ advantage 
API ion-trap mass spectrometer with ESI ion source. 
Sheath and auxiliary gases were at 50 and 40 arbitrary units, respectively. MS parameters 
were optimized to the following: source voltage = 4.5 kV, capillary voltage = 25.00 V, tube 
lens offset = 0.0 V and capillary temperature = 250 ° C. 
174 
6.3. Results and discussion 
6.3.1 LC-ESI-MS of underivatized oligosaccharide mixtures on the Cyclobond I 2000 
column 
It is well known that mass spectrometry is one of the most sensitive LC detection methods 
for many ionizable organic compounds, especially those with a poor UV-absorptivity. In this 
paper, cyclodextrin based LC-ESI-MS was examined as a way to rapidly separate and 
characterize underivatized oligosaccharides using a MS-compatible mobile phase. 
Figure 1 shows the mass spectra of sodium adduct peaks observed in the ESI positive ion 
mode for standards of different oligosaccharides (initial test analytes). Cello-oligosaccharide 
and malto-oligosaccharide with the same degree of polymerization (d.p.), or the same 
number of glucose units, have similar mass spectra (results not shown). Figure 2 shows the 
LC-ESI-MS separation of an underivatized cello-oligosaccharide standard mixture (d.p 2-7) 
using selected ion chromatography. The retention of cello-oligosaccharides increases with 
the elongation of the dextran chain, because the retention of the oligosaccharides on 
cyclodextrin bonded phases are based on the hydrogen bonding interactions of 
oligosaccharide hydroxyl groups with those of the stationary phase. In general, the more 
hydroxyl groups the oligosaccharide has, the greater the number of hydrogen bonding 
interactions with the stationary phase and the longer is the retention. Within a homologous 
series, this allows the prediction of elution positions in terms of the number of the analyte's 
constituent monosaccharide units. 
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Figure 1. Mass spectra of sodium adduct peaks observed in ESI positive ion mode for each 
underivatized oligosaccharide. 
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Figure 2. LC-ESI-MS of underivatized cellooligosaccharide standard mixture (d.p. 2-7). Selected ion 
chromatography at [M+Na]+. Column: Cyclobond 12000 column (250 x 4.6 mm ID), flow rate at 400 
p.l/min. Mobile phase: 65:35 acetonitrile-water (0.1 % formic acid) 
6.3.2 LC-ESI-MS separation of disaccharides 
The separation of structural isomers in mixtures of oligosaccharides is frequently not easy. 
Cellobiose, maltose, lactose, and sucrose are all disaccharides with the same molecular 
weight of 342, and they all gave the same 365 m/z peak ([M+Na]+ MS response) in the ESI 
positive ion mode. Therefore, it was not possible to identify each disaccharide from the 
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mixture simply using mass spectrometry. Figure 3 shows the LC-ESI-MS separation of 
mixtures of the four isomeric disaccharides. Three peaks were 
Int. 
12.5e6~ 
7500e3" 
10.0 20.0 30.0 min 
Int 
500e3 
300e3 
100e3 
10 20 30 40 min 
Figure 3. LC-ESI-MS of disaccharide separation. 
(a) Total ion chromatography. Scanned from m/z 200 to 500. 
(b) Selected ion chromatography at 365, [M+Na]T 
Under both conditions, peaks from left to right correspond sucrose, a mixture of cellobiose and 
maltose, and lactose, respectively. 
Column: Cyclobond I 2000 column (250 x 4.6 mm ID), flow rate at 400 pd/min. Mobile phase is 
80:20 acetonitrile-water (0.1 % formic acid). 
observed. By spiking pure standards, it was found that cellobiose could be separated from 
sucrose and lactose, but could not be separated from maltose. Sucrose has the shortest 
retention time because it has the smallest size due to the combination of six-member ring 
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(glucose) and five-member ring (fructose), while lactose has the longest retention time. 
Cellobiose and maltose are both composed of two glucose units and differ only in the type of 
linkage. Cellobiose is connected by a beta (1,4) glycosidic linkage, while maltose has an 
alpha (1,4) glycosidic linkage. It seems that the native cyclodextrin column can only 
differentiate the position of hydroxyl groups, but can not differentiate the type of linkage. 
Similar results were also obtained for mixtures of maltotriose and cellotriose, mixtures of 
maltotetraose and cellotetraose, etc. Separation of compounds with identical molecular 
weights and numbers of hydroxyl groups can be accomplished by cyclodextrin based 
stationary phases provided each compound has different numbers of hydroxyl groups 
available for simultaneous interactions with the stationary phase. This can occur for 
geometrical reasons since different saccharides with the same number of hydroxyl groups can 
have different ring sizes, configurations and stereochemistry. 
6.3.3. Effect of acetonitrile concentration on capacity factor 
The concentration of organic modifier in the mobile phase controls the retention and 
selectivity of oligosaccharides on cyclodextrin columns. Unlike traditional reversed-phase 
LC, the retention of each underivatized oligosaccharide increases when acetonitrile 
concentration increases from 50 % to 90 %, as shown as in Figure 4. This is because the 
retention of oligosaccharides on cyclodextrin columns is based on the hydrogen bonding 
interactions between the oligosaccharide hydroxyl groups and the stationary phase. A high 
percentage of acetonitrile (a poor hydrogen bonding solvent) accentuates hydrogen-bonding 
interactions between the analyte and the stationary phase. With higher percentages of water 
in the mobile phase, the hydroxyl groups of the oligosaccharides are preferentially solvated 
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by the water in the mobile phase, thus, diminishing hydrogen bonding interactions between 
the oligosaccharide and the stationary phase, resulting in shorter retention times. In addition, 
better solubility in water (of the mobile phase) also shortens retention times. Finally, the 
retention/solvent effect is always greater for longer disaccharides compared with their 
smaller analogues as seen by the steeper slopes in Figure 4. This retention behavior is 
analogous to that reported for sugars on alkylamine, polyol and diol columns. 
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Figure 4. Effect of acetonitrile concentration on capacity factor. 
Experimental conditions: Cyclobond 12000 column (4.6 mm ID, 25 cm), UV detection at 195 nm, 
sample concentration for each oligosaccharide is 10 mg/mL, injection volume is 10 ju.1. 
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Figure 5. Effect of additive on sensitivity for maltotriose. Column: Cyclobond 12000 column (250 x 
4.6 mm ID). Mobile phase: 60:40 acetonitrile-water (0.1 % formic acid). Flow rate: 400 pi/min. MS: 
ESI positive SIM at [M+Na]+, 527. 
6.3.4. Effect of additives on sensitivity 
The effect of acidic additives on MS detection sensitivity was investigated, as shown in 
Figure 5. The addition of small amount of acidic additives to the mobile phase greatly 
increased MS sensitivity in the positive ion mode (to over ten times that without the 
additive). The addition of either formic acid or acetic acid produces a similar enhancement 
in sensitivity. The concentration of the additives does not have a significant effect on 
sensitivity since the role of the additive is to aid in ionization in ESI-MS techniques. 
Therefore, all the experiments were performed with the addition of an acidic additive for 
enhanced sensitivity. 
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6.3.5. Effect of flow rates on sensitivity 
The effect of flow rates on the detection sensitivity of maltotriose was investigated using the 
Cyclobond I 2000 column (25 cm x 4.6 mm ID). The flow rate was varied from 200 pl/min 
to 800 jal/min. As seen in Figure 6, the sensitivity at 200 |al/min is about 5 times higher than 
that found at 400 p.l/min, and about 20 times higher than that found at 800 p,l/min. This 
observed behavior has been discussed previously [49-52], A lower flow rate 
o 800 ul/min 
o 400 ul/min 
A 200 ul/min 
1.00E+07 -
< 
« 
Q. 
5.00E+06 
0 0.5 1 1.5 2 2.5 
Concentration (|aM) 
Figure 6. Effect of flow rate on sensitivity for maltotriose. Mobile phase: 60:40 ACN-water (0.1 % 
formic acid). Column: Cyclobond 12000 (250 x 4.6 mm ID). MS: ESI positive SIM at [M+Na]+, 527. 
is known to reduce the size of the charged droplets initially produced in the electrospraying 
process. These smaller initial droplets require fewer droplet fission events and less solvent 
evaporation prior to ion release into the gas phase. Thus, lower flow rates, especially with 
water-acetonitrile mobile phases, favor higher sensitivity in LC-ESI-MS. 
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Figure 7. Effect of column IDs on sensitivity for maltotriose. Column: Cyclobond 12000 column 
(250 x 4.6 mm ID). Mobile phase: 60:40 acetonitrile-water (0.1 % formic acid). Flow rate: 100 
pl/min. MS: ESI positive SIM at [M+Na]+, 527. 
6.3.6. Effect of column internal diameters (IDs) on sensitivity 
The effect of column ID on sensitivity of maltotriose was also investigated. The experiments 
were performed on three different 25 cm long analytical columns with inner diameters of 1.0 
mm, 2.0 mm, and 4.6 mm, respectively. As is known, columns of different sizes need 
different optimized experimental parameters to produce the optimum MS sensitivity. 
However, in order to simplify the experiment, all the LC and MS conditions were kept 
consistent for each individual column in this assay. For better comparison, a flow rate of 100 
(0,1/min was used in order to obtain an acceptable backpressure when using the small ID 
column. As seen in Figure 7, under the experimental conditions selected, the sensitivity on 
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the 2 mm ID column is about two times higher than that on the traditional ID column (4.6 
mm ID), while the sensitivity on the 1 mm ID column is about five times higher compared to 
that found with the traditional ID column. Although each separation was not individually 
optimized, these experiments demonstrate the general trend that a smaller inner diameter 
column produces an increase in sensitivity over the conventional ID columns due to the 
relatively increased sample concentration at the detector. 
Under microbore LC conditions, the flow rate is reduced by a factor of 4, from 400 pi to 100 
pi per minute. This reduction brings an increase in MS sensitivity of up to eight -fold (results 
not shown). Compared to the traditional ID column, the total gain in sensitivity using on-line 
LC-ESI-MS can be as high as forty times. The present data indicate that lower flow rates and 
narrow ID columns favor high ESI-MS sensitivity for these oligosaccharide analyses. 
6.3.7. Limits of detection compared to UV 
The limits of detection (LOD) for UV (at 195 nm) were compared with those for ESI-SIM-
MS for selected underivatized oligosaccharides (Table 1) on the traditional size analytical 
Cyclobond 12000 column (250 x 4.6 mm ID). The LC conditions were kept constant for both 
detection systems for each individual oligosaccharide. In most cases, the LOD using ESI-MS 
detection is about 3 or 4 orders magnitude lower than that for UV detection. In MS 
detection, maltotriose had the lowest detection limit (50 picograms), while the detection 
limits became higher with further elongation of the oligosaccharide chain. The relatively 
higher detection limit of maltose (5 nanograms) may partially be due to the high MS 
background that occurs when m/z is below 500. 
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Table 1. Comparison of detection limits of ESI-MS vs UV. 
Sample 
Detection Limits' 
UV/visible2 MSJ 
Maltose 5 pg, S/N = 4 5 ng, S/N = 3 
Maltotriose 1 pg, S/N = 3 50 pg, S/N = 4 
Maltotetraose 5 pg, S/N = 3 250 pg, S/N = 3 
Maltopentaose 10 pg, S/N = 3 500 pg, S/N = 4 
1 Detection limit experiments were done on the Cyclobond 12000 column (4.6 mm ID, 25 cm), 
mobile phase composition 60: 40 ACN: H20, 0.1 % formic acid was added to water for ESI-MS. 
2 Detection at 195 nm. Flow rate at 1.0 ml/min. 
3 ESI-MS SIM at [M+Na]+ for each underivatized oligosaccharide. Flow rate at 400 pl/min. 
6.3.8. LC-ESI-MS of hydrolysis products of dextrin 
Fifty milligrams of dextran were treated in 1 ml of 0.1 M trifluoacetic acid for 16 hrs at room 
temperature, and the hydrolysis products were analyzed using online LC-ESI-MS (Figure 8). 
All oligosaccharides (up to 11 glucose units in the mixture) were separated and identified. 
With this simple dextran "ladder", all of the elution positions in terms of the number of 
glucose units are fixed and easily determined. The hydrolysis product of mannan was also 
analyzed using this method. Mannan digestion products were prepared by incubating mannan 
in 0.5 M hydrochloride acid in a microwave oven (1.1 kV) for 30 seconds. Figure 9 shows 
the LC-ESI-MS of mannan digest separated on the Cyclobond I 2000 column. Up to eight 
mannose units of the oligosaccharide mixture were observed. Clearly, this method is very 
suitable for most low to moderate molecular weight oligosaccharide mixtures produced by 
digestion of polysaccharides. 
185 
400e3 
200e3_ 
(b) SIM Chromatography 
glucose 
m/z 365 
m/z 527 
d.p. 1, 2 
m/z 689 
m/z 851 
m/z 1013 
m/z 1175 
m/z 1337 
m/z 1499 
d.p. 10 
m/z 1823 , dp 11 
5.0 10.0 15.0 20.0 
min 
25.0 30.0 35.0 
Figure 8. LC-ESI-MS of dextran "ladder" on Cyclobond I 2000 column (250 x 4.6 mm ID) 
(a) LC-ESI-MS of underivatized malto-oligosaccharide standard mixture (d.p. 2-7). 
(b) LC-ESI-MS of hydrolysis product of dextran. Experimental conditions: selected ion 
chromatography at [M+Na]+; 65:35 acetonitrile-water (0.1 % formic acid) mobile phase; flow rate at 
400 pl/min. 
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Figure 9. LC-ESI-MS of mannan digest on Cyclobond 12000 column (250 x 4.6 mm ID) 
Mannan was prepared by incubating mannan in 0.5 M hydrochloride acid in a microwave 
oven (1.1 kV) for 30 s. Mobile phase composition: 65:35 acetonitrile-water (0.1 % formic 
acid). ESI SIM mode, flow rate at 0.4 ml/min. 
6.4. Conclusions 
Native beta cyclodextrin stationary phases have proven to be particularly useful for the 
analysis of oligosaccharides because the retention of these carbohydrates is based on the 
hydrogen bonding interactions of the oligosaccharide hydroxyl groups with those of the 
stationary phases. Thus, the retention time predictably increases with the elongation of 
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oligosaccharide chain. This system is characterized by its selectivity, which also allows the 
separation of certain isomers, e.g., of some disaccharides. HPLC coupled with MS was 
shown to be a viable alternative to traditional detection techniques for the separation and 
characterization of underivatized oligosaccharides. The limits of detection can go down to as 
low as picogram levels for ESI-MS, which are orders of magnitude lower than low 
wavelength UV detection. The use of low flow rates and narrow bore columns can further 
enhance ESI-MS sensitivity. All individual components of oligosaccharide mixtures (up to 
11 glucose units long) can be successfully separated using this method in less than 30 
minutes. The method showed potential usefulness for the sensitive and quick analysis of 
hydrolysis products of polysaccharides, and individual oligosaccharides from biological 
systems as well. 
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CHAPTER 7 
GENERAL CONCLUSIONS 
The research outlined in Chapter 2 of this dissertation demonstrates an in-depth evaluation of 
the enantiomeric separation capabilities of macrocyclic glycopeptides CSPs with SFC mobile 
phases by using a set of over 100 chiral compounds. It was found that the macrocyclic based 
CSPs were able to separate enantiomers of widely different compounds with various 
functionalities and polarities, such as heterocycles, analgesics (nonsteroidal anti­
inflammatory compounds), (3-blockers, sulfoxides, N-protected amino acids and native amino 
acids. Seventy percent of all separations were achieved in less than 4 min due to the high 
flow rate (4.0 ml/min) that can be used in SFC. 
The research described in Chapter 3 gives an example of a successful enantiomeric 
separation of a series of unique chiral compounds, substituted dihydrofurocoumarins and 
related derivatives using macrocyclic antibiotic-based CSPs. The factors that influenced 
enantioseparations were: organic modifier concentration, temperature and pressure, all of 
which were investigated in detail. In this work, bulky groups that cause steric repulsion are 
found to be important for chiral recognition. The increase in steric bulk on the stereogenic 
center or on the carbon alpha to it enhanced the enantiomeric separation. However, chiral 
recognition was affected differently if the bulky substituent is further from the stereogenic 
center. 
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We can conclude, from the results in Chapters 2 and 3, that the teicoplanin aglycone and 
teicoplanin CSPs seem to be the most effective chiral stationary phases when used with SFC 
mobile phases. The two major advantages of packed column SFC (pSFC) are fast separation 
speed (high flow rate that can be used in the SFC) and good compatibility with preparative 
mode (less solvent used, which makes solute recovery and solvent disposal easy). pSFC with 
macrocyclic glycopeptides based CSPs shows a great potential to become a promising chiral 
separation technique that will be used increasingly in industrial applications. 
Capillary electrophoresis (CE) is an alternative and complementary enantiomeric separation 
technique. The CE enantiomeric separations of chiral substituted dihydrofurocoumarin 
derivatives extended the applications of chiral separations in CE. In this assay, we proposed 
four different chiral separation methods using CE and micellar capillary electrophoresis 
(MCE). The best separation was obtained in the reversed polarity mode with sulfated-(3-
cyclodextrin as the chiral selector. MCE can also be used to separate these neutral 
dihydrofurocoumarin derivatives. In MCE, the addition of micelles (SDS) provides an 
anionic pseudophase in the running buffer, and thus permits the use of an uncharged 
cyclodextrin as the chiral selector. The presence of micelles increases the solubility of the 
hydrophobic coumarin derivatives in the run buffer. However, this method suffers from 
longer separation times. Overall, sulfated-13-cyclodextrin is the best chiral selector for this 
class of chiral compounds, but the MCE method produced good efficiencies. 
Chapter 5 expanded the applications of CE as a very useful analytical tool for examining the 
nature and strength of biological interactions between drugs and proteins. Frontal analysis 
(FA) method has been used to evaluate analyte binding behavior in two sample systems. Our 
results matched those obtained previously, in which a Job's plot spectroscopy method was 
used (Apomyoglobin/coumarin 153 system). In the second system, our results better 
explained and supported the FLNS spectroscopic phenomena observed for a chiral 
benzo(a)pyrenes tetrols/Anti-PAH MAb system. In addition, the more sensitive fluorescent 
detection induced by a UV argon laser greatly enhanced the capabilities of this method for a 
wide variety of drug-protein systems. 
The last part of this dissertation (Chapter 6) demonstrates a successful separation and 
characterization of underivatized oligosaccharides using LC and LC-ESI-MS. Native beta 
cyclodextrin stationary phases have been used in this assay because the retention of these 
carbohydrates is based on the hydrogen bonding interactions of the oligosaccharide hydroxyl 
groups with those of the stationary phases. Thus, the retention predictably increases with the 
elongation of the oligosaccharide chain. This system is characterized by high 
chromatographic resolution, high column stability, and low mass spectrometric detection 
limits at picogram (femtomole) sensitivity. In addition, this method shows potential 
usefulness for the sensitive and quick analysis of hydrolysis products of polysaccharides, and 
individual oligosaccharides from biological systems. Separation of certain isomers can also 
be achieved using this assay. 
194 
ACKNOWLEDGEMENTS 
As I finished my dissertation, I felt there were so many people that I would like to thank. 
Here, I just name some of them who have paved the path toward the pursuit of my Ph.D. 
degree. 
First of all, it has been my great honor to do my Ph.D. study under the guidance and 
supervision of my major professor, Dr. Daniel W. Armstrong, a brilliant scientist and a great 
mentor. His scientific intelligence and attitude toward science greatly influenced me and 
stimulated my interest in science and technology. It is his inspiration and encouragement that 
made my graduate study here at Iowa State unforgettable and worthwhile. 
Secondly, my sincere thanks go to my POS committee members, Prof. Robert S. Houk, Prof. 
Victor Shang-Yi Lin. Prof. Jacob W. Petrich, and Prof. Bonita A. Glatz for their time and 
support. 
Thirdly, my appreciation goes to all of our collaborators during my research, Prof. Larock's 
research group, Prof. Jenks' research group, Prof. Petrich's research group, Prof. Verkade's 
research group, and Prof. Small's research group at Iowa State University for their work and 
collaborations. In addition, I would like to thank Dr. Alain Berthod, a visiting professor from 
University of Lyon 1, France, for his help and enlightening discussions involving my 
research. I would also thank all of Professor Armstrong's group members who provided help 
and collaborations. I really enjoyed working as a part of this great team. 
Finally, I would especially like to thank my husband, Yu Ding, for his support. 
The financial support from Iowa State University for this work is greatly appreciated. 
